This is the Continuous Integration Build of FHIR (will be incorrect/inconsistent at times).
See the Directory of published versions
Orders and Observations Work Group | Maturity Level: 1 | Draft | Use Context: Country: World, Not Intended for Production use |
Official URL: http://hl7.org/fhir/ValueSet/observation-codes
|
Version: 6.0.0-ballot2 | |||
draft as of 2024-12-06 | Computable Name: LOINCCodes | |||
Flags: Experimental | OID: 2.16.840.1.113883.4.642.3.396 |
This value set is used in the following places:
This value set includes all LOINC codes
Generated Narrative: ValueSet observation-codes
Last updated: 2024-12-06T22:01:38.605Z
Profile: Shareable ValueSet
http://loinc.org
This expansion generated 06 Dec 2024
Generated Narrative: ValueSet
Last updated: 2024-09-26T14:04:25.528Z
Profile: Shareable ValueSet
Expansion based on Loinc v2.78
This value set has >1000 codes in it. In order to keep the publication size manageable, only a selection (1000 codes) of the whole set of codes is shown
Code | System | Display |
100000-9 | http://loinc.org | Health informatics pioneer and the father of LOINC |
100001-7 | http://loinc.org | Health informatics pioneer and cofounder of LOINC |
100002-5 | http://loinc.org | Specimen care is maintained |
100003-3 | http://loinc.org | Team communication is maintained throughout care |
100004-1 | http://loinc.org | Demonstrates knowledge of the expected psychosocial responses to the procedure |
100005-8 | http://loinc.org | Demonstrates knowledge of nutritional management related to the procedure |
100006-6 | http://loinc.org | Demonstrates knowledge of medication management |
100007-4 | http://loinc.org | Demonstrates knowledge of pain management |
10000-8 | http://loinc.org | R wave duration in lead AVR |
100008-2 | http://loinc.org | Demonstrates knowledge of wound management |
100009-0 | http://loinc.org | Demonstrates knowledge of the procedure and expected results |
100010-8 | http://loinc.org | No injury related to procedure equipment, medical supplies, or instrumentation |
100011-6 | http://loinc.org | No injury related to an electrical source |
100012-4 | http://loinc.org | Participates in decisions affecting the patient's plan of care |
100013-2 | http://loinc.org | Participates in the discharge process |
100014-0 | http://loinc.org | Psychosocial health is maintained at or improved from baseline |
100015-7 | http://loinc.org | No injury related to positioning due to care or procedure |
10001-6 | http://loinc.org | R wave duration in lead I |
100016-5 | http://loinc.org | No injury related to a laser source |
100017-3 | http://loinc.org | Perioperative nursing data set outcomes panel [PNDS] |
100018-1 | http://loinc.org | Hospice care Note |
100019-9 | http://loinc.org | ALK gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
100020-7 | http://loinc.org | GNA11 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
100021-5 | http://loinc.org | GNAQ gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
100022-3 | http://loinc.org | IDH1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
100023-1 | http://loinc.org | IDH2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
10002-4 | http://loinc.org | R wave duration in lead II |
100024-9 | http://loinc.org | SETBP1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
100025-6 | http://loinc.org | SRSF2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
100026-4 | http://loinc.org | MET gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
100027-2 | http://loinc.org | SMAD4 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
100028-0 | http://loinc.org | FBXW7 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
100029-8 | http://loinc.org | Cancer related multigene analysis in Plasma cell-free DNA by Molecular genetics method |
100030-6 | http://loinc.org | Axis I: Temporal aspects score [Mainz Pain Staging System] |
100031-4 | http://loinc.org | Axis II: Spatial aspects score [Mainz Pain Staging System] |
10003-2 | http://loinc.org | R wave duration in lead III |
100032-2 | http://loinc.org | Axis III: Drug taking behavior score [Mainz Pain Staging System] |
100033-0 | http://loinc.org | Axis IV: Utilization of the health care system score [Mainz Pain Staging System] |
100034-8 | http://loinc.org | Provider of automated external defibrillator use |
100035-5 | http://loinc.org | Exam finding location of Chest |
100036-3 | http://loinc.org | Exam finding location of Lung |
100037-1 | http://loinc.org | Patient contact disposition EMS unit |
100038-9 | http://loinc.org | Patient evaluation disposition EMS unit |
100039-7 | http://loinc.org | Crew disposition for patient care EMS unit |
10004-0 | http://loinc.org | R wave duration in lead V1 |
100040-5 | http://loinc.org | Patient transport disposition EMS unit |
100041-3 | http://loinc.org | Aminoglycoside [Susceptibility] |
100042-1 | http://loinc.org | Atovaquone [Susceptibility] |
100043-9 | http://loinc.org | Azithromycin+Ethambutol [Susceptibility] |
100044-7 | http://loinc.org | Cefcapene [Susceptibility] |
100045-4 | http://loinc.org | Cefozopran [Susceptibility] |
100046-2 | http://loinc.org | Cefquinome [Susceptibility] |
100047-0 | http://loinc.org | Cefteram [Susceptibility] |
100048-8 | http://loinc.org | Clarithromycin+Ethambutol [Susceptibility] |
100049-6 | http://loinc.org | Eravacycline [Susceptibility] |
100050-4 | http://loinc.org | Erythromycin+Ethambutol [Susceptibility] |
100051-2 | http://loinc.org | Ethambutol+rifAMPin [Susceptibility] |
100052-0 | http://loinc.org | Flomoxef [Susceptibility] |
100053-8 | http://loinc.org | Fluoroquinolone [Susceptibility] |
100054-6 | http://loinc.org | Gamithromycin [Susceptibility] |
100055-3 | http://loinc.org | Optochin [Susceptibility] |
100056-1 | http://loinc.org | Panipenem [Susceptibility] |
10005-7 | http://loinc.org | R wave duration in lead V2 |
100057-9 | http://loinc.org | Prothionamide [Susceptibility] |
100058-7 | http://loinc.org | Prulifloxacin [Susceptibility] |
100059-5 | http://loinc.org | Rifapentine [Susceptibility] |
100060-3 | http://loinc.org | Tildipirosin [Susceptibility] |
100061-1 | http://loinc.org | Tosufloxacin [Susceptibility] |
100062-9 | http://loinc.org | Standard Dermatology Outcome Measures panel |
100063-7 | http://loinc.org | Primary skin concern |
100064-5 | http://loinc.org | Itch severity Reporting Period - Reported |
10006-5 | http://loinc.org | R wave duration in lead V3 |
100065-2 | http://loinc.org | Satisfied with treatment |
100066-0 | http://loinc.org | Specular microscopy panel |
100067-8 | http://loinc.org | Eye Image magnification |
100068-6 | http://loinc.org | Right eye Fixation point [Angle] |
100069-4 | http://loinc.org | Left eye Fixation point [Angle] |
100070-2 | http://loinc.org | Right cornea Cell density |
100071-0 | http://loinc.org | Left cornea Cell density |
100072-8 | http://loinc.org | Right cornea Coefficient of variation |
10007-3 | http://loinc.org | R wave duration in lead V4 |
100073-6 | http://loinc.org | Left cornea Coefficient of variation |
100074-4 | http://loinc.org | Right cornea Hexagonality |
100075-1 | http://loinc.org | Left cornea Hexagonality |
100076-9 | http://loinc.org | Right cornea Endothelial cells counted |
100077-7 | http://loinc.org | Left cornea Endothelial cells counted |
100078-5 | http://loinc.org | Right cornea Endothelial cell area.min |
100079-3 | http://loinc.org | Left cornea Endothelial cell area.min |
100080-1 | http://loinc.org | Right cornea Endothelial cell area.max |
10008-1 | http://loinc.org | R wave duration in lead V5 |
100081-9 | http://loinc.org | Left cornea Endothelial cell area.max |
100082-7 | http://loinc.org | Right cornea Endothelial cell area.mean |
100083-5 | http://loinc.org | Left cornea Endothelial cell area.mean |
100084-3 | http://loinc.org | Right cornea Cell area.standard deviation |
100085-0 | http://loinc.org | Left cornea Cell area.standard deviation |
100086-8 | http://loinc.org | Right cornea Type of Analysis method by Specular microscopy |
100087-6 | http://loinc.org | Toxocara canis 24-35kD IgG Ab [Presence] in Serum by Immunoblot |
100088-4 | http://loinc.org | Taenia solium larva Ab bands panel - Serum by Immunoblot |
100089-2 | http://loinc.org | Taenia solium larva 6-8kD Ab [Presence] in Serum by Immunoblot |
1000-9 | http://loinc.org | DBG Ab [Presence] in Serum or Plasma from Blood product unit |
100090-0 | http://loinc.org | Taenia solium larva 45kD Ab [Presence] in Serum by Immunoblot |
100091-8 | http://loinc.org | Trypanosoma cruzi Ab [Units/volume] in Serum by Immunoassay |
100092-6 | http://loinc.org | Trypanosoma cruzi Ab bands panel - Serum by Immunoblot |
100093-4 | http://loinc.org | Trypanosoma cruzi 15-16kD IgG Ab [Presence] in Serum by Immunoblot |
100094-2 | http://loinc.org | Trypanosoma cruzi 21-22kD IgG Ab [Presence] in Serum by Immunoblot |
100095-9 | http://loinc.org | Trypanosoma cruzi 27-28kD IgG Ab [Presence] in Serum by Immunoblot |
100096-7 | http://loinc.org | Trypanosoma cruzi 42kD IgG Ab [Presence] in Serum by Immunoblot |
100097-5 | http://loinc.org | Trypanosoma cruzi 45-47kD IgG Ab [Presence] in Serum by Immunoblot |
100098-3 | http://loinc.org | Trypanosoma cruzi 120-200kD IgG Ab [Presence] in Serum by Immunoblot |
10009-9 | http://loinc.org | R wave duration in lead V6 |
100099-1 | http://loinc.org | Trypanosoma cruzi 160kD IgG Ab [Presence] in Serum by Immunoblot |
100100-7 | http://loinc.org | Fasciola sp IgG Ab [Presence] in Serum by Immunoassay |
100101-5 | http://loinc.org | Fasciola sp 8-9kD IgG Ab [Presence] in Serum by Immunoblot |
100102-3 | http://loinc.org | Fasciola sp 27-28kD IgG Ab [Presence] in Serum by Immunoblot |
100103-1 | http://loinc.org | Fasciola sp 60kD IgG Ab [Presence] in Serum by Immunoblot |
100104-9 | http://loinc.org | Fasciola sp 42kD IgG Ab [Presence] in Serum by Immunoblot |
100105-6 | http://loinc.org | Filaria IgG and IgM panel - Serum |
100106-4 | http://loinc.org | Filaria IgG Ab [Presence] in Serum by Immunoassay |
10010-7 | http://loinc.org | R' wave amplitude in lead AVF |
100107-2 | http://loinc.org | Leishmania sp IgG Ab [Presence] in Serum by Immunoassay |
100108-0 | http://loinc.org | Leishmania sp IgG Ab [Units/volume] in Serum by Immunoassay |
100109-8 | http://loinc.org | Leishmania sp Ab bands panel - Serum by Immunoblot |
100110-6 | http://loinc.org | Leishmania sp 14kD IgG Ab [Presence] in Serum by Immunoblot |
100111-4 | http://loinc.org | Leishmania sp 16kD IgG Ab [Presence] in Serum by Immunoblot |
100112-2 | http://loinc.org | Fasciola sp Ab bands panel - Serum by Immunoblot |
100113-0 | http://loinc.org | Helicobacter pylori Ab panel - Serum |
100114-8 | http://loinc.org | Toxoplasma gondii 30kD Ab [Presence] in Serum by Immunoblot |
10011-5 | http://loinc.org | R' wave amplitude in lead AVL |
100115-5 | http://loinc.org | Toxoplasma gondii 31kD Ab [Presence] in Serum by Immunoblot |
100116-3 | http://loinc.org | Toxoplasma gondii 33kD Ab [Presence] in Serum by Immunoblot |
100117-1 | http://loinc.org | Toxoplasma gondii 40kD Ab [Presence] in Serum by Immunoblot |
100118-9 | http://loinc.org | Toxoplasma gondii 41kD Ab [Presence] in Serum by Immunoblot |
100119-7 | http://loinc.org | Toxoplasma gondii 45kD Ab [Presence] in Serum by Immunoblot |
100120-5 | http://loinc.org | Chlamydia trachomatis Ab panel - Serum |
100121-3 | http://loinc.org | Chlamydia trachomatis IgA Ab [Presence] in Serum by Immunoassay |
100122-1 | http://loinc.org | Chlamydophila pneumoniae Ab panel - Serum |
10012-3 | http://loinc.org | R' wave amplitude in lead AVR |
100123-9 | http://loinc.org | Chlamydophila pneumoniae IgA Ab [Presence] in Serum by Immunoassay |
100124-7 | http://loinc.org | Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum by Immunoassay |
100125-4 | http://loinc.org | Chlamydophila psittaci Ab panel - Serum |
100126-2 | http://loinc.org | Bordetella pertussis Ab.IgG panel - Serum |
100127-0 | http://loinc.org | Campylobacter sp Ab panel - Serum |
100128-8 | http://loinc.org | Cryptococcus sp Ag panel - Serum |
100129-6 | http://loinc.org | Schistosoma sp Ab [Titer] in Serum by Hemagglutination |
100130-4 | http://loinc.org | Schistosoma mansoni Ab [Presence] in Serum by Immunoblot |
10013-1 | http://loinc.org | R' wave amplitude in lead I |
100131-2 | http://loinc.org | Schistosoma sp 8kD Ab [Presence] in Serum by Immunoblot |
100132-0 | http://loinc.org | Schistosoma sp 9kD Ab [Presence] in Serum by Immunoblot |
100133-8 | http://loinc.org | Schistosoma sp 10kD Ab [Presence] in Serum by Immunoblot |
100134-6 | http://loinc.org | Schistosoma sp 11kD Ab [Presence] in Serum by Immunoblot |
100135-3 | http://loinc.org | Schistosoma sp 12-13kD Ab [Presence] in Serum by Immunoblot |
100136-1 | http://loinc.org | Schistosoma sp 14-15kD Ab [Presence] in Serum by Immunoblot |
100137-9 | http://loinc.org | Schistosoma sp 15-16kD Ab [Presence] in Serum by Immunoblot |
100138-7 | http://loinc.org | Schistosoma sp 18-19kD Ab [Presence] in Serum by Immunoblot |
100139-5 | http://loinc.org | Schistosoma sp 22-24kD Ab [Presence] in Serum by Immunoblot |
100140-3 | http://loinc.org | Schistosoma sp 30-34kD Ab [Presence] in Serum by Immunoblot |
100141-1 | http://loinc.org | Schistosoma sp 65kD Ab [Presence] in Serum by Immunoblot |
100142-9 | http://loinc.org | Schistosoma sp 70kD Ab [Presence] in Serum by Immunoblot |
100143-7 | http://loinc.org | Schistosoma sp 80kD Ab [Presence] in Serum by Immunoblot |
100144-5 | http://loinc.org | Schistosoma sp 95kD Ab [Presence] in Serum by Immunoblot |
100145-2 | http://loinc.org | Schistosoma sp 110kD Ab [Presence] in Serum by Immunoblot |
100146-0 | http://loinc.org | Schistosoma sp 120kD Ab [Presence] in Serum by Immunoblot |
100147-8 | http://loinc.org | Toxoplasma gondii Ab bands panel - Serum by Immunoblot |
100148-6 | http://loinc.org | Schistosoma sp Ab bands panel - Serum by Immunoblot |
10014-9 | http://loinc.org | R' wave amplitude in lead II |
100149-4 | http://loinc.org | 6-oxo-piperidine-2-carboxylate and 6(R+S)-oxo-propylpiperidine-2-carboxylate panel - Urine and Serum or Plasma |
100150-2 | http://loinc.org | 6(R+S)-oxo-propylpiperidine-2-carboxylate [Moles/volume] in Plasma |
100151-0 | http://loinc.org | 6-oxo-piperidine-2-carboxylate [Moles/volume] in Plasma |
100152-8 | http://loinc.org | 6-oxo-piperidine-2-carboxylate/Creatinine [Molar ratio] in Urine |
100153-6 | http://loinc.org | 6(R+S)-oxo-propylpiperidine-2-carboxylate/Creatinine [Molar ratio] in Urine |
100154-4 | http://loinc.org | Specimen collection supervision level |
100155-1 | http://loinc.org | Left cornea Type of Analysis method by Specular microscopy |
10015-6 | http://loinc.org | R' wave amplitude in lead III |
100156-9 | http://loinc.org | SARS-CoV-2 (COVID-19) variant [Type] in Specimen by NAA with probe detection |
100157-7 | http://loinc.org | SARS-CoV-2 (COVID-19) lineage [Type] in Specimen by Sequencing |
100158-5 | http://loinc.org | Microalbumin [Mass/volume] in Urine collected for unspecified duration |
100159-3 | http://loinc.org | Knee Society Score pre-op panel [Knee Society Score] |
100160-1 | http://loinc.org | Knee replacement |
100161-9 | http://loinc.org | Charnley Functional Classification |
100162-7 | http://loinc.org | Knee alignment W standing X-ray measured |
100163-5 | http://loinc.org | Knee medial AndOr lateral instability W full extension |
10016-4 | http://loinc.org | R' wave amplitude in lead V1 |
100164-3 | http://loinc.org | Knee AP instability W 90 degree flexion |
100165-0 | http://loinc.org | Knee range of motion |
100166-8 | http://loinc.org | Flexion contracture range of Knee |
100167-6 | http://loinc.org | Extensor lag range of Knee |
100168-4 | http://loinc.org | Knee pain severity with level walking |
100169-2 | http://loinc.org | Knee pain severity with stairs or inclines |
1001-7 | http://loinc.org | DBG Ab [Presence] in Serum or Plasma from Donor |
100170-0 | http://loinc.org | Knee feels normal |
100171-8 | http://loinc.org | Satisfaction with level of knee pain while sitting |
10017-2 | http://loinc.org | R' wave amplitude in lead V2 |
100172-6 | http://loinc.org | Satisfaction with level of knee pain while lying in bed |
100173-4 | http://loinc.org | Satisfaction with knee function while getting out of bed |
100174-2 | http://loinc.org | Satisfaction with knee function while performing light household duties |
100175-9 | http://loinc.org | Satisfaction with knee function while performing recreational activities |
100176-7 | http://loinc.org | Expect surgery to relieve pain |
100177-5 | http://loinc.org | Expect surgery will improve ability to perform activities of daily living |
100178-3 | http://loinc.org | Expect surgery will improve ability to perform leisure, recreational, or sports activities |
100179-1 | http://loinc.org | Walk without assistive mobility devices |
10018-0 | http://loinc.org | R' wave amplitude in lead V3 |
100180-9 | http://loinc.org | Assistive mobility devices used |
100181-7 | http://loinc.org | Assistive mobility devices used due to health condition |
100182-5 | http://loinc.org | Duration of standing before sitting due to knee discomfort |
100183-3 | http://loinc.org | Duration of walking before stopping due to knee discomfort |
100184-1 | http://loinc.org | How bothersome is knee when walking on an uneven surface |
100185-8 | http://loinc.org | How bothersome is knee when turning or pivoting leg |
100186-6 | http://loinc.org | How bothersome is knee when climbing up or down a flight of stairs |
100187-4 | http://loinc.org | How bothersome is knee when getting up from a low seat without armrests |
100188-2 | http://loinc.org | How bothersome is knee when getting into or out of a car |
100189-0 | http://loinc.org | How bothersome is knee when moving laterally |
100190-8 | http://loinc.org | How bothersome is knee when climbing a ladder or step stool |
100191-6 | http://loinc.org | How bothersome is knee when carrying a bag for one block |
100192-4 | http://loinc.org | How bothersome is knee when squatting |
100193-2 | http://loinc.org | How bothersome is knee when kneeling |
100194-0 | http://loinc.org | How bothersome is knee when running |
100195-7 | http://loinc.org | Pain severity--during activity |
100196-5 | http://loinc.org | Pre-op total score [Knee Society Score] |
100197-3 | http://loinc.org | Exercise activity and pain severity panel |
10019-8 | http://loinc.org | R' wave amplitude in lead V4 |
100198-1 | http://loinc.org | Pre-op objective knee indicators score [Knee Society Score] |
100199-9 | http://loinc.org | Pre-op symptoms score [Knee Society Score] |
100200-5 | http://loinc.org | Pre-op patient expectations score [Knee Society Score] |
100201-3 | http://loinc.org | Pre-op functional activities score [Knee Society Score] |
100202-1 | http://loinc.org | Pre-op discretionary knee activities score [Knee Society Score] |
100203-9 | http://loinc.org | Knee Society Score post-op panel [Knee Society Score] |
100204-7 | http://loinc.org | Accuracy of pre-surgery expectations of pain relief |
100205-4 | http://loinc.org | Accuracy of pre-surgery expectations to perform activities of daily living |
10020-6 | http://loinc.org | R' wave amplitude in lead V5 |
100206-2 | http://loinc.org | Accuracy of pre-surgery expectations to perform leisure, recreational, or sports activities |
100207-0 | http://loinc.org | Post-op total score [Knee Society Score] |
100208-8 | http://loinc.org | Post-op objective knee indicators score [Knee Society Score] |
100209-6 | http://loinc.org | Post-op symptoms score [Knee Society Score] |
100210-4 | http://loinc.org | Post-op patient expectations score [Knee Society Score] |
100211-2 | http://loinc.org | Post-op functional activities score [Knee Society Score] |
100212-0 | http://loinc.org | Post-op discretionary knee activities score [Knee Society Score] |
100213-8 | http://loinc.org | Prostate cancer multigene analysis in Blood or Tissue by Molecular genetics method |
10021-4 | http://loinc.org | R' wave amplitude in lead V6 |
100214-6 | http://loinc.org | Dental model prior authorization Document |
100215-3 | http://loinc.org | Episode of care medical records Document Transplant surgery |
100216-1 | http://loinc.org | Surgical synoptic report |
100217-9 | http://loinc.org | Synoptic report Narrative Surgical oncology |
100218-7 | http://loinc.org | Surgical oncology of colon cancer synoptic report |
100219-5 | http://loinc.org | Surgical oncology of melanoma cancer synoptic report |
100220-3 | http://loinc.org | Surgical oncology of breast cancer synoptic report |
100221-1 | http://loinc.org | Surgical oncology of thyroid cancer synoptic report |
10022-2 | http://loinc.org | R' wave duration in lead AVF |
100222-9 | http://loinc.org | Surgical oncology of pancreas cancer synoptic report |
100223-7 | http://loinc.org | Physical findings of Retina Narrative |
100224-5 | http://loinc.org | Cardiac left ventricular segmental wall motion by echo panel |
100225-2 | http://loinc.org | Bone density quantitative ultrasound study |
100226-0 | http://loinc.org | Small bowel capsule endoscopy study Document |
100227-8 | http://loinc.org | Colon capsule endoscopy study Document |
100228-6 | http://loinc.org | Upper gastrointestinal capsule endoscopy study Document |
100229-4 | http://loinc.org | Endoscopic ultrasound study Document |
10023-0 | http://loinc.org | R' wave duration in lead AVL |
100230-2 | http://loinc.org | Routine prenatal assessment panel |
100231-0 | http://loinc.org | Endobronchial ultrasound study |
100232-8 | http://loinc.org | Impacts of Events Scale-Revised panel |
100233-6 | http://loinc.org | Reminders brought back feelings about adverse event |
100234-4 | http://loinc.org | Trouble staying asleep |
100235-1 | http://loinc.org | Other things triggered persistent thoughts about adverse event |
100236-9 | http://loinc.org | Felt irritable AndOr angry |
100237-7 | http://loinc.org | Avoided getting upset when unintentionally thought about adverse event |
100238-5 | http://loinc.org | Thought about adverse event unintentionally |
100239-3 | http://loinc.org | Felt as if adverse event did not happen |
100240-1 | http://loinc.org | Avoided reminders of adverse event |
100241-9 | http://loinc.org | Experienced mental images of adverse event |
100242-7 | http://loinc.org | Easily startled |
100243-5 | http://loinc.org | Tried to not think of adverse event |
100244-3 | http://loinc.org | Aware of feelings about adverse event, but did not address them |
100245-0 | http://loinc.org | Feelings about adverse event were numb |
100246-8 | http://loinc.org | Acted or felt the same as during adverse event |
100247-6 | http://loinc.org | Trouble falling asleep |
10024-8 | http://loinc.org | R' wave duration in lead AVR |
100248-4 | http://loinc.org | Waves of strong feelings about adverse event |
100249-2 | http://loinc.org | Tried to remove adverse event from memory |
1002-5 | http://loinc.org | DBG Ab [Presence] in Serum or Plasma |
100250-0 | http://loinc.org | Trouble concentrating |
100251-8 | http://loinc.org | Reminders of adverse event caused physical reactions |
100252-6 | http://loinc.org | Had dreams about adverse event |
100253-4 | http://loinc.org | Felt watchful and on-guard |
100254-2 | http://loinc.org | Tried not to talk about adverse event |
10025-5 | http://loinc.org | R' wave duration in lead I |
100255-9 | http://loinc.org | Total score [Impact of Event Scale-Revised] |
100256-7 | http://loinc.org | Fallen in last 6 months |
100257-5 | http://loinc.org | Feel unsteady when standing or walking |
100258-3 | http://loinc.org | History of fall related injury |
100259-1 | http://loinc.org | Aware of tactile sensations |
100260-9 | http://loinc.org | Easy to describe thoughts AndOr feelings |
100261-7 | http://loinc.org | Critical of own thoughts AndOr feelings |
100262-5 | http://loinc.org | Able to notice distressing thoughts AndOr feelings without having to react |
10026-3 | http://loinc.org | R' wave duration in lead II |
100263-3 | http://loinc.org | Easily distracted |
100264-1 | http://loinc.org | Able to notice thoughts AndOr feelings without being overwhelmed |
100265-8 | http://loinc.org | Aware of dietary intake impact on self |
100266-6 | http://loinc.org | Difficult to describe thoughts AndOr feelings |
100267-4 | http://loinc.org | Aware of auditory stimuli |
100268-2 | http://loinc.org | Able to avoid immediate reaction in difficult situations |
100269-0 | http://loinc.org | Do things without paying attention |
100270-8 | http://loinc.org | Recover quickly from distressing thoughts AndOr images |
10027-1 | http://loinc.org | R' wave duration in lead III |
100271-6 | http://loinc.org | Aware of olfactory stimuli |
100272-4 | http://loinc.org | Aware of visual stimuli |
100273-2 | http://loinc.org | Aware of emotions affect on thoughts AndOr behavior |
100274-0 | http://loinc.org | Observing score [FFMQ] |
100275-7 | http://loinc.org | Describing score [FFMQ] |
100276-5 | http://loinc.org | Acting with awareness score [FFMQ] |
100277-3 | http://loinc.org | Nonjudging score [FFMQ] |
100278-1 | http://loinc.org | Nonreactivity score [FFMQ] |
100279-9 | http://loinc.org | Total score [FFMQ] |
100280-7 | http://loinc.org | Five Facet Mindfulness Questionnaire panel [FFMQ] |
100281-5 | http://loinc.org | D Ab [Units/volume] in Serum or Plasma |
100282-3 | http://loinc.org | Vaccine exemption certificate |
100283-1 | http://loinc.org | Harris Hip Score panel [Harris Hip Score] |
100284-9 | http://loinc.org | Walking - functional ability |
100285-6 | http://loinc.org | Comfortable seated position |
100286-4 | http://loinc.org | Able to board public transportation |
100287-2 | http://loinc.org | Put on shoes and socks |
100288-0 | http://loinc.org | Absence of deformity score [Harris Hip Score] |
10028-9 | http://loinc.org | R' wave duration in lead V1 |
100289-8 | http://loinc.org | Absence of hip deformity measurements |
100290-6 | http://loinc.org | Range of motion score [Harris Hip Score] |
100291-4 | http://loinc.org | Total score [Harris Hip Score] |
100292-2 | http://loinc.org | Pre-op patient satisfaction score [Knee Society Score] |
100293-0 | http://loinc.org | Hip Flexion range of motion |
100294-8 | http://loinc.org | Hip Abduction range of motion |
100295-5 | http://loinc.org | Hip Adduction range of motion |
100296-3 | http://loinc.org | Hip External rotation range of motion |
10029-7 | http://loinc.org | R' wave duration in lead V2 |
100297-1 | http://loinc.org | Hip Internal rotation range of motion |
100298-9 | http://loinc.org | Repetition count |
100299-7 | http://loinc.org | Post-op patient satisfaction score [Knee Society Score] |
100300-3 | http://loinc.org | End time Unspecified body region |
100301-1 | http://loinc.org | Start time Unspecified body region |
100302-9 | http://loinc.org | Time period start and end panel Unspecified body region |
100303-7 | http://loinc.org | Condition certainty of presence |
100304-5 | http://loinc.org | Flights climbed [#] Reporting Period |
10030-5 | http://loinc.org | R' wave duration in lead V3 |
100305-2 | http://loinc.org | IDH1 gene exon 4 targeted mutation analysis [Presence] in Blood or Marrow by Molecular genetics method |
100306-0 | http://loinc.org | IDH2 gene exon 4 targeted mutation analysis [Presence] in Blood or Marrow by Molecular genetics method |
100307-8 | http://loinc.org | Behavioral screening elder mistreatment |
100308-6 | http://loinc.org | Need help getting to essential places |
100309-4 | http://loinc.org | Activity support person |
100310-2 | http://loinc.org | Reliability of support person |
100311-0 | http://loinc.org | Need help to make sure there is enough food, medicines or any other things needed in house |
100312-8 | http://loinc.org | Person or persons that makes sure there is enough food, medicines or any other things needed in house |
10031-3 | http://loinc.org | R' wave duration in lead V4 |
100313-6 | http://loinc.org | Need help with household things such as cook meals, help feed, or provide correct medicines each day |
100314-4 | http://loinc.org | Need help with house cleaning or yard work |
100315-1 | http://loinc.org | Need help getting out of bed, showered, or dressed |
100316-9 | http://loinc.org | Need help to make sure bills get paid |
100317-7 | http://loinc.org | Relationship of usual support person for daily activities |
100318-5 | http://loinc.org | Have help with finances AndOr financial decisions |
100319-3 | http://loinc.org | Relationship of financial support person |
100320-1 | http://loinc.org | Financial support person usually asks for permission before making decisions |
10032-1 | http://loinc.org | R' wave duration in lead V5 |
100321-9 | http://loinc.org | Financial support person usually makes good decisions about finances |
100322-7 | http://loinc.org | Have access to paperwork for financial decisions made |
100323-5 | http://loinc.org | Financial support person forged signature |
100324-3 | http://loinc.org | Coercion of financial support person for signing a document in order to get money or possessions |
100325-0 | http://loinc.org | Experienced theft by support person |
100326-8 | http://loinc.org | Money spent or property sold without permission |
100327-6 | http://loinc.org | Stranger forged signature for financial gain |
100328-4 | http://loinc.org | Stranger forced document signature for financial gain |
100329-2 | http://loinc.org | Feared for safety due to verbal attack |
1003-3 | http://loinc.org | Indirect antiglobulin test.complement specific reagent [Presence] in Serum or Plasma |
100330-0 | http://loinc.org | Felt humiliated due to ridicule |
100331-8 | http://loinc.org | Coerced to do something |
100332-6 | http://loinc.org | Ignored by close friend or relative for extended period |
100333-4 | http://loinc.org | Physically hit or threatened |
100334-2 | http://loinc.org | Been physically hurt with some degree of injury |
100335-9 | http://loinc.org | Coerced sexual activity |
100336-7 | http://loinc.org | Coerced touching of private body parts of self or others |
100337-5 | http://loinc.org | Coerced to undress or expose private body area |
100338-3 | http://loinc.org | Photographed in any degree of nudity without consent |
10033-9 | http://loinc.org | R' wave duration in lead V6 |
100339-1 | http://loinc.org | Experienced attempted physical restraint |
100340-9 | http://loinc.org | Range of motion panel Hip |
100341-7 | http://loinc.org | Rubella virus IgG Ab index [Units/volume] in Serum and CSF |
100342-5 | http://loinc.org | Volatile Organic Compounds associated with SARS-CoV-2 infection [Presence] in Exhaled gas by Gas chromatography-mass spectrometry |
100343-3 | http://loinc.org | Influenza virus B RNA [Presence] in Saliva (oral fluid) by NAA with probe detection |
100344-1 | http://loinc.org | Influenza virus A RNA [Presence] in Saliva (oral fluid) by NAA with probe detection |
100345-8 | http://loinc.org | Influenza virus A and B and SARS-CoV-2 (COVID-19) RNA panel - Specimen by NAA with probe detection |
100346-6 | http://loinc.org | Clotting time.extrinsic coagulation system activated.platelets inhibited of Blood by Rotational TEG |
10034-7 | http://loinc.org | S wave amplitude in lead AVF |
100347-4 | http://loinc.org | Clot formation.extrinsic coagulation system activated.platelets inhibited [Time] in Blood by Rotational TEG |
100348-2 | http://loinc.org | Model for end-stage liver disease sodium score |
100349-0 | http://loinc.org | US.doppler Penis vessels W vasodilator IV |
100350-8 | http://loinc.org | Sesamum indicum 1 IgE Ab [Units/volume] in Serum |
100351-6 | http://loinc.org | Pioglitazone [Presence] in Serum or Plasma |
100352-4 | http://loinc.org | Rosiglitazone [Presence] in Serum or Plasma |
100353-2 | http://loinc.org | Norwalk Community Health Center Screening Tool [NCHC] |
10035-4 | http://loinc.org | S wave amplitude in lead AVL |
100354-0 | http://loinc.org | Frequency of participating in multi-modal communication without assistance |
100355-7 | http://loinc.org | Frequency of participating in spoken language expression communication without assistance |
100356-5 | http://loinc.org | Chlamydia trachomatis and Neisseria gonorrhoeae and Trichomonas vaginalis DNA [Identifier] in Specimen by NAA with probe detection |
100357-3 | http://loinc.org | Naloxone [Presence] in Cord tissue by Screen method |
100358-1 | http://loinc.org | Phentermine [Presence] in Cord tissue by Screen method |
100359-9 | http://loinc.org | Gliadin 33 mer peptide [Mass/volume] in Stool by Immunoassay |
100360-7 | http://loinc.org | Brief Resilience Scale panel [BRS] |
100361-5 | http://loinc.org | Quickly recover from bad events |
10036-2 | http://loinc.org | S wave amplitude in lead AVR |
100362-3 | http://loinc.org | Difficulty making it through stressful events |
100363-1 | http://loinc.org | Easily recover from a stressful event |
100364-9 | http://loinc.org | Difficulty recovering from bad events |
100365-6 | http://loinc.org | Easily recover from difficulties |
100366-4 | http://loinc.org | Lengthy recovery from setbacks |
100367-2 | http://loinc.org | Total Score BRS |
100368-0 | http://loinc.org | Amino Acids Urea Cycle Panel - Serum or Plasma by LC/MS/MS |
100369-8 | http://loinc.org | NM Thyroid gland Views W Tl-201 IV |
10037-0 | http://loinc.org | S wave amplitude in lead I |
100370-6 | http://loinc.org | Orthopoxvirus DNA [Identifier] in Specimen by NAA with probe detection |
100371-4 | http://loinc.org | Titin Ab [Units/volume] in Serum by Immunoassay |
100372-2 | http://loinc.org | Abiraterone [Mass/volume] in Serum or Plasma |
100373-0 | http://loinc.org | Eucheuma IgG Ab [Units/volume] in Serum |
100374-8 | http://loinc.org | Aloe vera IgG Ab [Units/volume] in Serum |
100375-5 | http://loinc.org | Anise IgG Ab [Units/volume] in Serum |
100376-3 | http://loinc.org | Bambusa vulgaris IgG Ab [Units/volume] in Serum |
100377-1 | http://loinc.org | Goat cheese IgG Ab [Units/volume] in Serum |
100378-9 | http://loinc.org | Sheep cheese IgG Ab [Units/volume] in Serum |
100379-7 | http://loinc.org | Leeks IgG Ab [Units/volume] in Serum |
100380-5 | http://loinc.org | Red cabbage IgG Ab [Units/volume] in Serum |
100381-3 | http://loinc.org | Mentha balsamea Wild IgG Ab [Units/volume] in Serum |
100382-1 | http://loinc.org | FDA package insert REMS addressed risk |
100383-9 | http://loinc.org | Monkeypox virus DNA [Presence] in Specimen by NAA with probe detection |
100384-7 | http://loinc.org | Rapeseed IgG Ab [Units/volume] in Serum |
100385-4 | http://loinc.org | Corn salad IgG Ab [Units/volume] in Serum |
100386-2 | http://loinc.org | Rosemary IgG Ab [Units/volume] in Serum |
100387-0 | http://loinc.org | Poppy Seed IgG Ab [Units/volume] in Serum |
10038-8 | http://loinc.org | S wave amplitude in lead II |
100388-8 | http://loinc.org | Cocoa IgG Ab [Units/volume] in Serum |
100389-6 | http://loinc.org | Pistachio IgG Ab [Units/volume] in Serum |
100390-4 | http://loinc.org | Sunflower Seed IgG Ab [Units/volume] in Serum |
100391-2 | http://loinc.org | Dates IgG Ab [Units/volume] in Serum |
100392-0 | http://loinc.org | Duck meat IgG Ab [Units/volume] in Serum |
100393-8 | http://loinc.org | Allergen Mushroom mix 2 (Xerocomus, Boletus) IgG Ab [Units/volume] in Serum |
100394-6 | http://loinc.org | Astacoidea IgG Ab [Units/volume] in Serum |
100395-3 | http://loinc.org | Carob IgG Ab [Units/volume] in Serum |
10039-6 | http://loinc.org | S wave amplitude in lead III |
100396-1 | http://loinc.org | Brassica napus IgG Ab [Units/volume] in Serum |
100397-9 | http://loinc.org | Goat Meat IgG Ab [Units/volume] in Serum |
100398-7 | http://loinc.org | Goose meat IgG Ab [Units/volume] in Serum |
100399-5 | http://loinc.org | Ostrich meat IgG Ab [Units/volume] in Serum |
100400-1 | http://loinc.org | Quail meat IgG Ab [Units/volume] in Serum |
100401-9 | http://loinc.org | Rabbit meat IgG Ab [Units/volume] in Serum |
100402-7 | http://loinc.org | Venison meat IgG Ab [Units/volume] in Serum |
100403-5 | http://loinc.org | Guineafowl IgG Ab [Units/volume] in Serum |
10040-4 | http://loinc.org | S wave amplitude in lead V1 |
100404-3 | http://loinc.org | Horse meat IgG Ab [Units/volume] in Serum |
100405-0 | http://loinc.org | Kefir IgG Ab [Units/volume] in Serum |
100406-8 | http://loinc.org | Butter IgG Ab [Units/volume] in Serum |
100407-6 | http://loinc.org | Camembert cheese IgG Ab [Units/volume] in Serum |
100408-4 | http://loinc.org | Emmental cheese IgG Ab [Units/volume] in Serum |
100409-2 | http://loinc.org | Processed cheese IgG Ab [Units/volume] in Serum |
1004-1 | http://loinc.org | Direct antiglobulin test.complement specific reagent [Presence] on Red Blood Cells |
100410-0 | http://loinc.org | Curd cheese IgG Ab [Units/volume] in Serum |
100411-8 | http://loinc.org | Sugar Beet IgG Ab [Units/volume] in Serum |
10041-2 | http://loinc.org | S wave amplitude in lead V2 |
100412-6 | http://loinc.org | Chinese cabbage IgG Ab [Units/volume] in Serum |
100413-4 | http://loinc.org | Fennel Fresh IgG Ab [Units/volume] in Serum |
100414-2 | http://loinc.org | Gourd IgG Ab [Units/volume] in Serum |
100415-9 | http://loinc.org | Kale IgG Ab [Units/volume] in Serum |
100416-7 | http://loinc.org | Savoy cabbage IgG Ab [Units/volume] in Serum |
100417-5 | http://loinc.org | Vitis sp leaf IgG Ab [Units/volume] in Serum |
100418-3 | http://loinc.org | Liquorice IgG Ab [Units/volume] in Serum |
100419-1 | http://loinc.org | Snow pea IgG Ab [Units/volume] in Serum |
10042-0 | http://loinc.org | S wave amplitude in lead V3 |
100420-9 | http://loinc.org | Fava bean IgG Ab [Units/volume] in Serum |
100421-7 | http://loinc.org | Chick Pea IgG Ab [Units/volume] in Serum |
100422-5 | http://loinc.org | Chicory IgG Ab [Units/volume] in Serum |
100423-3 | http://loinc.org | Allergy Mushroom Mix 1 (Button + oyster + Shiitaki + chanterelle mushroom) IgG Ab [Units/volume] in Serum |
100424-1 | http://loinc.org | 8(9)-Cholestenol [Mass/volume] in Serum or Plasma |
100425-8 | http://loinc.org | DiHydro T-Mas [Mass/volume] in Serum or Plasma |
100426-6 | http://loinc.org | Squalene [Mass/volume] in Serum or Plasma |
100427-4 | http://loinc.org | Stigmasterol [Mass/volume] in Serum or Plasma |
100428-2 | http://loinc.org | Carnitine free and total and acylcarnitine panel - Urine |
100429-0 | http://loinc.org | LRBA deficiency panel - Blood |
100430-8 | http://loinc.org | Cells.LRBA+/100 Cells.CD3+CD14-CD45+ in Blood by Flow cytometry (FC) |
100431-6 | http://loinc.org | Cells.CD3+CD14-CD45+.LRBA mean fluorescence intensity in Blood by Flow cytometry (FC) |
100432-4 | http://loinc.org | Cells.LRBA+/100 Cells.CD3-CD14-CD19+CD45+ in Blood by Flow cytometry (FC) |
100433-2 | http://loinc.org | Cells.CD3-CD14-CD19+CD45+.LRBA mean fluorescence intensity in Blood by Flow cytometry (FC) |
100434-0 | http://loinc.org | Orthopoxvirus.non-variola DNA [Presence] in Specimen by NAA with probe detection |
100435-7 | http://loinc.org | Glial fibrillary acidic protein [Mass/volume] in Serum by Immunoassay |
100436-5 | http://loinc.org | Ubiquitin carboxyl-terminal hydrolase-L1 [Mass/volume] in Serum by Immunoassay |
100437-3 | http://loinc.org | Norsufentanil [Mass/volume] in Urine by Confirmatory method |
10043-8 | http://loinc.org | S wave amplitude in lead V4 |
100438-1 | http://loinc.org | Adolescent medicine Outpatient Progress note |
100439-9 | http://loinc.org | Allergy and Immunology Outpatient Progress note |
100440-7 | http://loinc.org | Allergy Outpatient Progress note |
100441-5 | http://loinc.org | Attending Outpatient Progress note |
100442-3 | http://loinc.org | Audiology Outpatient Progress note |
100443-1 | http://loinc.org | Bariatric surgery Outpatient Progress note |
100444-9 | http://loinc.org | Blood banking and transfusion medicine Outpatient Progress note |
100445-6 | http://loinc.org | Bone Marrow Transplant Outpatient Progress note |
10044-6 | http://loinc.org | S wave amplitude in lead V5 |
100446-4 | http://loinc.org | Breastfeeding Outpatient Progress note |
100447-2 | http://loinc.org | Burn management Outpatient Progress note |
100448-0 | http://loinc.org | Cardiac surgery Outpatient Progress note |
100449-8 | http://loinc.org | Cardiopulmonary Outpatient Progress note |
100450-6 | http://loinc.org | Child and adolescent psychiatry Outpatient Progress note |
100451-4 | http://loinc.org | Chiropractic medicine Outpatient Progress note |
100452-2 | http://loinc.org | Clinical cardiac electrophysiology Outpatient Progress note |
10045-3 | http://loinc.org | S wave amplitude in lead V6 |
100453-0 | http://loinc.org | Clinical genetics Outpatient Progress note |
100454-8 | http://loinc.org | Clinical neurophysiology Outpatient Progress note |
100455-5 | http://loinc.org | Clinical pathology Outpatient Progress note |
100456-3 | http://loinc.org | Colon and rectal surgery Outpatient Progress note |
100457-1 | http://loinc.org | Consultant Outpatient Progress note |
100458-9 | http://loinc.org | Outpatient COVID-19 Intubation Progress note |
100459-7 | http://loinc.org | Outpatient COVID-19 Progress note |
100460-5 | http://loinc.org | Dermatology Outpatient Progress note |
10046-1 | http://loinc.org | S wave duration in lead AVF |
100461-3 | http://loinc.org | Developmental-behavioral pediatrics Outpatient Progress note |
100462-1 | http://loinc.org | Dialysis and Therapeutic apheresis Outpatient Progress note |
100463-9 | http://loinc.org | Eating disorders Outpatient Progress note |
100464-7 | http://loinc.org | Endocrinology Outpatient Progress note |
100465-4 | http://loinc.org | Family medicine Outpatient Progress note |
100466-2 | http://loinc.org | Gastroenterology Outpatient Progress note |
100467-0 | http://loinc.org | Geriatric medicine Outpatient Progress note |
100468-8 | http://loinc.org | Gynecologic oncology Outpatient Progress note |
100469-6 | http://loinc.org | Gynecology Outpatient Progress note |
100470-4 | http://loinc.org | Healthcare navigator Outpatient Progress note |
100471-2 | http://loinc.org | Heart failure Outpatient Progress note |
100472-0 | http://loinc.org | Heart failure+Transplant cardiology Outpatient Progress note |
100473-8 | http://loinc.org | Hematology Outpatient Progress note |
100474-6 | http://loinc.org | Hematology+Medical oncology Outpatient Progress note |
100475-3 | http://loinc.org | Hepatology Outpatient Progress note |
100476-1 | http://loinc.org | Immunology Outpatient Progress note |
100477-9 | http://loinc.org | Infectious disease Outpatient Progress note |
100478-7 | http://loinc.org | Internal medicine Outpatient Progress note |
10047-9 | http://loinc.org | S wave duration in lead AVL |
100479-5 | http://loinc.org | Interventional cardiology Outpatient Progress note |
100480-3 | http://loinc.org | Interventional radiology Outpatient Progress note |
100481-1 | http://loinc.org | Outpatient Mechanical circulatory support Progress note |
100482-9 | http://loinc.org | Medical Aid in Dying Outpatient Progress note |
100483-7 | http://loinc.org | Mental health Outpatient Progress note |
100484-5 | http://loinc.org | Multi-specialty program Outpatient Progress note |
100485-2 | http://loinc.org | Neonatal perinatal medicine Outpatient Progress note |
100486-0 | http://loinc.org | Nephrology Outpatient Progress note |
10048-7 | http://loinc.org | S wave duration in lead AVR |
100487-8 | http://loinc.org | Neurological surgery Outpatient Progress note |
100488-6 | http://loinc.org | Neurology Outpatient Progress note |
100489-4 | http://loinc.org | Neurology with special qualifications in child neurology Outpatient Progress note |
100490-2 | http://loinc.org | Nurse practitioner Outpatient Progress note |
100491-0 | http://loinc.org | Nurse Outpatient Progress note |
100492-8 | http://loinc.org | Nutrition and dietetics Outpatient Progress note |
100493-6 | http://loinc.org | Obstetrics and Gynecology Outpatient Progress note |
100494-4 | http://loinc.org | Obstetrics Outpatient Progress note |
10049-5 | http://loinc.org | S wave duration in lead I |
100495-1 | http://loinc.org | Occupational therapy Outpatient Progress note |
100496-9 | http://loinc.org | Oncology Outpatient Progress note |
100497-7 | http://loinc.org | Ophthalmology Outpatient Progress note |
100498-5 | http://loinc.org | Optometry Outpatient Progress note |
100499-3 | http://loinc.org | Oral and Maxillofacial Surgery Outpatient Progress note |
100500-8 | http://loinc.org | Orthopaedic surgery Outpatient Progress note |
100501-6 | http://loinc.org | Orthotics prosthetics Outpatient Progress note |
100502-4 | http://loinc.org | Otolaryngology Outpatient Progress note |
10050-3 | http://loinc.org | S wave duration in lead II |
100503-2 | http://loinc.org | Pain medicine Outpatient Progress note |
100504-0 | http://loinc.org | Palliative care Outpatient Progress note |
100505-7 | http://loinc.org | Pediatric cardiology Outpatient Progress note |
100506-5 | http://loinc.org | Pediatric dermatology Outpatient Progress note |
100507-3 | http://loinc.org | Pediatric endocrinology Outpatient Progress note |
100508-1 | http://loinc.org | Pediatric gastroenterology Outpatient Progress note |
100509-9 | http://loinc.org | Pediatric hematology-oncology Outpatient Progress note |
100510-7 | http://loinc.org | Pediatric infectious diseases Outpatient Progress note |
10051-1 | http://loinc.org | S wave duration in lead III |
100511-5 | http://loinc.org | Pediatric otolaryngology Outpatient Progress note |
100512-3 | http://loinc.org | Pediatric pulmonology Outpatient Progress note |
100513-1 | http://loinc.org | Pediatric rheumatology Outpatient Progress note |
100514-9 | http://loinc.org | Pediatric surgery Outpatient Progress note |
100515-6 | http://loinc.org | Pediatric transplant hepatology Outpatient Progress note |
100516-4 | http://loinc.org | Pediatric urology Outpatient Progress note |
100517-2 | http://loinc.org | Pharmacogenomics Outpatient Progress note |
100518-0 | http://loinc.org | Physical medicine and rehab Outpatient Progress note |
100519-8 | http://loinc.org | Physical therapy Outpatient Progress note |
100520-6 | http://loinc.org | Plastic surgery Outpatient Progress note |
100521-4 | http://loinc.org | Podiatry Outpatient Progress note |
100522-2 | http://loinc.org | Psychiatry Hospital Progress note |
100523-0 | http://loinc.org | Psychology Outpatient Progress note |
100524-8 | http://loinc.org | Pulmonary Outpatient Progress note |
100525-5 | http://loinc.org | Radiation oncology Outpatient Progress note |
100526-3 | http://loinc.org | Radiology Outpatient Progress note |
100527-1 | http://loinc.org | Recreational therapy Outpatient Progress note |
100528-9 | http://loinc.org | Reproductive endocrinology and infertility Outpatient Progress note |
10052-9 | http://loinc.org | S wave duration in lead V1 |
100529-7 | http://loinc.org | Research Outpatient Progress note |
100530-5 | http://loinc.org | Rheumatology Outpatient Progress note |
100531-3 | http://loinc.org | Sleep medicine Outpatient Progress note |
100532-1 | http://loinc.org | Social worker Outpatient Progress note |
100533-9 | http://loinc.org | Solid Organ Transplant Outpatient Progress note |
100534-7 | http://loinc.org | Speech-language pathology Outpatient Progress note |
100535-4 | http://loinc.org | Spinal surgery Outpatient Progress note |
100536-2 | http://loinc.org | Sports medicine Outpatient Progress note |
10053-7 | http://loinc.org | S wave duration in lead V2 |
100537-0 | http://loinc.org | Surgery of the hand Outpatient Progress note |
100538-8 | http://loinc.org | Telehealth+Outpatient Progress note |
100539-6 | http://loinc.org | Thromboembolism Outpatient Progress note |
100540-4 | http://loinc.org | Transplant surgery Outpatient Progress note |
100541-2 | http://loinc.org | Trauma Outpatient Progress note |
100542-0 | http://loinc.org | Urology Outpatient Progress note |
100543-8 | http://loinc.org | Vascular neurology Outpatient Progress note |
100544-6 | http://loinc.org | Vascular surgery Outpatient Progress note |
10054-5 | http://loinc.org | S wave duration in lead V3 |
100545-3 | http://loinc.org | Wound care management Outpatient Progress note |
100546-1 | http://loinc.org | Wound, Ostomy, and Continence Care Outpatient Progress note |
100547-9 | http://loinc.org | Adolescent medicine Hospital Progress note |
100548-7 | http://loinc.org | Allergy and Immunology Hospital Progress note |
100549-5 | http://loinc.org | Allergy Hospital Progress note |
100550-3 | http://loinc.org | Attending Hospital Progress note |
100551-1 | http://loinc.org | Audiology Hospital Progress note |
10055-2 | http://loinc.org | S wave duration in lead V4 |
100552-9 | http://loinc.org | Bariatric surgery Hospital Progress note |
100553-7 | http://loinc.org | Blood banking and transfusion medicine Hospital Progress note |
100554-5 | http://loinc.org | Bone Marrow Transplant Hospital Progress note |
100555-2 | http://loinc.org | Breastfeeding Hospital Progress note |
100556-0 | http://loinc.org | Burn management Hospital Progress note |
100557-8 | http://loinc.org | Cardiac surgery Hospital Progress note |
100558-6 | http://loinc.org | Cardiopulmonary Hospital Progress note |
100559-4 | http://loinc.org | Child and adolescent psychiatry Hospital Progress note |
10056-0 | http://loinc.org | S wave duration in lead V5 |
100560-2 | http://loinc.org | Clinical cardiac electrophysiology Hospital Progress note |
100561-0 | http://loinc.org | Clinical genetics Hospital Progress note |
100562-8 | http://loinc.org | Clinical neurophysiology Hospital Progress note |
100563-6 | http://loinc.org | Clinical pathology Hospital Progress note |
100564-4 | http://loinc.org | Colon and rectal surgery Hospital Progress note |
100565-1 | http://loinc.org | Consultant Hospital Progress note |
100566-9 | http://loinc.org | Dentistry Hospital Progress note |
100567-7 | http://loinc.org | Dermatology Hospital Progress note |
100568-5 | http://loinc.org | Developmental-behavioral pediatrics Hospital Progress note |
100569-3 | http://loinc.org | Dialysis and Therapeutic apheresis Hospital Progress note |
100570-1 | http://loinc.org | Eating disorders Hospital Progress note |
100571-9 | http://loinc.org | Endocrinology Hospital Progress note |
100572-7 | http://loinc.org | Family medicine Hospital Progress note |
100573-5 | http://loinc.org | Gastroenterology Hospital Progress note |
100574-3 | http://loinc.org | General medicine Hospital Progress note |
100575-0 | http://loinc.org | Geriatric medicine Hospital Progress note |
100576-8 | http://loinc.org | Gynecologic oncology Hospital Progress note |
100577-6 | http://loinc.org | Gynecology Hospital Progress note |
10057-8 | http://loinc.org | S wave duration in lead V6 |
100578-4 | http://loinc.org | Healthcare navigator Hospital Progress note |
100579-2 | http://loinc.org | Heart failure Hospital Progress note |
1005-8 | http://loinc.org | Indirect antiglobulin test.IgG specific reagent [Presence] in Serum or Plasma |
100580-0 | http://loinc.org | Heart failure+Transplant cardiology Hospital Progress note |
100581-8 | http://loinc.org | Hematology Hospital Progress note |
100582-6 | http://loinc.org | Hematology+Medical oncology Hospital Progress note |
100583-4 | http://loinc.org | Hepatology Hospital Progress note |
100584-2 | http://loinc.org | Immunology Hospital Progress note |
100585-9 | http://loinc.org | Infectious disease Hospital Progress note |
10058-6 | http://loinc.org | S' wave amplitude in lead AVF |
100586-7 | http://loinc.org | Internal medicine Hospital Progress note |
100587-5 | http://loinc.org | Interventional cardiology Hospital Progress note |
100588-3 | http://loinc.org | Interventional radiology Hospital Progress note |
100589-1 | http://loinc.org | Hospital Mechanical circulatory support Progress note |
100590-9 | http://loinc.org | Medical Aid in Dying Hospital Progress note |
100591-7 | http://loinc.org | Mental health Hospital Progress note |
100592-5 | http://loinc.org | Multi-specialty program Hospital Progress note |
100593-3 | http://loinc.org | Neonatal perinatal medicine Hospital Progress note |
10059-4 | http://loinc.org | S' wave amplitude in lead AVL |
100594-1 | http://loinc.org | Nephrology Hospital Progress note |
100595-8 | http://loinc.org | Neurological surgery Hospital Progress note |
100596-6 | http://loinc.org | Neurology Hospital Progress note |
100597-4 | http://loinc.org | Neurology with special qualifications in child neurology Hospital Progress note |
100598-2 | http://loinc.org | Nurse practitioner Hospital Progress note |
100599-0 | http://loinc.org | Nurse Hospital Progress note |
100600-6 | http://loinc.org | Nutrition and dietetics Hospital Progress note |
100601-4 | http://loinc.org | Obstetrics and Gynecology Hospital Progress note |
10060-2 | http://loinc.org | S' wave amplitude in lead AVR |
100602-2 | http://loinc.org | Obstetrics Hospital Progress note |
100603-0 | http://loinc.org | Occupational therapy Hospital Progress note |
100604-8 | http://loinc.org | Oncology Hospital Progress note |
100605-5 | http://loinc.org | Ophthalmology Hospital Progress note |
100606-3 | http://loinc.org | Oral and Maxillofacial Surgery Hospital Progress note |
100607-1 | http://loinc.org | Orthopaedic surgery Hospital Progress note |
100608-9 | http://loinc.org | Orthotics prosthetics Hospital Progress note |
100609-7 | http://loinc.org | Otolaryngology Hospital Progress note |
10061-0 | http://loinc.org | S' wave amplitude in lead I |
100610-5 | http://loinc.org | Pain medicine Hospital Progress note |
100611-3 | http://loinc.org | Palliative care Hospital Progress note |
100612-1 | http://loinc.org | Pastoral care Hospital Progress note |
100613-9 | http://loinc.org | Pediatric cardiology Hospital Progress note |
100614-7 | http://loinc.org | Pediatric dermatology Hospital Progress note |
100615-4 | http://loinc.org | Pediatric endocrinology Hospital Progress note |
100616-2 | http://loinc.org | Pediatric gastroenterology Hospital Progress note |
100617-0 | http://loinc.org | Pediatric hematology-oncology Hospital Progress note |
100618-8 | http://loinc.org | Pediatric infectious diseases Hospital Progress note |
100619-6 | http://loinc.org | Pediatric otolaryngology Hospital Progress note |
100620-4 | http://loinc.org | Pediatric pulmonology Hospital Progress note |
100621-2 | http://loinc.org | Pediatric rheumatology Hospital Progress note |
100622-0 | http://loinc.org | Pediatric surgery Hospital Progress note |
100623-8 | http://loinc.org | Pediatric transplant hepatology Hospital Progress note |
100624-6 | http://loinc.org | Pharmacogenomics Hospital Progress note |
100625-3 | http://loinc.org | Pharmacology Hospital Progress note |
100626-1 | http://loinc.org | Physical medicine and rehab Hospital Progress note |
100627-9 | http://loinc.org | Physical therapy Hospital Progress note |
10062-8 | http://loinc.org | S' wave amplitude in lead II |
100628-7 | http://loinc.org | Plastic surgery Hospital Progress note |
100629-5 | http://loinc.org | Podiatry Hospital Progress note |
100630-3 | http://loinc.org | Psychology Hospital Progress note |
100631-1 | http://loinc.org | Radiation oncology Hospital Progress note |
100632-9 | http://loinc.org | Radiology Hospital Progress note |
100633-7 | http://loinc.org | Rapid response team Hospital Progress note |
100634-5 | http://loinc.org | Recreational therapy Hospital Progress note |
100635-2 | http://loinc.org | Reproductive endocrinology and infertility Hospital Progress note |
10063-6 | http://loinc.org | S' wave amplitude in lead III |
100636-0 | http://loinc.org | Research Hospital Progress note |
100637-8 | http://loinc.org | Rheumatology Hospital Progress note |
100638-6 | http://loinc.org | Sleep medicine Hospital Progress note |
100639-4 | http://loinc.org | Social worker Hospital Progress note |
100640-2 | http://loinc.org | Solid Organ Transplant Hospital Progress note |
100641-0 | http://loinc.org | Speech-language pathology Hospital Progress note |
100642-8 | http://loinc.org | Spinal surgery Hospital Progress note |
100643-6 | http://loinc.org | Surgery of the hand Hospital Progress note |
10064-4 | http://loinc.org | S' wave amplitude in lead V1 |
100644-4 | http://loinc.org | Thromboembolism Hospital Progress note |
100645-1 | http://loinc.org | Trauma Hospital Progress note |
100646-9 | http://loinc.org | Urology Hospital Progress note |
100647-7 | http://loinc.org | Vascular neurology Hospital Progress note |
100648-5 | http://loinc.org | Vascular surgery Hospital Progress note |
100649-3 | http://loinc.org | Wound care management Hospital Progress note |
100650-1 | http://loinc.org | Wound, Ostomy, and Continence Care Hospital Progress note |
10065-1 | http://loinc.org | S' wave amplitude in lead V2 |
100651-9 | http://loinc.org | Hospital COVID-19 Intubation Progress note |
100652-7 | http://loinc.org | Pure tone bone conduction threshold audiometry panel |
100653-5 | http://loinc.org | Pure tone air conduction threshold audiometry panel |
100654-3 | http://loinc.org | Pyruvate kinase M2 [Presence] in Stool |
100655-0 | http://loinc.org | XR Sella turcica Lateral |
100656-8 | http://loinc.org | Maternal and fetal medicine Outpatient Progress note |
100657-6 | http://loinc.org | Maternal and fetal medicine Telephone encounter+Hospital Progress note |
100658-4 | http://loinc.org | Hospital COVID-19 Progress note |
100659-2 | http://loinc.org | Maternal and fetal medicine Hospital Progress note |
1006-6 | http://loinc.org | Direct antiglobulin test.IgG specific reagent [Interpretation] on Red Blood Cells |
100660-0 | http://loinc.org | Maternal and fetal medicine Telephone encounter+Outpatient Progress note |
100661-8 | http://loinc.org | Psychiatry Outpatient Progress note |
100662-6 | http://loinc.org | Cortisol free and total panel - Serum or Plasma |
100663-4 | http://loinc.org | TPMT gene c.460G>A and c.719A>G [Presence] in Blood by Molecular genetics method |
100664-2 | http://loinc.org | NUDT15 gene c.50_55dup and c.415C>T [Presence] in Blood by Molecular genetics method |
100665-9 | http://loinc.org | NUDT15 gene c.415C>T [Presence] in Blood by Molecular genetics method |
100666-7 | http://loinc.org | NUDT15 gene c.416G>A [Presence] in Blood by Molecular genetics method |
100667-5 | http://loinc.org | NUDT15 gene c.52G>A [Presence] in Blood by Molecular genetics method |
100668-3 | http://loinc.org | NUDT15 gene c.50_55dup [Presence] in Blood by Molecular genetics method |
10066-9 | http://loinc.org | S' wave amplitude in lead V3 |
100669-1 | http://loinc.org | NUDT15 gene c.50_55del [Presence] in Blood by Molecular genetics method |
100670-9 | http://loinc.org | RHD gene allele [Identifier] in Plasma cell-free DNA Nominal--fetus |
100671-7 | http://loinc.org | Aspergillus sp DNA [Presence] in Blood by NAA with probe detection |
100672-5 | http://loinc.org | Aspergillus fumigatus DNA [Presence] in Blood by NAA with probe detection |
100673-3 | http://loinc.org | Aspergillus terreus DNA [Presence] in Blood by NAA with probe detection |
100674-1 | http://loinc.org | BK virus DNA [Log #/volume] (viral load) in Blood by NAA with probe detection |
100675-8 | http://loinc.org | Cytomegalovirus DNA [Units/volume] (viral load) in Blood by NAA with probe detection |
100676-6 | http://loinc.org | Cytomegalovirus DNA [log units/volume] (viral load) in Blood by NAA with probe detection |
10067-7 | http://loinc.org | S' wave amplitude in lead V4 |
100677-4 | http://loinc.org | Epstein Barr virus DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection |
100678-2 | http://loinc.org | Epstein Barr virus DNA [Log #/volume] (viral load) in Blood by NAA with probe detection |
100679-0 | http://loinc.org | Herpes virus 6 DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection |
100680-8 | http://loinc.org | Herpes virus 6 DNA [Log #/volume] (viral load) in Blood by NAA with probe detection |
100681-6 | http://loinc.org | Herpes virus 7 DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection |
100682-4 | http://loinc.org | Herpes virus 7 DNA [Log #/volume] (viral load) in Blood by NAA with probe detection |
100683-2 | http://loinc.org | Herpes virus 8 DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection |
100684-0 | http://loinc.org | Herpes virus 8 DNA [Log #/volume] (viral load) in Blood by NAA with probe detection |
10068-5 | http://loinc.org | S' wave amplitude in lead V5 |
100685-7 | http://loinc.org | JC virus DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection |
100686-5 | http://loinc.org | JC virus DNA [Log #/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection |
100687-3 | http://loinc.org | JC virus DNA [Log #/volume] (viral load) in Urine by NAA with probe detection |
100688-1 | http://loinc.org | Parvovirus B19 DNA [Log #/volume] (viral load) in Blood by NAA with probe detection |
100689-9 | http://loinc.org | Toxoplasma gondii DNA [Log #/volume] in Serum or Plasma by NAA with probe detection |
100690-7 | http://loinc.org | Toxoplasma gondii DNA [Log #/volume] in Cerebral spinal fluid by NAA with probe detection |
100691-5 | http://loinc.org | Varicella zoster virus DNA [Log #/volume] (viral load) in Blood by NAA with probe detection |
100692-3 | http://loinc.org | Varicella zoster virus DNA [Log #/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection |
10069-3 | http://loinc.org | S' wave amplitude in lead V6 |
100693-1 | http://loinc.org | Pneumocystis jiroveci DNA [Log #/volume] in Respiratory system specimen by NAA with probe detection |
100694-9 | http://loinc.org | SMN1 gene silent carrier analysis [Presence] in Blood or Tissue by Molecular genetics method |
100695-6 | http://loinc.org | Genetic disease analysis overall carrier interpretation in Blood or Tissue by Molecular genetics method Narrative |
100696-4 | http://loinc.org | CTNS related multigene analysis [Identifier] in Bodyfluid and Serum or Plasma by Molecular genetics method Nominal |
100697-2 | http://loinc.org | Interventional radiology Outpatient Note |
100698-0 | http://loinc.org | Social Determinants of Health screening report Document |
100699-8 | http://loinc.org | Rifabutin+Ethambutol [Susceptibility] |
100700-4 | http://loinc.org | Trichomonas vaginalis DNA [Presence] in Urethra by NAA with probe detection |
10070-1 | http://loinc.org | S' wave duration in lead AVF |
100701-2 | http://loinc.org | Trichomonas vaginalis rRNA [Presence] in Urethra by NAA with probe detection |
100702-0 | http://loinc.org | Mycoplasma genitalium rRNA [Presence] in Urethra by NAA with probe detection |
100703-8 | http://loinc.org | Mycoplasma genitalium rRNA [Presence] in Urine by NAA with probe detection |
100704-6 | http://loinc.org | Mycoplasma genitalium rRNA [Presence] in Cervix by NAA with probe detection |
100705-3 | http://loinc.org | Mycoplasma genitalium rRNA [Presence] in Anorectal by NAA with probe detection |
100706-1 | http://loinc.org | Mycoplasma genitalium rRNA [Presence] in Specimen by NAA with probe detection |
100707-9 | http://loinc.org | Polymorphonuclear cells [#/volume] in Peritoneal dialysis fluid by Automated count |
100708-7 | http://loinc.org | Plasma cells/100 leukocytes in Synovial fluid |
100709-5 | http://loinc.org | Hepatocellular carcinoma risk [Score] by GAAD |
100710-3 | http://loinc.org | Chlamydia trachomatis and Neisseria gonorrhoeae rRNA panel - Throat by NAA with probe detection |
100711-1 | http://loinc.org | Borrelia burgdorferi.VlsE1+pepC10 Ab [Units/volume] in Serum by Immunoassay |
100712-9 | http://loinc.org | Brexpiprazole [Mass/volume] in Serum or Plasma |
100713-7 | http://loinc.org | Cariprazine [Mass/volume] in Serum or Plasma |
100714-5 | http://loinc.org | Guanfacine [Mass/volume] in Serum or Plasma |
100715-2 | http://loinc.org | Prothipendyl [Mass/volume] in Serum or Plasma |
100716-0 | http://loinc.org | Prostate specific Ag [Mass/volume] in DBS |
100717-8 | http://loinc.org | FCGR3A gene.p.Phe176Val [Presence] in Blood or Tissue by Molecular genetics method |
100718-6 | http://loinc.org | Undersea and hyperbaric medicine Discharge summary |
10071-9 | http://loinc.org | S' wave duration in lead AVL |
100719-4 | http://loinc.org | Surgical oncology Discharge summary |
100720-2 | http://loinc.org | Reproductive endocrinology and infertility Discharge summary |
100721-0 | http://loinc.org | Community health care Discharge summary |
100722-8 | http://loinc.org | Integrative medicine Discharge summary |
100723-6 | http://loinc.org | Sports medicine Discharge summary |
100724-4 | http://loinc.org | Diabetology Discharge summary |
100725-1 | http://loinc.org | Optometry Discharge summary |
100726-9 | http://loinc.org | Podiatry Discharge summary |
10072-7 | http://loinc.org | S' wave duration in lead AVR |
100727-7 | http://loinc.org | Chiropractic medicine Discharge summary |
100728-5 | http://loinc.org | Cardiac surgery Discharge summary |
100729-3 | http://loinc.org | Breastfeeding Discharge summary |
100730-1 | http://loinc.org | Transplant surgery Discharge summary |
100731-9 | http://loinc.org | Urgent care center Discharge summary |
100732-7 | http://loinc.org | Cholesterol.in lipoprotein (little a) and Cholesterol.in LDL panel - Serum |
100733-5 | http://loinc.org | Cholesterol in LDL [Mass/volume] in Serum by calculation --corrected for Cholesterol.in lipoprotein (little a) |
100734-3 | http://loinc.org | traMADol and Metabolites Panel - Urine by Confirmatory method |
10073-5 | http://loinc.org | S' wave duration in lead I |
100735-0 | http://loinc.org | Mannose-6-phosphate isomerase and phosphomannomutase 1 panel - Leukocytes |
100736-8 | http://loinc.org | Acylcarnitine Analysis Post Mortem in Specimen Document |
100737-6 | http://loinc.org | Alkaline phosphatase.macromolecular [Presence] in Serum or Plasma |
100738-4 | http://loinc.org | Alanine aminotransferase.macromolecular [Presence] in Serum or Plasma |
100739-2 | http://loinc.org | Aspartate aminotransferase.macromolecular [Presence] in Serum or Plasma |
1007-4 | http://loinc.org | Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells |
100740-0 | http://loinc.org | Amylase.macromolecular [Presence] in Serum or Plasma |
100741-8 | http://loinc.org | Gamma glutamyl transferase.macromolecular [Presence] in Serum or Plasma |
100742-6 | http://loinc.org | Lactate dehydrogenase.macromolecular [Presence] in Serum or Plasma |
10074-3 | http://loinc.org | S' wave duration in lead II |
100743-4 | http://loinc.org | Lipase.macromolecular [Presence] in Serum or Plasma |
100744-2 | http://loinc.org | Alpha-1-acid glycoprotein [Mass/volume] in Serum or Plasma by Electrophoresis |
100745-9 | http://loinc.org | Chloride [Moles/volume] in Mixed venous blood |
100746-7 | http://loinc.org | Glucose [Moles/volume] in Mixed venous blood |
100747-5 | http://loinc.org | Legionella serogroup panel - Specimen |
100748-3 | http://loinc.org | Legionella spp [Presence] in Specimen by NAA with probe detection |
100749-1 | http://loinc.org | Legionella pneumophila serogroup 1 [Presence] in Specimen by NAA with probe detection |
10075-0 | http://loinc.org | S' wave duration in lead III |
100750-9 | http://loinc.org | Legionella pneumophila non-serogroup 1 [Presence] in Specimen by NAA with probe detection |
100751-7 | http://loinc.org | Galactose-alpha-1,3-galactose (Alpha-Gal) panel - Serum or Plasma |
100752-5 | http://loinc.org | Exacerbating factors - Reported |
100753-3 | http://loinc.org | Alleviating factors - Reported |
100754-1 | http://loinc.org | Platelet disorders multigene analysis in Blood or Tissue by Sequencing |
100755-8 | http://loinc.org | Oligoclonal bands [#] in Serum or Plasma by Isoelectric focusing |
100756-6 | http://loinc.org | Oligoclonal bands [Interpretation] in Cerebral spinal fluid by Isoelectric focusing |
100757-4 | http://loinc.org | Protein fractions.oligoclonal bands panel - Serum and CSF by Isoelectric focusing |
100758-2 | http://loinc.org | Estimated lung age by based on clinical data |
100759-0 | http://loinc.org | Inspiratory reserve [Volume] Respiratory system by Spirometry |
100760-8 | http://loinc.org | XR Radius and Ulna - left Single view |
100761-6 | http://loinc.org | PALB2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
100762-4 | http://loinc.org | HBA2 gene.c.377T>C [Presence] in Blood by Molecular genetics method |
100763-2 | http://loinc.org | Mycobacterium sp comparative reaction interpretation Narrative |
100764-0 | http://loinc.org | Mycobacterium bovis reaction wheal [Diameter] Qualitative --3 days post dose mammalian tuberculin intradermal |
100765-7 | http://loinc.org | Homocysteine and methylmalonate and methylcitrate panel - DBS |
100766-5 | http://loinc.org | Center for Epidemiologic Studies Depression Scale panel [CES-D] |
100767-3 | http://loinc.org | Bothered by things that are not usually bothersome |
10076-8 | http://loinc.org | S' wave duration in lead V1 |
100768-1 | http://loinc.org | Poor appetite |
100769-9 | http://loinc.org | Unhappy even with help from my family or friends |
100770-7 | http://loinc.org | Feeling just as good as others |
100771-5 | http://loinc.org | Trouble focusing |
100772-3 | http://loinc.org | Feeling depressed |
100773-1 | http://loinc.org | Feeling everything is too much of an effort |
100774-9 | http://loinc.org | Feeling hopeful about the future |
100775-6 | http://loinc.org | Feeling life had been a failure |
10077-6 | http://loinc.org | S' wave duration in lead V2 |
100776-4 | http://loinc.org | Feeling fearful |
100777-2 | http://loinc.org | Restless sleep |
100778-0 | http://loinc.org | Feeling happy |
100779-8 | http://loinc.org | Quieter than usual |
100780-6 | http://loinc.org | Feeling lonely |
100781-4 | http://loinc.org | People were unfriendly |
100782-2 | http://loinc.org | Enjoying life |
100783-0 | http://loinc.org | Crying spells |
10078-4 | http://loinc.org | S' wave duration in lead V3 |
100784-8 | http://loinc.org | Feeling sad |
100785-5 | http://loinc.org | Feeling people dislike me |
100786-3 | http://loinc.org | Lack of energy |
100787-1 | http://loinc.org | Total Score CES-D |
100788-9 | http://loinc.org | Stemphylium botryosum IgG4 Ab [Mass/volume] in Serum |
100789-7 | http://loinc.org | Rhizopus nigricans IgG4 Ab [Mass/volume] in Serum |
100790-5 | http://loinc.org | Lepidoglyphus destructor IgG Ab [Mass/volume] in Serum |
100791-3 | http://loinc.org | Hamster epithelium IgG Ab [Mass/volume] in Serum |
10079-2 | http://loinc.org | S' wave duration in lead V4 |
100792-1 | http://loinc.org | Forsythia IgE Ab [Units/volume] in Serum |
100793-9 | http://loinc.org | Testosterone [Mass/volume] in Body fluid |
100794-7 | http://loinc.org | Follitropin [Units/volume] in Body fluid |
100795-4 | http://loinc.org | S100 calcium binding protein B [Mass/volume] in Body fluid |
100796-2 | http://loinc.org | Thyroglobulin [Mass/volume] in Body fluid |
100797-0 | http://loinc.org | Testosterone Free [Mass/volume] in Serum --1st specimen post XXX challenge |
100798-8 | http://loinc.org | Testosterone Free [Mass/volume] in Serum --2nd specimen post XXX challenge |
100799-6 | http://loinc.org | 21-Deoxycortisol [Mass/volume] in Serum --1st specimen post XXX challenge |
100-8 | http://loinc.org | Cefoperazone [Susceptibility] by Minimum inhibitory concentration (MIC) |
10080-0 | http://loinc.org | S' wave duration in lead V5 |
100800-2 | http://loinc.org | 21-Deoxycortisol [Mass/volume] in Serum --2nd specimen post XXX challenge |
100801-0 | http://loinc.org | 21-Deoxycortisol [Mass/volume] in Serum --3rd specimen post XXX challenge |
100802-8 | http://loinc.org | 21-Deoxycortisol [Mass/volume] in Serum --4th specimen post XXX challenge |
100803-6 | http://loinc.org | 21-Deoxycortisol [Mass/volume] in Serum --5th specimen post XXX challenge |
100804-4 | http://loinc.org | Vasopressin [Moles/volume] in Plasma --1st specimen post XXX challenge |
100805-1 | http://loinc.org | Vasopressin [Moles/volume] in Plasma --2nd specimen post XXX challenge |
100806-9 | http://loinc.org | Vasopressin [Moles/volume] in Plasma --3rd specimen post XXX challenge |
100807-7 | http://loinc.org | Vasopressin [Moles/volume] in Plasma --4th specimen post XXX challenge |
100808-5 | http://loinc.org | Vasopressin [Moles/volume] in Plasma --5th specimen post XXX challenge |
100809-3 | http://loinc.org | Vasopressin [Moles/volume] in Plasma --6th specimen post XXX challenge |
100810-1 | http://loinc.org | Vasopressin [Moles/volume] in Plasma --7th specimen post XXX challenge |
100811-9 | http://loinc.org | Vasopressin [Moles/volume] in Plasma --8th specimen post XXX challenge |
100812-7 | http://loinc.org | Vasopressin [Moles/volume] in Plasma --9th specimen post XXX challenge |
100813-5 | http://loinc.org | Vasopressin [Moles/volume] in Plasma --10th specimen post XXX challenge |
100814-3 | http://loinc.org | Vasopressin [Moles/volume] in Plasma --11th specimen post XXX challenge |
100815-0 | http://loinc.org | Vasopressin [Moles/volume] in Plasma --12th specimen post XXX challenge |
100816-8 | http://loinc.org | Glucagon [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge |
100817-6 | http://loinc.org | Glucagon [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge |
10081-8 | http://loinc.org | S' wave duration in lead V6 |
100818-4 | http://loinc.org | Renin [Mass/volume] in Plasma --1st specimen post XXX challenge |
100819-2 | http://loinc.org | Renin [Mass/volume] in Plasma --2nd specimen post XXX challenge |
1008-2 | http://loinc.org | Indirect antiglobulin test.polyspecific reagent [Presence] in Serum or Plasma |
100820-0 | http://loinc.org | Renin [Mass/volume] in Plasma --3rd specimen post XXX challenge |
100821-8 | http://loinc.org | National POLST form: portable medical order panel |
100822-6 | http://loinc.org | Cardiopulmonary resuscitation orders |
100823-4 | http://loinc.org | Initial portable medical treatment orders |
100824-2 | http://loinc.org | Additional portable medical orders or instructions |
100825-9 | http://loinc.org | Medically assisted nutrition orders |
10082-6 | http://loinc.org | ST initial amplitude 6 ms in lead AVF |
100826-7 | http://loinc.org | Portable medical order AndOr advance directive review |
100827-5 | http://loinc.org | Portable medical order discussion participants |
100828-3 | http://loinc.org | Portable medical order administrative information |
100829-1 | http://loinc.org | Renin [Mass/volume] in Plasma --4th specimen post XXX challenge |
100830-9 | http://loinc.org | Alpha subunit free [Units/volume] in Serum or Plasma --1st specimen post XXX challenge |
100831-7 | http://loinc.org | Alpha subunit free [Units/volume] in Serum or Plasma --2nd specimen post XXX challenge |
100832-5 | http://loinc.org | Alpha subunit free [Units/volume] in Serum or Plasma --3rd specimen post XXX challenge |
100833-3 | http://loinc.org | Alpha subunit free [Units/volume] in Serum or Plasma --4th specimen post XXX challenge |
10083-4 | http://loinc.org | ST initial amplitude 6 ms in lead AVL |
100834-1 | http://loinc.org | Alpha subunit free [Units/volume] in Serum or Plasma --5th specimen post XXX challenge |
100835-8 | http://loinc.org | Alpha subunit free [Units/volume] in Serum or Plasma --6th specimen post XXX challenge |
100836-6 | http://loinc.org | Alpha subunit free [Units/volume] in Serum or Plasma --7th specimen post XXX challenge |
100837-4 | http://loinc.org | Insulin-like growth factor-I [Mass/volume] in Serum or Plasma --9th specimen post XXX challenge |
100838-2 | http://loinc.org | Testosterone [Mass/volume] in Serum or Plasma --9th specimen post XXX challenge |
100839-0 | http://loinc.org | Vitamin A/Retinol binding protein [Ratio] in Serum or Plasma |
100840-8 | http://loinc.org | IgE [Units/volume] in Body fluid |
100841-6 | http://loinc.org | Zinc finger protein of the cerebellum 4 Ab [Presence] in Cerebral spinal fluid by Line blot |
10084-2 | http://loinc.org | ST initial amplitude 6 ms in lead AVR |
100842-4 | http://loinc.org | Nonalcoholic steatohepatitis score in Serum or Plasma Calculated by FAST |
100843-2 | http://loinc.org | Liver fibrosis score in Serum or Plasma by Calculated.Agile3+ |
100844-0 | http://loinc.org | Liver fibrosis score in Serum or Plasma by Calculated.Agile4 |
100845-7 | http://loinc.org | Neurofascin155 IgG4 Ab [Presence] in Serum by Flow cytometry (FC) |
100846-5 | http://loinc.org | Dengue virus 1+2+3+4 nsP1 IgG Ab [Presence] in Serum or Plasma by Immunoassay |
100847-3 | http://loinc.org | Gas and ammonia panel - Arterial blood |
100848-1 | http://loinc.org | Cell count and Differential panel - Amniotic fluid by Manual count |
100849-9 | http://loinc.org | Leukocytes [#/volume] in Amniotic fluid by Manual count |
100850-7 | http://loinc.org | Neutrophils [#/volume] in Amniotic fluid by Manual count |
100851-5 | http://loinc.org | Other cells [#/volume] in Amniotic fluid by Manual count |
100852-3 | http://loinc.org | NM Bones Views for metastasis W Sr-89 IV |
100853-1 | http://loinc.org | NM Pericardial space Pericardial effusion |
100854-9 | http://loinc.org | Lymphocytes/100 cells in Blood mononuclear cells by Immunoassay |
100855-6 | http://loinc.org | CD3 cells/100 cells in Blood mononuclear cells |
100856-4 | http://loinc.org | CD3+CD4+ (T4 helper) cells/100 cells in Blood mononuclear cells |
100857-2 | http://loinc.org | CD3+CD8+ (T8 suppressor) cells/100 cells in Blood mononuclear cells |
100858-0 | http://loinc.org | Cells.CD4+CD154+/CD4 cells in Blood --after stimulation with SARS-CoV-2 Spike peptide |
10085-9 | http://loinc.org | ST initial amplitude 6 ms in lead I |
100859-8 | http://loinc.org | Cells.CD4.Interferon gamma-expressing/CD4 cells in Blood --after stimulation with SARS-CoV-2 Spike peptide |
100860-6 | http://loinc.org | Cells.CD4.Tumor necrosis factor alfa-expressing/CD4 cells in Blood --after stimulation with SARS-CoV-2 Spike peptide |
100861-4 | http://loinc.org | Cells.CD4+CD154+/CD4 cells in Blood --after stimulation with SARS-CoV-2 Nucleocapsid peptide |
100862-2 | http://loinc.org | Cells.CD4.Interferon gamma-expressing/CD4 cells in Blood --after stimulation with SARS-CoV-2 Nucleocapsid peptide |
100863-0 | http://loinc.org | Cells.CD4.Tumor necrosis factor alfa-expressing/CD4 cells in Blood --after stimulation with SARS-CoV-2 Nucleocapsid peptide |
100864-8 | http://loinc.org | Giardia lamblia bg gene [Genotype] in Specimen by Molecular genetics method |
100865-5 | http://loinc.org | Avian schistosomes DNA [Presence] in Specimen by NAA with probe detection |
100866-3 | http://loinc.org | Febrile antibody profile in Serum |
10086-7 | http://loinc.org | ST initial amplitude 6 ms in lead II |
100867-1 | http://loinc.org | Campylobacter jejuni+coli+lari+upsaliensis Ag [Presence] in Stool by Rapid immunoassay |
100868-9 | http://loinc.org | Cryptosporidium sp 18S-LC2 rRNA [Genotype] in Specimen by Molecular genetics method |
100869-7 | http://loinc.org | Cryptosporidium gp60 gene [Type] in Specimen by Molecular genetics method |
100870-5 | http://loinc.org | Cryptosporidium 18S rRNA [Genotype] in Specimen by Molecular genetics method |
100871-3 | http://loinc.org | Giardia lamblia gdh gene [Genotype] in Specimen by Molecular genetics method |
100872-1 | http://loinc.org | Bacteria producing polysaccharide from sucrose [Presence] in Isolate |
100873-9 | http://loinc.org | Giardia lamblia tpi gene [Genotype] in Specimen by Molecular genetics method |
100874-7 | http://loinc.org | Basidiobolus sp [Presence] in Specimen |
10087-5 | http://loinc.org | ST initial amplitude 6 ms in lead III |
100875-4 | http://loinc.org | Fetal Heart Document limited US |
100876-2 | http://loinc.org | Fetal Heart Document US |
100877-0 | http://loinc.org | US Heart Transesophageal during surgery |
100878-8 | http://loinc.org | Endoscopic ultrasound study Upper GI tract Document |
100879-6 | http://loinc.org | US Guidance for cryoablation of Breast - right |
100880-4 | http://loinc.org | US Guidance for cryoablation of Breast - left |
100881-2 | http://loinc.org | MR Guidance for cryoablation of Bone |
100882-0 | http://loinc.org | MR Peritoneum W contrast percutaneous intraperitoneal |
10088-3 | http://loinc.org | ST initial amplitude 6 ms in lead V1 |
100883-8 | http://loinc.org | MR Guidance for biopsy of Kidney - left |
100884-6 | http://loinc.org | MR Guidance for biopsy of Kidney - right |
100885-3 | http://loinc.org | Parapoxvirus DNA [Presence] in Specimen by NAA with probe detection |
100886-1 | http://loinc.org | Orf virus DNA [Presence] in Specimen by NAA with probe detection |
100887-9 | http://loinc.org | Pseudocowpox virus DNA [Presence] in Specimen by NAA with probe detection |
100888-7 | http://loinc.org | Monkeypox virus clade II DNA [Presence] in Specimen by NAA with probe detection |
100889-5 | http://loinc.org | Monkeypox virus clade I DNA [Presence] in Specimen by NAA with probe detection |
100890-3 | http://loinc.org | Poxvirus DNA panel |
10089-1 | http://loinc.org | ST initial amplitude 6 ms in lead V2 |
100891-1 | http://loinc.org | Orthopoxvirus IgG Ab [Presence] in Serum or Plasma by Immunoassay |
100892-9 | http://loinc.org | Orthopoxvirus IgM Ab [Presence] in Serum or Plasma by Immunoassay |
100893-7 | http://loinc.org | Orthopoxvirus IgG and IgM Ab panel - Serum or Plasma |
100894-5 | http://loinc.org | Recommended screening frequency Narrative |
100895-2 | http://loinc.org | Rickettsia conorii IgG and IgM [Interpretation] in Serum |
100896-0 | http://loinc.org | Vasopressin [Moles/volume] in Plasma --13th specimen post XXX challenge |
100897-8 | http://loinc.org | Staphylococcus aureus [Presence] in Specimen by Organism specific culture |
100898-6 | http://loinc.org | Lipid panel - Serum or Plasma |
100899-4 | http://loinc.org | Enterobacteriaceae.extended spectrum beta lactamase resistance phenotype [Identifier] in Specimen by Organism specific culture |
Additional Language Displays
Code | Deutsch (Österreich) (German (Austria), de) | Deutsch (Deutschland) (German (Germany), de) | English (United States) (English (United States), en) | Spanish (Argentina) (es) | Spanish (es) | Nederlands (Nederland) (Dutch (Netherlands), nl) | Portuguese (Brazil) (pt) |
100000-9 | Health Info Pioneer+Father of LOINC | ||||||
100001-7 | Health Info Pioneer+Cofound LOINC | ||||||
100002-5 | Specimen care is maintained | ||||||
100003-3 | Team communication is maintained throughout care | ||||||
100004-1 | Demonstrates knowledge of the expected psychosocial responses to the procedure | ||||||
100005-8 | Demonstrates knowledge of nutritional management related to the procedure | ||||||
100006-6 | Demonstrates knowledge of medication management | ||||||
100007-4 | Demonstrates knowledge of pain management | ||||||
10000-8 | R wave dur L-AVR | duración de la onda R.derivación AVR:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda R. Lead AVR:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | R onda dur L-AVR | |||
100008-2 | Demonstrates knowledge of wound management | ||||||
100009-0 | Demonstrates knowledge of the procedure and expected results | ||||||
100010-8 | No injury related to procedure equipment, medical supplies, or instrumentation | ||||||
100011-6 | No injury related to an electrical source | ||||||
100012-4 | Participates in decisions affecting the patient's plan of care | ||||||
100013-2 | Participates in the discharge process | ||||||
100014-0 | Psychosocial health is maintained at or improved from baseline | ||||||
100015-7 | No injury related to positioning due to care or procedure | ||||||
10001-6 | R wave dur L-I | duración de la onda R.derivación I:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda R.:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | R onda dur L-I | |||
100016-5 | No injury related to a laser source | ||||||
100017-3 | Perioperative nursing data set outcomes panel [PNDS] | ||||||
100018-1 | Hospice care Note | Verslag [bevinding] in {instelling} d.m.v. hospicezorg (document) | |||||
100019-9 | ALK gene targeted mutation analysis, Blood or tissue specimen | ALK-gen doelgerichte mutatie-analyse [identificator] in bloed of weefsel d.m.v. moleculair genetisch onderzoek | |||||
100020-7 | GNA11 gene targeted mutation analysis, Blood or tissue specimen | GNA11-gen doelgerichte mutatie-analyse [identificator] in bloed of weefsel d.m.v. moleculair genetisch onderzoek | |||||
100021-5 | GNAQ gene targeted mutation analysis, Blood or tissue specimen | GNAQ-gen doelgerichte mutatie-analyse [identificator] in bloed of weefsel d.m.v. moleculair genetisch onderzoek | |||||
100022-3 | IDH1 gene targeted mutation analysis, Blood or tissue specimen | IDH1-gen doelgerichte mutatie-analyse [identificator] in bloed of weefsel d.m.v. moleculair genetisch onderzoek | |||||
100023-1 | IDH2 gene targeted mutation analysis, Blood or tissue specimen | IDH2-gen doelgerichte mutatie-analyse [identificator] in bloed of weefsel d.m.v. moleculair genetisch onderzoek | |||||
10002-4 | R wave dur L-II | duración de la onda R.derivación II:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda R. derivación II:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | R onda dur L-II | |||
100024-9 | SETBP1 gene targeted mutation analysis, Blood or tissue specimen | SETBP1-gen doelgerichte mutatie-analyse [identificator] in bloed of weefsel d.m.v. moleculair genetisch onderzoek | |||||
100025-6 | SRSF2 gene targeted mutation analysis, Blood or tissue specimen | SRSF2-gen doelgerichte mutatie-analyse [identificator] in bloed of weefsel d.m.v. moleculair genetisch onderzoek | |||||
100026-4 | MET gene targeted mutation analysis, Blood or tissue specimen | MET-gen doelgerichte mutatie-analyse [identificator] in bloed of weefsel d.m.v. moleculair genetisch onderzoek | |||||
100027-2 | SMAD4 gene targeted mutation analysis, Blood or tissue specimen | SMAD4-gen doelgerichte mutatie-analyse [identificator] in bloed of weefsel d.m.v. moleculair genetisch onderzoek | |||||
100028-0 | FBXW7 gene targeted mutation analysis, Blood or tissue specimen | FBXW7-gen doelgerichte mutatie-analyse [identificator] in bloed of weefsel d.m.v. moleculair genetisch onderzoek | |||||
100029-8 | Cancer related multigene analysis (cfDNA) | Kankergerelateerde multigen-analyse [bevinding] in plasma.celvrij DNA d.m.v. moleculair genetisch onderzoek (document) | |||||
100030-6 | Axis I: Temporal aspects score [Mainz Pain Staging System] | ||||||
100031-4 | Axis II: Spatial aspects score [Mainz Pain Staging System] | ||||||
10003-2 | R wave dur L-III | duración de la onda R.derivación III:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda R. derivación III:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | R onda dur L-III | |||
100032-2 | Axis III: Drug taking behavior score [Mainz Pain Staging System] | ||||||
100033-0 | Axis IV: Utilization of the health care system score [Mainz Pain Staging System] | ||||||
100034-8 | Provider of AED | ||||||
100035-5 | Exam finding location Chest | ||||||
100036-3 | Exam finding location Lung | ||||||
100037-1 | Patient contact disposition EMS unit | ||||||
100038-9 | Patient eval disposition EMS unit | ||||||
100039-7 | Crew disposition EMS unit | ||||||
10004-0 | R wave dur L-V1 | duración de la onda R.derivación V1:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda R. derivación V1:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | R onda dur L-V1 | |||
100040-5 | Pt transport disposition EMS unit | ||||||
100041-3 | Aminoglycosid-Empfindlichkeit | Aminoglycosid [Empfindlichkeit] | Susceptibility to Aminoglycoside | ||||
100042-1 | Atovaquon-Empfindlichkeit | Susceptibility to Atovaquone | Atovaquone [gevoeligheid] in isolaat | ||||
100043-9 | Azithromycin/Ethambutol-Empfindlichkeit | Azithromycin+Ethambutol [Empfindlichkeit] | Susceptibility to Azithromycin+Ethambutol | Azitromycine + ethambutol [gevoeligheid] in isolaat | |||
100044-7 | Cefcapene-Empfindlichkeit | Cefcapen [Empfindlichkeit] | Susceptibility to Cefcapene | Cefcapeen [gevoeligheid] in isolaat | |||
100045-4 | Cefozopran-Empfindlichkeit | Susceptibility to Cefozopran | Cefozopran [gevoeligheid] in isolaat | ||||
100046-2 | Cefquinom-Empfindlichkeit | Susceptibility to Cefquinome | Cefquinome [gevoeligheid] in isolaat | ||||
100047-0 | Cefteram-Empfindlichkeit | Susceptibility to Cefteram | Cefteram [gevoeligheid] in isolaat | ||||
100048-8 | Clarithromycin/Ethambutol-Empfindlichkeit | Clarithromycin+Ethambutol [Empfindlichkeit] | Susceptibility to Clarithromycin+Ethambutol | Clarithromycine + ethambutol [gevoeligheid] in isolaat | |||
100049-6 | Eravacycline-Empfindlichkeit | Eravacyclin [Empfindlichkeit] | Susceptibility to Eravacycline | Eravacycline [gevoeligheid] in isolaat | |||
100050-4 | Erythromycin/Ethambutol-Empfindlichkeit | Erythromycin+Ethambutol [Empfindlichkeit] | Susceptibility to Erythromycin+Ethambutol | Erytromycine + ethambutol [gevoeligheid] in isolaat | |||
100051-2 | Ethambutol/rifAMPin-Empfindlichkeit | Ethambutol+Rifampicin [Empfindlichkeit] | Susceptibility to Ethambutol+rifAMPin | Ethambutol + rifampicine [gevoeligheid] in isolaat | |||
100052-0 | Flomoxef-Empfindlichkeit | Flomoxef [Empfindlichkeit] | Susceptibility to Flomoxef | Flomoxef [gevoeligheid] in isolaat | |||
100053-8 | Fluoroquinolon-Empfindlichkeit | Fluorchinolon [Empfindlichkeit] | Susceptibility to Fluoroquinolone | Fluorchinolon [gevoeligheid] in isolaat | |||
100054-6 | Gamithromycin-Empfindlichkeit | Susceptibility to Gamithromycin | |||||
100055-3 | Optochin-Empfindlichkeit | Optochin [Empfindlichkeit] | Susceptibility to Optochin | Optochine [gevoeligheid] in isolaat | |||
100056-1 | Panipenem-Empfindlichkeit | Panipenem [Empfindlichkeit] | Susceptibility to Panipenem | Panipenem [gevoeligheid] in isolaat | |||
10005-7 | R wave dur L-V2 | duración de la onda R.derivación V2:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda R. derivación V2:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | R onda dur L-V2 | |||
100057-9 | Prothionamid-Empfindlichkeit | Prothionamid [Empfindlichkeit] | Susceptibility to Prothionamide | Prothionamide [gevoeligheid] in isolaat | |||
100058-7 | Prulifloxacin-Empfindlichkeit | Prulifloxacin [Empfindlichkeit] | Susceptibility to Prulifloxacin | Prulifloxacine [gevoeligheid] in isolaat | |||
100059-5 | Rifapentin-Empfindlichkeit | Rifapentin [Empfindlichkeit] | Susceptibility to Rifapentine | Rifapentine [gevoeligheid] in isolaat | |||
100060-3 | Tildipirosin-Empfindlichkeit | Susceptibility to Tildipirosin | |||||
100061-1 | Tosufloxacin-Empfindlichkeit | Tosufloxacin [Empfindlichkeit] | Susceptibility to Tosufloxacin | Tosufloxacine [gevoeligheid] in isolaat | |||
100062-9 | SDOM panel | ||||||
100063-7 | Primary skin concern | ||||||
100064-5 | Itch severity RptPeriod Reported | ||||||
10006-5 | R wave dur L-V3 | duración de la onda R.derivación V3:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda R. derivación V3:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | R onda dur L-V3 | |||
100065-2 | Satisfied with treatment | ||||||
100066-0 | Specular microscopy panel | Endotheelcelmicroscopie panel in oog d.m.v. endotheelcelmicroscopie | |||||
100067-8 | Eye Image magnification | ||||||
100068-6 | R eye Fixation point [Angle] | ||||||
100069-4 | L eye Fixation point [Angle] | ||||||
100070-2 | R cornea Cell density | ||||||
100071-0 | L cornea Cell density | ||||||
100072-8 | R cornea Coefficient of variation | ||||||
10007-3 | R wave dur L-V4 | duración de la onda R.derivación V4:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda R. derivación V4:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | R onda dur L-V4 | |||
100073-6 | L cornea Coefficient of variation | ||||||
100074-4 | R cornea Hexagonality | ||||||
100075-1 | L cornea Hexagonality | ||||||
100076-9 | R cornea Endothelial cells counted | ||||||
100077-7 | L cornea Endothelial cells counted | ||||||
100078-5 | R cornea Endothelial cell area.min | ||||||
100079-3 | L cornea Endothelial cell area.min | ||||||
100080-1 | R cornea Endothelial cell area.max | ||||||
10008-1 | R wave dur L-V5 | duración de la onda R.derivación V5:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda R. Plomo V5:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | R onda dur L-V5 | |||
100081-9 | L cornea Endothelial cell area.max | ||||||
100082-7 | R cornea Endothelial cell area.mean | ||||||
100083-5 | L cornea Endothelial cell area.mean | ||||||
100084-3 | R cornea Cell area.sd | ||||||
100085-0 | L cornea Cell area.sd | ||||||
100086-8 | R cornea Analysis method | ||||||
100087-6 | Toxocara canis 24-35kD IgG antibody, Blood | Toxocara canis 24-35kD As.IgG [aanwezigheid] in serum d.m.v. immunoblotting | |||||
100088-4 | Taenia solium larva Ab bands panel, Blood | Taenia solium larve As banden panel in serum d.m.v. immunoblotting | |||||
100089-2 | Taenia solium larva 6-8kD antibody, Blood | Taenia solium larve 6-8kD As [aanwezigheid] in serum d.m.v. immunoblotting | |||||
1000-9 | DBG antibody, Blood Product Unit | [anticuerpo anti - ] DBG [Ac]:concentración arbitraria:punto en el tiempo:suero/plasma^unidad de hemoderivado:ordinal: | DBG Ab: Suero o plasma Unidad de hemoderivado: Punto temporal: Presencia o umbral: Ordinal: | DBG As [aanwezigheid] in serum of plasma^bloedproducteenheid | DBG Ac SerPl BPU Ql | ||
100090-0 | Taenia solium larva 45kD antibody, Blood | Taenia solium larve 45kD As [aanwezigheid] in serum d.m.v. immunoblotting | |||||
100091-8 | Trypanosoma cruzi antibody, Blood | Trypanosoma cruzi As [eenheid/volume] in serum d.m.v. immunoassay | |||||
100092-6 | Trypanosoma cruzi Ab bands panel, Blood | Trypanosoma cruzi As banden panel in serum d.m.v. immunoblotting | |||||
100093-4 | Trypanosoma cruzi 15-16kD IgG antibody, Blood | Trypanosoma cruzi 15-16kD As.IgG [aanwezigheid] in serum d.m.v. immunoblotting | |||||
100094-2 | Trypanosoma cruzi 21-22kD IgG antibody, Blood | Trypanosoma cruzi 21-22kD As.IgG [aanwezigheid] in serum d.m.v. immunoblotting | |||||
100095-9 | Trypanosoma cruzi 27-28kD IgG antibody, Blood | Trypanosoma cruzi 27-28kD As.IgG [aanwezigheid] in serum d.m.v. immunoblotting | |||||
100096-7 | Trypanosoma cruzi 42kD IgG antibody, Blood | Trypanosoma cruzi 42kD As.IgG [aanwezigheid] in serum d.m.v. immunoblotting | |||||
100097-5 | Trypanosoma cruzi 45-47kD IgG antibody, Blood | Trypanosoma cruzi 45-47kD As.IgG [aanwezigheid] in serum d.m.v. immunoblotting | |||||
100098-3 | Trypanosoma cruzi 120-200kD IgG antibody, Blood | Trypanosoma cruzi 120-200kD As.IgG [aanwezigheid] in serum d.m.v. immunoblotting | |||||
10009-9 | R wave dur L-V6 | duración de la onda R.derivación V6:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda R. Plomo V6:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | R onda dur L-V6 | |||
100099-1 | Trypanosoma cruzi 160kD IgG antibody, Blood | Trypanosoma cruzi 160kD As.IgG [aanwezigheid] in serum d.m.v. immunoblotting | |||||
100100-7 | Fasciola sp IgG antibody, Blood | Fasciola sp. As.IgG [aanwezigheid] in serum d.m.v. immunoassay | |||||
100101-5 | Fasciola sp 8-9kD IgG antibody, Blood | Fasciola sp. 8-9kD As.IgG [aanwezigheid] in serum d.m.v. immunoblotting | |||||
100102-3 | Fasciola sp 27-28kD IgG antibody, Blood | Fasciola sp. 27-28kD As.IgG [aanwezigheid] in serum d.m.v. immunoblotting | |||||
100103-1 | Fasciola sp 60kD IgG antibody, Blood | Fasciola sp. 60kD As.IgG [aanwezigheid] in serum d.m.v. immunoblotting | |||||
100104-9 | Fasciola sp 42kD IgG antibody, Blood | Fasciola sp. 42kD As.IgG [aanwezigheid] in serum d.m.v. immunoblotting | |||||
100105-6 | Filaria IgG and IgM panel, Blood | Filaria As.IgG & IgM panel in serum | |||||
100106-4 | Filaria IgG antibody, Blood | Filaria As.IgG [aanwezigheid] in serum d.m.v. immunoassay | |||||
10010-7 | R' wave Amp L-AVF | amplitud de la onda R'.derivación AVF:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de onda R 'plomo AVF:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | R' onda Amp L-AVF | |||
100107-2 | Leishmania sp IgG antibody, Blood | Leishmania sp. As.IgG [aanwezigheid] in serum d.m.v. immunoassay | |||||
100108-0 | Leishmania sp IgG antibody, Blood | Leishmania sp. As.IgG [eenheid/volume] in serum d.m.v. immunoassay | |||||
100109-8 | Leishmania sp Ab bands panel, Blood | Leishmania sp. As banden panel in serum d.m.v. immunoblotting | |||||
100110-6 | Leishmania sp 14kD IgG antibody, Blood | Leishmania sp. 14kD As.IgG [aanwezigheid] in serum d.m.v. immunoblotting | |||||
100111-4 | Leishmania sp 16kD IgG antibody, Blood | Leishmania sp. 16kD As.IgG [aanwezigheid] in serum d.m.v. immunoblotting | |||||
100112-2 | Fasciola sp Ab bands panel, Blood | Fasciola sp. As-banden panel in serum d.m.v. immunoblotting | |||||
100113-0 | Helicobacter pylori Ab panel, Blood | Helicobacter pylori As panel in serum | |||||
100114-8 | Toxoplasma gondii 30kD antibody, Blood | Toxoplasma gondii 30kD As [aanwezigheid] in serum d.m.v. immunoblotting | |||||
10011-5 | R' wave Amp L-AVL | amplitud de la onda R'.derivación AVL:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de onda R 'plomo AVL:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | R' onda Amp L-AVL | |||
100115-5 | Toxoplasma gondii 31kD antibody, Blood | Toxoplasma gondii 31kD As [aanwezigheid] in serum d.m.v. immunoblotting | |||||
100116-3 | Toxoplasma gondii 33kD antibody, Blood | Toxoplasma gondii 33kD As [aanwezigheid] in serum d.m.v. immunoblotting | |||||
100117-1 | Toxoplasma gondii 40kD antibody, Blood | Toxoplasma gondii 40kD As [aanwezigheid] in serum d.m.v. immunoblotting | |||||
100118-9 | Toxoplasma gondii 41kD antibody, Blood | Toxoplasma gondii 41kD As [aanwezigheid] in serum d.m.v. immunoblotting | |||||
100119-7 | Toxoplasma gondii 45kD antibody, Blood | Toxoplasma gondii 45kD As [aanwezigheid] in serum d.m.v. immunoblotting | |||||
100120-5 | Chlamydia trachomatis Ab panel, Blood | Chlamydia trachomatis As panel in serum | |||||
100121-3 | Chlamydia trachomatis IgA-Antikörper [Nachweis] in Serum mittels Immunoassay | Chlamydia trachomatis IgA antibody, Blood | Chlamydia trachomatis As.IgA [aanwezigheid] in serum d.m.v. immunoassay | ||||
100122-1 | C. pneumoniae Ab panel, Blood | Chlamydophila pneumoniae As panel in serum | |||||
10012-3 | R' wave Amp L-AVR | amplitud de la onda R'.derivación AVR:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de onda R 'plomo AVR:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | R' onda Amp L-AVR | |||
100123-9 | Chlamydophila pneumoniae IgA antibody, Blood | Chlamydophila pneumoniae As.IgA [aanwezigheid] in serum d.m.v. immunoassay | |||||
100124-7 | Chlamydophila pneumoniae IgA antibody, Blood | Chlamydophila pneumoniae As.IgA [eenheid/volume] in serum d.m.v. immunoassay | |||||
100125-4 | C. psittaci Ab panel, Blood | Chlamydophila psittaci As panel in serum | |||||
100126-2 | Bordetella pertussis Ab.IgG panel, Blood | Bordetella pertussis As.IgG panel in serum | |||||
100127-0 | Campylobacter sp Ab panel, Blood | Campylobacter sp. As panel in serum | |||||
100128-8 | Cryptococcus sp Ag panel, Blood | Cryptococcus sp. Ag panel in serum | |||||
100129-6 | Schistosoma sp antibody, Blood | Schistosoma sp. As [titer] in serum d.m.v. hemagglutinatie | |||||
100130-4 | Schistosoma mansoni antibody, Blood | Schistosoma mansoni As [aanwezigheid] in serum d.m.v. immunoblotting | |||||
10013-1 | R' wave Amp L-I | amplitud de la onda R'.derivación I:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de la onda R '. I:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | R' onda Amp L-I | |||
100131-2 | Schistosoma sp 8kD antibody, Blood | Schistosoma sp. 8kD As [aanwezigheid] in serum d.m.v. immunoblotting | |||||
100132-0 | Schistosoma sp 9kD antibody, Blood | Schistosoma sp. 9kD As [aanwezigheid] in serum d.m.v. immunoblotting | |||||
100133-8 | Schistosoma sp 10kD antibody, Blood | Schistosoma sp. 10kD As [aanwezigheid] in serum d.m.v. immunoblotting | |||||
100134-6 | Schistosoma sp 11kD antibody, Blood | Schistosoma sp. 11kD As [aanwezigheid] in serum d.m.v. immunoblotting | |||||
100135-3 | Schistosoma sp 12-13kD antibody, Blood | Schistosoma sp. 12-13kD As [aanwezigheid] in serum d.m.v. immunoblotting | |||||
100136-1 | Schistosoma sp 14-15kD antibody, Blood | Schistosoma sp. 14-15kD As [aanwezigheid] in serum d.m.v. immunoblotting | |||||
100137-9 | Schistosoma sp 15-16kD antibody, Blood | Schistosoma sp. 15-16kD As [aanwezigheid] in serum d.m.v. immunoblotting | |||||
100138-7 | Schistosoma sp 18-19kD antibody, Blood | Schistosoma sp. 18-19kD As [aanwezigheid] in serum d.m.v. immunoblotting | |||||
100139-5 | Schistosoma sp 22-24kD antibody, Blood | Schistosoma sp. 22-24kD As [aanwezigheid] in serum d.m.v. immunoblotting | |||||
100140-3 | Schistosoma sp 30-34kD antibody, Blood | Schistosoma sp. 30-34kD As [aanwezigheid] in serum d.m.v. immunoblotting | |||||
100141-1 | Schistosoma sp 65kD antibody, Blood | Schistosoma sp. 65kD As [aanwezigheid] in serum d.m.v. immunoblotting | |||||
100142-9 | Schistosoma sp 70kD antibody, Blood | Schistosoma sp. 70kD As [aanwezigheid] in serum d.m.v. immunoblotting | |||||
100143-7 | Schistosoma sp 80kD antibody, Blood | Schistosoma sp. 80kD As [aanwezigheid] in serum d.m.v. immunoblotting | |||||
100144-5 | Schistosoma sp 95kD antibody, Blood | Schistosoma sp. 95kD As [aanwezigheid] in serum d.m.v. immunoblotting | |||||
100145-2 | Schistosoma sp 110kD antibody, Blood | Schistosoma sp. 110kD As [aanwezigheid] in serum d.m.v. immunoblotting | |||||
100146-0 | Schistosoma sp 120kD antibody, Blood | Schistosoma sp. 120kD As [aanwezigheid] in serum d.m.v. immunoblotting | |||||
100147-8 | Toxoplasma gondii Ab bands panel, Blood | Toxoplasma gondii As banden panel in serum d.m.v. immunoblotting | |||||
100148-6 | Schistosoma sp Ab bands panel, Blood | Schistosoma sp. As banden panel in serum d.m.v. immunoblotting | |||||
10014-9 | R' wave Amp L-II | amplitud de la onda R'.derivación II:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de onda R 'derivación II:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | R' onda Amp L-II | |||
100149-4 | 6-oxo-piperidine-2-carboxylate and 6(R+S)-oxo-propylpiperidine-2-carboxylate panel, Urine+Blood | 6-oxo-piperidine-2-carboxylaat & 6(R+S)-oxo-propylpiperidine-2-carboxylaat in urine en serum of plasma | |||||
100150-2 | 6(R+S)-oxo-propylpiperidine-2-carboxylate, Blood | 6(R+S)-oxo-propylpiperidine-2-carboxylaat [mol/volume] in plasma | |||||
100151-0 | 6-oxo-piperidine-2-carboxylate, Blood | 6-oxo-piperidine-2-carboxylaat [mol/volume] in plasma | |||||
100152-8 | 6-oxo-piperidine-2-carboxylate/Creatinine, Urine | 6-oxo-piperidine-2-carboxylaat/creatinine [molaire verhouding] in urine | |||||
100153-6 | 6(R+S)-oxo-propylpiperidine-2-carboxylate/Creatinine, Urine | 6(R+S)-oxo-propylpiperidine-2-carboxylaat/creatinine [molaire verhouding] in urine | |||||
100154-4 | Collection supervision level, Specimen | ||||||
100155-1 | L cornea Analysis method | ||||||
10015-6 | R' wave Amp L-III | amplitud de la onda R'.derivación III:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de onda R 'derivación III:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | R' onda Amp L-III | |||
100156-9 | SARS-CoV-2 (COVID-19)-Variante [Typ] in Probenmaterial mittels Nukleinsäureamplifikation mit Sondendetektion | SARS-CoV-2 (COVID-19) variant, Specimen | SARS-CoV-2-variant [type] d.m.v. probe-detectie | ||||
100157-7 | SARS-CoV-2 (COVID-19)-Abstammungslinie [Typ] in Probenmaterial mittels Sequenzierung | SARS-CoV-2 (COVID-19) lineage, Specimen | SARS-CoV-2 lineage [type] d.m.v. sequencing | ||||
100158-5 | Albumin, Urine | Albumine [massa/volume] in urine (verzamelduur niet gespecificeerd) d.m.v. detectielimiet <= 20 mg/L | |||||
100159-3 | Knee Society Score pre-op panel [Knee Society Score] | ||||||
100160-1 | Knee replacement | ||||||
100161-9 | Charnley Functional Classification | ||||||
100162-7 | Alignment W Stand Knee XR | ||||||
100163-5 | Knee medial AndOr lateral instability W full extension | ||||||
10016-4 | R' wave Amp L-V1 | amplitud de la onda R'.derivación V1:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de onda R 'derivación V1:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | R' onda Amp L-V1 | |||
100164-3 | Knee AP instability W 90 degree flexion | ||||||
100165-0 | Knee Qn | ||||||
100166-8 | Flexion contracture range Knee | ||||||
100167-6 | Extensor lag range Knee | ||||||
100168-4 | Knee pain severity with level walking | ||||||
100169-2 | Knee pain severity with stairs or inclines | ||||||
1001-7 | DBG antibody, Donor Blood | [anticuerpo anti - ] DBG [Ac]:concentración arbitraria:punto en el tiempo:relación suero/plasma^donante:ordinal: | DBG Ab: Suero o plasma Donante: Punto temporal: Presencia o umbral: Ordinal: | DBG As [aanwezigheid] in serum of plasma^donor | DBG Ac SerPl Donr Ql | ||
100170-0 | Knee feels normal | ||||||
100171-8 | Satisfaction with level of knee pain while sitting | ||||||
10017-2 | R' wave Amp L-V2 | amplitud de la onda R'.derivación V2:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de onda R 'derivación V2:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | R' onda Amp L-V2 | |||
100172-6 | Satisfaction with level of knee pain while lying in bed | ||||||
100173-4 | Satisfaction with knee function while getting out of bed | ||||||
100174-2 | Satisfaction with knee function while performing light household duties | ||||||
100175-9 | Satisfaction with knee function while performing recreational activities | ||||||
100176-7 | Expect surgery to relieve pain | ||||||
100177-5 | Expect surgery will improve ability to perform activities of daily living | ||||||
100178-3 | Expect surgery will improve ability to perform leisure, recreational, or sports activities | ||||||
100179-1 | Walk without assistive mobility devices | ||||||
10018-0 | R' wave Amp L-V3 | amplitud de la onda R'.derivación V3:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de onda R 'derivación V3:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | R' onda Amp L-V3 | |||
100180-9 | Assistive mobility devices used | ||||||
100181-7 | Assistive mobility devices used due to health condition | ||||||
100182-5 | Duration of standing before sitting due to knee discomfort | ||||||
100183-3 | Duration of walking before stopping due to knee discomfort | ||||||
100184-1 | How bothersome is knee when walking on an uneven surface | ||||||
100185-8 | How bothersome is knee when turning or pivoting leg | ||||||
100186-6 | How bothersome is knee when climbing up or down a flight of stairs | ||||||
100187-4 | How bothersome is knee when getting up from a low seat without armrests | ||||||
100188-2 | How bothersome is knee when getting into or out of a car | ||||||
100189-0 | How bothersome is knee when moving laterally | ||||||
100190-8 | How bothersome is knee when climbing a ladder or step stool | ||||||
100191-6 | How bothersome is knee when carrying a bag for one block | ||||||
100192-4 | How bothersome is knee when squatting | ||||||
100193-2 | How bothersome is knee when kneeling | ||||||
100194-0 | How bothersome is knee when running | ||||||
100195-7 | Pain severity--during activity | ||||||
100196-5 | Pre-op total score [Knee Society Score] | ||||||
100197-3 | Exercise activity and pain severity panel | ||||||
10019-8 | R' wave Amp L-V4 | amplitud de la onda R'.derivación V4:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de onda R 'derivación V4:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | R' onda Amp L-V4 | |||
100198-1 | Pre-op objective knee indicators score [Knee Society Score] | ||||||
100199-9 | Pre-op symptoms score [Knee Society Score] | ||||||
100200-5 | Pre-op patient expectations score [Knee Society Score] | ||||||
100201-3 | Pre-op functional activities score [Knee Society Score] | ||||||
100202-1 | Pre-op discretionary knee activities score [Knee Society Score] | ||||||
100203-9 | Knee Society Score post-op panel [Knee Society Score] | ||||||
100204-7 | Accuracy of pre-surgery expectations of pain relief | ||||||
100205-4 | Accuracy of pre-surgery expectations to perform activities of daily living | ||||||
10020-6 | R' wave Amp L-V5 | amplitud de la onda R'.derivación V5:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de onda R 'derivación V5:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | R' onda Amp L-V5 | |||
100206-2 | Accuracy of pre-surgery expectations to perform leisure, recreational, or sports activities | ||||||
100207-0 | Post-op total score [Knee Society Score] | ||||||
100208-8 | Post-op objective knee indicators score [Knee Society Score] | ||||||
100209-6 | Post-op symptoms score [Knee Society Score] | ||||||
100210-4 | Post-op patient expectations score [Knee Society Score] | ||||||
100211-2 | Post-op functional activities score [Knee Society Score] | ||||||
100212-0 | Post-op discretionary knee activities score [Knee Society Score] | ||||||
100213-8 | Prostate cancer multigene analysis, Blood or tissue specimen | Prostaatkanker multigen-analyse [bevinding] in bloed of weefsel d.m.v. moleculair genetisch onderzoek (document) | |||||
10021-4 | R' wave Amp L-V6 | amplitud de la onda R'.derivación V6:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de onda R 'derivación V6:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | R' onda Amp L-V6 | |||
100214-6 | Dental model prior auth Doc | ||||||
100215-3 | Episode of care med rec Doc Transpl surg | Verslag van zorgepisode [bevinding] d.m.v. transplantatiechirurgie (document) | |||||
100216-1 | Surgical synoptic report | Beknopt rapport [bevinding] d.m.v. chirurgie (tekstueel) | |||||
100217-9 | Synoptic report Surg Onc | ||||||
100218-7 | Surg onc colon CA synoptic rep | ||||||
100219-5 | Surg onc melanoma CA synoptic rep | ||||||
100220-3 | Surg onc breast CA synoptic rep | ||||||
100221-1 | Surg onc thyroid CA synoptic rep | ||||||
10022-2 | R' wave dur L-AVF | duración de la onda R'.derivación AVF:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda R 'plomo AVF:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | R' onda dur L-AVF | |||
100222-9 | Surg onc pancreas CA synoptic rep | ||||||
100223-7 | Retina Phys find | ||||||
100224-5 | Cardiac LV SWM Pnl LV US | ||||||
100225-2 | Bone density QUS | ||||||
100226-0 | Sm bowel capsule endo study Doc | ||||||
100227-8 | Colon capsule endo study Doc | ||||||
100228-6 | UGI capsule endo study Doc | ||||||
100229-4 | Endo US study Doc | ||||||
10023-0 | R' wave dur L-AVL | duración de la onda R'.derivación AVL:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda R 'plomo AVL:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | R' onda dur L-AVL | |||
100230-2 | Routine prenatal pnl | ||||||
100231-0 | EBUS study | ||||||
100232-8 | Impacts of Events Scale-Revised panel | ||||||
100233-6 | Reminders brought back feelings about adverse event | ||||||
100234-4 | Trouble staying asleep | ||||||
100235-1 | Other things triggered persistent thoughts about adverse event | ||||||
100236-9 | Felt irritable AndOr angry | ||||||
100237-7 | Avoided getting upset when unintentionally thought about adverse event | ||||||
100238-5 | Thought about adverse event unintentionally | ||||||
100239-3 | Felt as if adverse event did not happen | ||||||
100240-1 | Avoided reminders of adverse event | ||||||
100241-9 | Experienced mental images of adverse event | ||||||
100242-7 | Easily startled | ||||||
100243-5 | Tried to not think of adverse event | ||||||
100244-3 | Aware of feelings about adverse event, but did not address them | ||||||
100245-0 | Feelings about adverse event were numb | ||||||
100246-8 | Acted or felt the same as during adverse event | ||||||
100247-6 | Trouble falling asleep | ||||||
10024-8 | R' wave dur L-AVR | duración de la onda R'.derivación AVR:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda R 'plomo AVR:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | R' onda dur L-AVR | |||
100248-4 | Waves of strong feelings about adverse event | ||||||
100249-2 | Tried to remove adverse event from memory | ||||||
1002-5 | DBG antibody, Blood | [anticuerpo anti - ] DBG [Ac]:concentración arbitraria:punto en el tiempo:suero/plasma:ordinal: | DBG Ab: Suero o Plasma : Punto temporal: Presencia o umbral: Ordinal: | DBG As [aanwezigheid] in serum of plasma | DBG Ac SerPl Ql | ||
100250-0 | Trouble concentrating | ||||||
100251-8 | Reminders of adverse event caused physical reactions | ||||||
100252-6 | Had dreams about adverse event | ||||||
100253-4 | Felt watchful and on-guard | ||||||
100254-2 | Tried not to talk about adverse event | ||||||
10025-5 | R' wave dur L-I | duración de la onda R'.derivación I:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda R '.:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | R' onda dur L-I | |||
100255-9 | Total score [Impact of Event Scale-Revised] | ||||||
100256-7 | Fallen in last 6Mo | ||||||
100257-5 | Feel unsteady when standing or walking | ||||||
100258-3 | History of fall related injury | ||||||
100259-1 | Aware of tactile sensations | ||||||
100260-9 | Easy to describe thoughts AndOr feelings | ||||||
100261-7 | Critical of own thoughts AndOr feelings | ||||||
100262-5 | Able to notice distressing thoughts AndOr feelings without having to react | ||||||
10026-3 | R' wave dur L-II | duración de la onda R'.derivación II:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda R 'derivación II:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | R' onda dur L-II | |||
100263-3 | Easily distracted | ||||||
100264-1 | Able to notice thoughts AndOr feelings without being overwhelmed | ||||||
100265-8 | Aware of dietary intake impact on self | ||||||
100266-6 | Difficult to describe thoughts AndOr feelings | ||||||
100267-4 | Aware of auditory stimuli | ||||||
100268-2 | Able to avoid immediate reaction in difficult situations | ||||||
100269-0 | Do things without paying attention | ||||||
100270-8 | Recover quickly from distressing thoughts AndOr images | ||||||
10027-1 | R' wave dur L-III | duración de la onda R'.derivación III:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda R 'derivación III:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | R' onda dur L-III | |||
100271-6 | Aware of olfactory stimuli | ||||||
100272-4 | Aware of visual stimuli | ||||||
100273-2 | Aware of emotions affect on thoughts AndOr behavior | ||||||
100274-0 | Observing score [FFMQ] | ||||||
100275-7 | Describing score [FFMQ] | ||||||
100276-5 | Acting with awareness score [FFMQ] | ||||||
100277-3 | Nonjudging score [FFMQ] | ||||||
100278-1 | Nonreactivity score [FFMQ] | ||||||
100279-9 | Total score [FFMQ] | ||||||
100280-7 | Five Facet Mindfulness Questionnaire panel [FFMQ] | ||||||
100281-5 | D antibody, Blood | D As [eenheid/volume] in serum of plasma | |||||
100282-3 | Vaccine exemption cert | ||||||
100283-1 | Harris Hip Score panel [Harris Hip Score] | ||||||
100284-9 | Walking - functional ability | ||||||
100285-6 | Comfortable seated position | ||||||
100286-4 | Able to board public transportation | ||||||
100287-2 | Put on shoes and socks | ||||||
100288-0 | Absence of deformity score [Harris Hip Score] | ||||||
10028-9 | R' wave dur L-V1 | duración de la onda R'.derivación V1:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda R 'derivación V1:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | R' onda dur L-V1 | |||
100289-8 | Absence of hip deformity measurements | ||||||
100290-6 | Range of motion score [Harris Hip Score] | ||||||
100291-4 | Total score [Harris Hip Score] | ||||||
100292-2 | Pre-op patient satisfaction score [Knee Society Score] | ||||||
100293-0 | Hip Flexion range of motion | ||||||
100294-8 | Hip Abduction range of motion | ||||||
100295-5 | Hip Adduction range of motion | ||||||
100296-3 | Hip External rotation range of motion | ||||||
10029-7 | R' wave dur L-V2 | duración de la onda R'.derivación V2:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda R 'derivación V2:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | R' onda dur L-V2 | |||
100297-1 | Hip Internal rotation range of motion | ||||||
100298-9 | Rep count | ||||||
100299-7 | Post-op patient satisfaction score [Knee Society Score] | ||||||
100300-3 | End time | ||||||
100301-1 | Start time | ||||||
100302-9 | Time start/end panel Spec | ||||||
100303-7 | Condition certainty of presence | ||||||
100304-5 | Flights climbed RptPeriod | ||||||
10030-5 | R' wave dur L-V3 | duración de la onda R'.derivación V3:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda R 'derivación V3:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | R' onda dur L-V3 | |||
100305-2 | IDH1 gene exon 4 targeted mutation analysis, Blood Or Bone marrow | IDH1-gen exon 4 doelgerichte mutatie-analyse [aanwezigheid] in bloed of beenmerg d.m.v. moleculair genetisch onderzoek | |||||
100306-0 | IDH2 gene exon 4 targeted mutation analysis, Blood Or Bone marrow | IDH2-gen exon 4 doelgerichte mutatie-analyse [aanwezigheid] in bloed of beenmerg d.m.v. moleculair genetisch onderzoek | |||||
100307-8 | Behavioral screening elder mistreatment | ||||||
100308-6 | Need help getting to essential places | ||||||
100309-4 | Activity support person | ||||||
100310-2 | Reliability of support person | ||||||
100311-0 | Need help to make sure there is enough food, medicines or any other things needed in house | ||||||
100312-8 | Person or persons that makes sure there is enough food, medicines or any other things needed in house | ||||||
10031-3 | R' wave dur L-V4 | duración de la onda R'.derivación V4:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda R 'derivación V4:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | R' onda dur L-V4 | |||
100313-6 | Need help with household things such as cook meals, help feed, or provide correct medicines each day | ||||||
100314-4 | Need help with house cleaning or yard work | ||||||
100315-1 | Need help getting out of bed, showered, or dressed | ||||||
100316-9 | Need help to make sure bills get paid | ||||||
100317-7 | Relationship of usual support person for daily activities | ||||||
100318-5 | Have help with finances AndOr financial decisions | ||||||
100319-3 | Relationship of financial support person | ||||||
100320-1 | Financial support person usually asks for permission before making decisions | ||||||
10032-1 | R' wave dur L-V5 | duración de la onda R'.derivación V5:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda R 'plomo V5:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | R' onda dur L-V5 | |||
100321-9 | Financial support person usually makes good decisions about finances | ||||||
100322-7 | Have access to paperwork for financial decisions made | ||||||
100323-5 | Financial support person forged signature | ||||||
100324-3 | Coercion of financial support person for signing a document in order to get money or possessions | ||||||
100325-0 | Experienced theft by support person | ||||||
100326-8 | Money spent or property sold without permission | ||||||
100327-6 | Stranger forged signature for financial gain | ||||||
100328-4 | Stranger forced document signature for financial gain | ||||||
100329-2 | Feared for safety due to verbal attack | ||||||
1003-3 | Indirect Antiglobulin Test (IAT; Indirect Coombs), Blood | prueba de antiglobulina indirecta.reactivo específico de complemento:concentración arbitraria:punto en el tiempo:suero/plasma:ordinal: | Prueba de antiglobulina indirecta, reactivo específico del complemento: Suero o Plasma : Punto temporal: Presencia o umbral: Ordinal: | Indirecte antiglobulinetest.complement-specifiek reagent [aanwezigheid] in serum of plasma | IAT Comp-Sp Reag SerPl Ql | ||
100330-0 | Felt humiliated due to ridicule | ||||||
100331-8 | Coerced to do something | ||||||
100332-6 | Ignored by close friend or relative for extended period | ||||||
100333-4 | Physically hit or threatened | ||||||
100334-2 | Been physically hurt with some degree of injury | ||||||
100335-9 | Coerced sexual activity | ||||||
100336-7 | Coerced touching of private body parts of self or others | ||||||
100337-5 | Coerced to undress or expose private body area | ||||||
100338-3 | Photographed in any degree of nudity without consent | ||||||
10033-9 | R' wave dur L-V6 | duración de la onda R'.derivación V6:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda R 'plomo V6:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | R' onda dur L-V6 | |||
100339-1 | Experienced attempted physical restraint | ||||||
100340-9 | Range of motion panel Hip | ||||||
100341-7 | Rötelnvirus Antikörper-Index | Röteln-Virus IgG-Antikörperindex [Einheiten/Volumen] in Serum und Liquor | Rubella virus IgG index, Serum+Cerebrospinal fluid | Rubellavirus As.IgG-index [eenheid/volume] in serum en liquor cerebrospinalis | |||
100342-5 | Flüchtige organische Verbindungen assoziiert mit SARS-CoV-2-Infektion [Nachweis] in Exhalat mittels GC-MS | Volatile Organic Compounds associated with SARS-CoV-2 infection, Exhaled gas | Vluchtige organische componenten bij SARS-CoV-2-infectie [aanwezigheid] in uitgeademde lucht d.m.v. gaschromatografie-massaspectrometrie | ||||
100343-3 | Influenza-Virus B RNA [Nachweis] in Speichel mittels Nukleinsäureamplifikation mit Sondendetektion | Influenza B (Flu B), Saliva | Influenzavirus B RNA [aanwezigheid] in speeksel d.m.v. probe-detectie | ||||
100344-1 | Influenza-Virus A RNA [Nachweis] in Speichel mittels Nukleinsäureamplifikation mit Sondendetektion | Influenza A (Flu A), Saliva | Influenzavirus A RNA [aanwezigheid] in speeksel d.m.v. probe-detectie | ||||
100345-8 | Influenza-Virus A und Influenza-Virus B und SARS-CoV-2 (COVID-19) RNA (Liste) - Probenmaterial mittels Nukleinsäureamplifikation mit Sondendetektion | Influenza virus A and B and SARS-CoV-2 (COVID-19) RNA panel, Specimen | Influenzavirus A & influenzavirus B & SARS-CoV-2 RNA panel d.m.v. probe-detectie | ||||
100346-6 | Clotting Time FIBTEM | Clotting time.extrinsic coagulation system activated.platelets inhibited, Blood | |||||
10034-7 | S wave Amp L-AVF | amplitud de la onda S.derivación AVF:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de onda S. Conducir AVF:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | S onda Amp L-AVF | |||
100347-4 | Clot Formation Time FIBTEM | Clot formation.extrinsic coagulation system activated.platelets inhibited, Blood | |||||
100348-2 | MELDNa score | ||||||
100349-0 | DOP Penis ves W vasodilator IV | ||||||
100350-8 | Sesamum indicum 1 allergy test | Sesamum indicum 1 As.IgE [eenheid/volume] in serum | |||||
100351-6 | Pioglitazone, Blood | Pioglitazon [aanwezigheid] in serum of plasma | |||||
100352-4 | Rosiglitazone, Blood | Rosiglitazon [aanwezigheid] in serum of plasma | |||||
100353-2 | Norwalk Community Health Center Screening Tool [NCHC] | ||||||
10035-4 | S wave Amp L-AVL | amplitud de la onda S.derivación AVL:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de onda S. Conducir AVL:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | S onda Amp L-AVL | |||
100354-0 | Frequency of participating in multi-modal communication without assistance | ||||||
100355-7 | Frequency of participating in spoken language expression communication without assistance | ||||||
100356-5 | Chlamydia trachomatis and Neisseria gonorrhoeae and Trichomonas vaginalis, Specimen | Chlamydia trachomatis & Neisseria gonorrhoeae & Trichomonas vaginalis DNA [identificator] d.m.v. probe-detectie | |||||
100357-3 | Naloxone, Umbilical cord tissue | Naloxon [aanwezigheid] in weefsel van navelstreng d.m.v. screening | |||||
100358-1 | Phentermine, Umbilical cord tissue | Fentermine [aanwezigheid] in weefsel van navelstreng d.m.v. screening | |||||
100359-9 | Gliadin 33 mer peptide, Stool | Gliadin 33-mer peptide [massa/volume] in feces d.m.v. immunoassay | |||||
100360-7 | Brief Resilience Scale panel [BRS] | ||||||
100361-5 | Quickly recover from bad events | ||||||
10036-2 | S wave Amp L-AVR | amplitud de la onda S.derivación AVR:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de onda S. Conducir AVR:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | S onda Amp L-AVR | |||
100362-3 | Difficulty making it through stressful events | ||||||
100363-1 | Easily recover from a stressful event | ||||||
100364-9 | Difficulty recovering from bad events | ||||||
100365-6 | Easily recover from difficulties | ||||||
100366-4 | Lengthy recovery from setbacks | ||||||
100367-2 | Total Score BRS | ||||||
100368-0 | Amino Acids Urea Cycle Panel, Blood | Aminozuren ureumcyclus panel in serum of plasma d.m.v. LC/MS/MS | |||||
100369-8 | NM Thyroid Views W Tl-201 IV | ||||||
10037-0 | S wave Amp L-I | amplitud de la onda S.derivación I:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de la onda S. Conduzca I:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | S onda Amp L-I | |||
100370-6 | Orthopoxvirus DNA [Nachweis oder Identität] in Probenmaterial mittels Nukleinsäureamplifikation mit Sondendetektion | Orthopoxvirus, Specimen | Orthopoxvirus DNA [identificator] d.m.v. probe-detectie | ||||
100371-4 | Titin antibody, Blood | ||||||
100372-2 | Abiraterone, Blood | Abirateron [massa/volume] in serum of plasma | |||||
100373-0 | Agar- agar IgG antibody | Eucheuma As.IgG [eenheid/volume] in serum | |||||
100374-8 | Aloe vera IgG antibody | Aloë vera As.IgG [eenheid/volume] in serum | |||||
100375-5 | Anise IgG antibody | Pimpinella anisum As.IgG [eenheid/volume] in serum | |||||
100376-3 | Bambusa vulgaris IgG antibody | Bambusa vulgaris As.IgG [eenheid/volume] in serum | |||||
100377-1 | Goat cheese IgG antibody | Geitenkaas As.IgG [eenheid/volume] in serum | |||||
100378-9 | Sheep cheese IgG antibody | Schapenkaas As.IgG [eenheid/volume] in serum | |||||
100379-7 | Leeks IgG antibody | Allium ampeloprasum As.IgG [eenheid/volume] in serum | |||||
100380-5 | Red cabbage IgG antibody | Brassica rubra As.IgG [eenheid/volume] in serum | |||||
100381-3 | Mentha balsamea Wild IgG antibody | Pepermunt As.IgG [eenheid/volume] in serum | |||||
100382-1 | FDA insert REMS addressed risk | ||||||
100383-9 | Affenpockenvirus-DNA ql. /Sondermaterial PCR | Affenpocken-Virus DNA [Nachweis] in Probenmaterial mittels Nukleinsäureamplifikation mit Sondendetektion | Monkeypox virus, Specimen | Mpoxvirus DNA [aanwezigheid] d.m.v. probe-detectie | |||
100384-7 | Rapeseed IgG antibody | Brassica rapa As.IgG [eenheid/volume] in serum | |||||
100385-4 | Corn salad IgG antibody | Valerianella locusta As.IgG [eenheid/volume] in serum | |||||
100386-2 | Rosemary IgG antibody | Rosmarinus officinalis As.IgG [eenheid/volume] in serum | |||||
100387-0 | Poppy seed IgG antibody | Papaver somniferum As.IgG [eenheid/volume] in serum | |||||
10038-8 | S wave Amp L-II | amplitud de la onda S.derivación II:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de onda S. derivación II:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | S onda Amp L-II | |||
100388-8 | Cocoa IgG antibody | Theobroma cacao As.IgG [eenheid/volume] in serum | |||||
100389-6 | Pistachio IgG antibody | Pistacia vera As.IgG [eenheid/volume] in serum | |||||
100390-4 | Sunflower seed IgG antibody | Helianthus annuus zaad As.IgG [eenheid/volume] in serum | |||||
100391-2 | Dates IgG antibody | Phoenix dactylifera As.IgG [eenheid/volume] in serum | |||||
100392-0 | Duck meat IgG antibody | Eendenvlees As.IgG [eenheid/volume] in serum | |||||
100393-8 | Allergen Mushroom mix 2 (Xerocomus, Boletus) IgG antibody | Paddenstoelallergenen mix 2 (Xerocomus + Boletus) As.IgG [eenheid/volume] in serum | |||||
100394-6 | Decapod crustaceans IgG antibody | Astacoidea As.IgG [eenheid/volume] in serum | |||||
100395-3 | Carob IgG antibody | Ceratonia siliqua As.IgG [eenheid/volume] in serum | |||||
10039-6 | S wave Amp L-III | amplitud de la onda S.derivación III:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de onda S. derivación III:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | S onda Amp L-III | |||
100396-1 | Brassica napus IgG antibody | Brassica napus As.IgG [eenheid/volume] in serum | |||||
100397-9 | Goat Meat IgG antibody | Geitenvlees As.IgG [eenheid/volume] in serum | |||||
100398-7 | Goose meat IgG antibody | Ganzenvlees As.IgG [eenheid/volume] in serum | |||||
100399-5 | Ostrich meat IgG antibody | Struisvogelvlees As.IgG [eenheid/volume] in serum | |||||
100400-1 | Quail meat IgG antibody | Kwartelvlees As.IgG [eenheid/volume] in serum | |||||
100401-9 | Rabbit meat IgG antibody | Konijnenvlees As.IgG [eenheid/volume] in serum | |||||
100402-7 | Venison meat IgG antibody | Hertenvlees As.IgG [eenheid/volume] in serum | |||||
100403-5 | Guineafowl IgG antibody | Parelhoen As.IgG [eenheid/volume] in serum | |||||
10040-4 | S wave Amp L-V1 | amplitud de la onda S.derivación V1:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de onda S. derivación V1:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | S onda Amp L-V1 | |||
100404-3 | Horse meat IgG antibody | Paardenvlees As.IgG [eenheid/volume] in serum | |||||
100405-0 | Kefir IgG antibody | Kefir As.IgG [eenheid/volume] in serum | |||||
100406-8 | Butter IgG antibody | Boter As.IgG [eenheid/volume] in serum | |||||
100407-6 | Camembert cheese IgG antibody | Camembert As.IgG [eenheid/volume] in serum | |||||
100408-4 | Emmental cheese IgG antibody | Emmentaler kaas As.IgG [eenheid/volume] in serum | |||||
100409-2 | Processed cheese IgG antibody | Smeltkaas As.IgG [eenheid/volume] in serum | |||||
1004-1 | Direct Antiglobulin Test (DAT; Direct Coombs), Red blood cells | prueba de antiglobulina directa.reactivo específico de complemento:concentración arbitraria:punto en el tiempo:eritrocitos:ordinal: | Test de antiglobulina directo, reactivo específico del complemento: Eritrocitos : Punto temporal: Presencia o umbral: Ordinal: | Directe antiglobulinetest.complement specifiek reagens [aanwezigheid] in erytrocyten | DAT Comp-Sp Reag RBC Ql | ||
100410-0 | Curd cheese IgG antibody | Kwark As.IgG [eenheid/volume] in serum | |||||
100411-8 | Sugar beet IgG antibody | Bèta-vulgaris As.IgG [eenheid/volume] in serum | |||||
10041-2 | S wave Amp L-V2 | amplitud de la onda S.derivación V2:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de onda S. derivación V2:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | S onda Amp L-V2 | |||
100412-6 | Chinese cabbage IgG antibody | Chinese kool As.IgG [eenheid/volume] in serum | |||||
100413-4 | Fennel fresh IgG antibody | Foeniculum vulgare vers As.IgG [eenheid/volume] in serum | |||||
100414-2 | Gourd IgG antibody | Genera in Cucurbitaceae As.IgG [eenheid/volume] in serum | |||||
100415-9 | Kale IgG antibody | Brassica oleracea var. Borecole As.IgG [eenheid/volume] in serum | |||||
100416-7 | Savoy cabbage IgG antibody | Brassica oleracea var. Sabauda As.IgG [eenheid/volume] in serum | |||||
100417-5 | Vitis sp leaf IgG antibody | Blad van Vitis sp. As.IgG [eenheid/volume] in serum | |||||
100418-3 | Liquorice IgG antibody | Glycyrrhiza glabra As.IgG [eenheid/volume] in serum | |||||
100419-1 | Snow pea IgG antibody | Pisum sativum var. saccharatum As.IgG [eenheid/volume] in serum | |||||
10042-0 | S wave Amp L-V3 | amplitud de la onda S.derivación V3:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de onda S. derivación V3:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | S onda Amp L-V3 | |||
100420-9 | Fava bean IgG antibody | Vicia faba As.IgG [eenheid/volume] in serum | |||||
100421-7 | Chick pea IgG antibody | Cicer arietinus As.IgG [eenheid/volume] in serum | |||||
100422-5 | Chicory IgG antibody | Cichorium intybus As.IgG [eenheid/volume] in serum | |||||
100423-3 | Button + oyster + Shiitaki + chanterelle mushroom IgG antibody | Paddenstoelallergenen mix 1 (Agaricus bisporus + Pleurotus ostreatus + Lentinula edodes + Cantharellus) As.IgG [eenheid/volume] in serum | |||||
100424-1 | 8(9)-Cholestenol, Blood | 8(9)-cholestenol [massa/volume] in serum of plasma | |||||
100425-8 | DiHydro T-Mas, Blood | DiHydro T-Mas [massa/volume] in serum of plasma | |||||
100426-6 | Squalene, Blood | ||||||
100427-4 | Stigmasterol, Blood | Stigmasterol [massa/volume] in serum of plasma | |||||
100428-2 | Carnitine free and total and acylcarnitine panel, Urine | Carnitine.vrij & totaal & acylcarnitine panel in urine | |||||
100429-0 | LRBA deficiency panel, Blood | LRBA-deficiëntie panel in bloed | |||||
100430-8 | Cells.LRBA+ 100 Cells.CD3+CD14-CD45+, Blood | Cellen.LRBA+/100 cellen.CD3+CD14-CD45+ [getalsfractie] in bloed d.m.v. flowcytometrie | |||||
100431-6 | T-cells LRBA MFI, Blood | Cellen.CD3+CD14-CD45+.LRBA gemiddelde fluorescentie-intensiteit [aanwezigheid] in bloed d.m.v. flowcytometrie | |||||
100432-4 | Cells.LRBA+ 100 Cells.CD3-CD14-CD19+CD45+, Blood | Cellen.LRBA+/100 cellen.CD3-CD14-CD19+CD45+ [getalsfractie] in bloed d.m.v. flowcytometrie | |||||
100433-2 | B-cells LRBA MFI, Blood | Cellen.CD3-CD14-CD19+CD45+.LRBA gemiddelde fluorescentie-intensiteit [aanwezigheid] in bloed d.m.v. flowcytometrie | |||||
100434-0 | Orthopoxvirus.nicht-variola DNA [Nachweis] in Probenmaterial mittels Nukleinsäureamplifikation mit Sondendetektion | Orthopoxvirus.non-variola, Specimen | Orthopoxvirus anders dan variolavirus DNA [aanwezigheid] d.m.v. probe-detectie | ||||
100435-7 | Glial fibrillary acidic protein, Blood | Gliaal fibrillair acidisch proteïne [massa/volume] in serum d.m.v. immunoassay | |||||
100436-5 | Ubiquitin carboxyl-terminal hydrolase-L1, Blood | ||||||
100437-3 | Norsufentanil, Urine | Norsufentanil [massa/volume] in urine d.m.v. bevestiging | |||||
10043-8 | S wave Amp L-V4 | amplitud de la onda S.derivación V4:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de onda S. derivación V4:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | S onda Amp L-V4 | |||
100438-1 | Adolescent med OP Prog note | ||||||
100439-9 | Allergy+Immunology OP Prog note | Voortgangsrapport [bevinding] in poliklinisch d.m.v. allergie+immunologie (document) | |||||
100440-7 | Allergy OP Prog note | ||||||
100441-5 | Attend OP Prog note | Voortgangsrapport [bevinding] in poliklinisch d.m.v. behandelend arts (document) | |||||
100442-3 | Audiology OP Prog note | Voortgangsrapport [bevinding] in poliklinisch d.m.v. audiologie (document) | |||||
100443-1 | Bariatric surg OP Prog note | ||||||
100444-9 | Bld Bnk+Trans Med OP Prog note | ||||||
100445-6 | BM Transplant OP Prog note | Voortgangsrapport [bevinding] in poliklinisch d.m.v. beenmergtransplantatie (document) | |||||
10044-6 | S wave Amp L-V5 | amplitud de la onda S.derivación V5:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de onda S. derivación V5:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | S onda Amp L-V5 | |||
100446-4 | Breastfeeding OP Prog note | Voortgangsrapport [bevinding] in poliklinisch d.m.v. borstvoeding (document) | |||||
100447-2 | Burn OP Prog note | ||||||
100448-0 | Cardiac surgery OP Prog note | Voortgangsrapport [bevinding] in poliklinisch d.m.v. cardiochirurgie (document) | |||||
100449-8 | Cardio+Pulm dis OP Prog note | ||||||
100450-6 | Child+teen psych OP Prog note | ||||||
100451-4 | Chiropractic med OP Prog note | Voortgangsrapport [bevinding] in poliklinisch d.m.v. chiropractie (document) | |||||
100452-2 | Electrophysiology OP Prog note | ||||||
10045-3 | S wave Amp L-V6 | amplitud de la onda S.derivación V6:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de onda S. derivación V6:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | S onda Amp L-V6 | |||
100453-0 | Clinical genetics OP Prog note | Voortgangsrapport [bevinding] in poliklinisch d.m.v. klinische genetica (document) | |||||
100454-8 | Clinical Neurophys OP Prog note | ||||||
100455-5 | Clin Path OP Prog note | ||||||
100456-3 | Col+rec surg OP Prog note | ||||||
100457-1 | Consultant OP Prog note | ||||||
100458-9 | OP COVID-19 Intub+Progress | ||||||
100459-7 | OP COVID-19 Progress note | ||||||
100460-5 | Dermatology OP Prog note | Voortgangsrapport [bevinding] in poliklinisch d.m.v. dermatologie (document) | |||||
10046-1 | S wave dur L-AVF | duración de la onda S.derivación AVF:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda S. plomo AVF:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | S onda dur L-AVF | |||
100461-3 | Develop-behav peds OP Prog note | ||||||
100462-1 | Dialy+Ther Apher OP Prog note | Voortgangsrapport [bevinding] in poliklinisch d.m.v. dialyse en therapeutische aferese (document) | |||||
100463-9 | Eating disorders OP Prog note | Voortgangsrapport [bevinding] in poliklinisch d.m.v. eetstoornis (document) | |||||
100464-7 | Endocrinology OP Prog note | Voortgangsrapport [bevinding] in poliklinisch d.m.v. endocrinologie (document) | |||||
100465-4 | Fam Med OP Prog note | ||||||
100466-2 | Gastroenterology OP Prog note | Voortgangsrapport [bevinding] in poliklinisch d.m.v. gastro-enterologie (document) | |||||
100467-0 | Geri med OP Prog note | Voortgangsrapport [bevinding] in poliklinisch d.m.v. geriatrie (document) | |||||
100468-8 | Gyn Onc OP Prog note | ||||||
100469-6 | Gynecology OP Prog note | Voortgangsrapport [bevinding] in poliklinisch d.m.v. gynaecologie (document) | |||||
100470-4 | Navigator OP Prog note | ||||||
100471-2 | Heart failure OP Prog note | ||||||
100472-0 | HF+TC OP Prog note | ||||||
100473-8 | Hematology OP Prog note | Voortgangsrapport [bevinding] in poliklinisch d.m.v. hematologie (document) | |||||
100474-6 | HemOnc OP Prog note | Voortgangsrapport [bevinding] in poliklinisch d.m.v. hematologie + oncologie (document) | |||||
100475-3 | Hepatology OP Prog note | ||||||
100476-1 | Immunology OP Prog note | Voortgangsrapport [bevinding] in poliklinisch d.m.v. immunologie (document) | |||||
100477-9 | Infectious disease OP Prog note | Voortgangsrapport [bevinding] in poliklinisch d.m.v. infectioloog (document) | |||||
100478-7 | Internal Med OP Prog note | Voortgangsrapport [bevinding] in poliklinisch d.m.v. interne geneeskunde (document) | |||||
10047-9 | S wave dur L-AVL | duración de la onda S.derivación AVL:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda S. Plomo AVL:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | S onda dur L-AVL | |||
100479-5 | IC OP Prog note | ||||||
100480-3 | IR OP Prog note | ||||||
100481-1 | OP MCS+progress note | ||||||
100482-9 | MAiD OP Prog note | Voortgangsrapport [bevinding] in poliklinisch d.m.v. medische zorg bij sterven (document) | |||||
100483-7 | Mental health OP Prog note | Voortgangsrapport [bevinding] in poliklinisch d.m.v. geestelijke gezondheidszorg (document) | |||||
100484-5 | Multi-spec prog OP Prog note | ||||||
100485-2 | Neo peri med OP Prog note | ||||||
100486-0 | Nephrology OP Prog note | Voortgangsrapport [bevinding] in poliklinisch d.m.v. nefrologie (document) | |||||
10048-7 | S wave dur L-AVR | duración de la onda S.derivación AVR:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda S. Lead AVR:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | S onda dur L-AVR | |||
100487-8 | Neuro surgery OP Prog note | Voortgangsrapport [bevinding] in poliklinisch d.m.v. neurochirurgie (document) | |||||
100488-6 | Neurology OP Prog note | Voortgangsrapport [bevinding] in poliklinisch d.m.v. neurologie (document) | |||||
100489-4 | Child neuro OP Prog note | ||||||
100490-2 | Nurse pract OP Prog note | ||||||
100491-0 | Nurse OP Prog note | Voortgangsrapport [bevinding] in poliklinisch d.m.v. verpleegkundige (document) | |||||
100492-8 | Nutr+diet OP Prog note | Voortgangsrapport [bevinding] in poliklinisch d.m.v. voeding en diëtetiek (document) | |||||
100493-6 | OBGYN OP Prog note | Voortgangsrapport [bevinding] in poliklinisch d.m.v. obstetrie en gynaecologie (document) | |||||
100494-4 | OB OP Prog note | Voortgangsrapport [bevinding] in poliklinisch d.m.v. obstetrie (document) | |||||
10049-5 | S wave dur L-I | duración de la onda S.derivación I:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda S. Conduzca I:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | S onda dur L-I | |||
100495-1 | OT OP Prog note | Voortgangsrapport [bevinding] in poliklinisch d.m.v. bezigheidstherapie (document) | |||||
100496-9 | Oncology OP Prog note | Voortgangsrapport [bevinding] in poliklinisch d.m.v. oncologie (document) | |||||
100497-7 | Ophthalmol OP Prog note | Voortgangsrapport [bevinding] in poliklinisch d.m.v. oogheelkunde (document) | |||||
100498-5 | Optometry OP Prog note | Voortgangsrapport [bevinding] in poliklinisch d.m.v. optometrie (document) | |||||
100499-3 | OMS OP Prog note | Voortgangsrapport [bevinding] in poliklinisch d.m.v. oromaxillofaciale chirurgie (document) | |||||
100500-8 | Orthopaedic surgery OP Prog note | Voortgangsrapport [bevinding] in poliklinisch d.m.v. orthopedische chirurgie (document) | |||||
100501-6 | Orthotics prosthetics OP Prog note | ||||||
100502-4 | Otolaryngology OP Prog note | Voortgangsrapport [bevinding] in poliklinisch d.m.v. KNO (document) | |||||
10050-3 | S wave dur L-II | duración de la onda S.derivación II:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda S. derivación II:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | S onda dur L-II | |||
100503-2 | Pain medicine OP Prog note | Voortgangsrapport [bevinding] in poliklinisch d.m.v. pijnbestrijding (document) | |||||
100504-0 | Palliative care OP Prog note | ||||||
100505-7 | Peds cardiology OP Prog note | ||||||
100506-5 | Peds dermatology OP Prog note | ||||||
100507-3 | Peds endocrinology OP Prog note | ||||||
100508-1 | Peds gastroenterology OP Prog note | ||||||
100509-9 | Peds hem-onc OP Prog note | ||||||
100510-7 | Peds infect disease OP Prog note | ||||||
10051-1 | S wave dur L-III | duración de la onda S.derivación III:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda S. Plomo III:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | S onda dur L-III | |||
100511-5 | Peds otolaryngology OP Prog note | ||||||
100512-3 | Peds pulmonology OP Prog note | ||||||
100513-1 | Peds rheumatology OP Prog note | ||||||
100514-9 | Peds surgery OP Prog note | ||||||
100515-6 | Peds transpl hepato OP Prog note | ||||||
100516-4 | Peds urology OP Prog note | ||||||
100517-2 | Pharmacogenomics OP Prog note | ||||||
100518-0 | PM+R OP Prog note | ||||||
100519-8 | PT OP Prog note | Voortgangsrapport [bevinding] in poliklinisch d.m.v. fysiotherapie (document) | |||||
100520-6 | Plastic surgery OP Prog note | Voortgangsrapport [bevinding] in poliklinisch d.m.v. plastische chirurgie (document) | |||||
100521-4 | Podiatry OP Prog note | Voortgangsrapport [bevinding] in poliklinisch d.m.v. podologie (document) | |||||
100522-2 | Psychiatric Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. psychiatrie (document) | |||||
100523-0 | Psych OP Prog note | Voortgangsrapport [bevinding] in poliklinisch d.m.v. psychologie (document) | |||||
100524-8 | Pulmonary disease OP Prog note | Voortgangsrapport [bevinding] in poliklinisch d.m.v. longaandoening (document) | |||||
100525-5 | Radiation Onc OP Prog note | Voortgangsrapport [bevinding] in poliklinisch d.m.v. radiotherapie (document) | |||||
100526-3 | Radiology OP Prog note | Voortgangsrapport [bevinding] in poliklinisch d.m.v. radiologie (document) | |||||
100527-1 | Rec therapy OP Prog note | Voortgangsrapport [bevinding] in poliklinisch d.m.v. recreationele therapie (document) | |||||
100528-9 | REI OP Prog note | ||||||
10052-9 | S wave dur L-V1 | duración de la onda S.derivación V1:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda S. derivación V1:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | S onda dur L-V1 | |||
100529-7 | Research OP Prog note | Voortgangsrapport [bevinding] in poliklinisch d.m.v. wetenschappelijk onderzoek (document) | |||||
100530-5 | Rheumatology OP Prog note | Voortgangsrapport [bevinding] in poliklinisch d.m.v. reumatologie (document) | |||||
100531-3 | Sleep med OP Prog note | ||||||
100532-1 | SW OP Prog note | ||||||
100533-9 | Solid Org Transplant OP Prog note | Voortgangsrapport [bevinding] in poliklinisch d.m.v. transplantatie van solide orgaan (document) | |||||
100534-7 | Speech-lang path OP Prog note | ||||||
100535-4 | Spinal surgery OP Prog note | ||||||
100536-2 | Sports medicine OP Prog note | ||||||
10053-7 | S wave dur L-V2 | duración de la onda S.derivación V2:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda S. derivación V2:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | S onda dur L-V2 | |||
100537-0 | Hand Surgery OP Prog note | ||||||
100538-8 | Telehealth+Outpatient Prog note | ||||||
100539-6 | Thromboemb OP Prog note | ||||||
100540-4 | Transpl surg OP Prog note | Voortgangsrapport [bevinding] in poliklinisch d.m.v. transplantatiechirurgie (document) | |||||
100541-2 | Trauma OP Prog note | ||||||
100542-0 | Urology OP Prog note | Voortgangsrapport [bevinding] in poliklinisch d.m.v. urologie (document) | |||||
100543-8 | Vasc Neuro OP Prog note | ||||||
100544-6 | Vascular surgery OP Prog note | Voortgangsrapport [bevinding] in poliklinisch d.m.v. vaatchirurgie (document) | |||||
10054-5 | S wave dur L-V3 | duración de la onda S.derivación V3:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda S. Plomo V3:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | S onda dur L-V3 | |||
100545-3 | Wound care management OP Prog note | Voortgangsrapport [bevinding] in poliklinisch d.m.v. wondzorg (document) | |||||
100546-1 | WOC OP Prog note | ||||||
100547-9 | Adolescent med Hosp Prog note | ||||||
100548-7 | Allergy+Immunology Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. allergie+immunologie (document) | |||||
100549-5 | Allergy Hosp Prog note | ||||||
100550-3 | Attend Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. behandelend arts (document) | |||||
100551-1 | Audiology Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. audiologie (document) | |||||
10055-2 | S wave dur L-V4 | duración de la onda S.derivación V4:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda S. Plomo V4:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | S onda dur L-V4 | |||
100552-9 | Bariatric surg Hosp Prog note | ||||||
100553-7 | Bld Bnk+Trans Med Hosp Prog note | ||||||
100554-5 | BM Transplant Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. beenmergtransplantatie (document) | |||||
100555-2 | Breastfeeding Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. borstvoeding (document) | |||||
100556-0 | Burn Hosp Prog note | ||||||
100557-8 | Cardiac surgery Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. cardiochirurgie (document) | |||||
100558-6 | Cardio+Pulm dis Hosp Prog note | ||||||
100559-4 | Child+teen psych Hosp Prog note | ||||||
10056-0 | S wave dur L-V5 | duración de la onda S.derivación V5:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda S. Plomo V5:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | S onda dur L-V5 | |||
100560-2 | Electrophysiology Hosp Prog note | ||||||
100561-0 | Clinical genetics Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. klinische genetica (document) | |||||
100562-8 | Clinical Neurophys Hosp Prog note | ||||||
100563-6 | Clin Path Hosp Prog note | ||||||
100564-4 | Col+rec surg Hosp Prog note | ||||||
100565-1 | Consultant Hosp Prog note | ||||||
100566-9 | Dentistry Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. tandheelkunde (document) | |||||
100567-7 | Dermatology Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. dermatologie (document) | |||||
100568-5 | Develop-behav peds Hosp Prog note | ||||||
100569-3 | Dialy+Ther Apher Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. dialyse en therapeutische aferese (document) | |||||
100570-1 | Eating disorders Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. eetstoornis (document) | |||||
100571-9 | Endocrinology Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. endocrinologie (document) | |||||
100572-7 | Fam Med Hosp Prog note | ||||||
100573-5 | Gastroenterology Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. gastro-enterologie (document) | |||||
100574-3 | General medicine Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. algemene geneeskunde (document) | |||||
100575-0 | Geri med Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. geriatrie (document) | |||||
100576-8 | Gyn Onc Hosp Prog note | ||||||
100577-6 | Gynecology Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. gynaecologie (document) | |||||
10057-8 | S wave dur L-V6 | duración de la onda S.derivación V6:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda S. Plomo V6:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | S onda dur L-V6 | |||
100578-4 | Navigator Hosp Prog note | ||||||
100579-2 | Heart failure Hosp Prog note | ||||||
1005-8 | Indirect Antiglobulin Test (IAT; Indirect Coombs), Blood | prueba de antiglobulina indirecta.reactivo específico de IgG [Inmunoglobulina G]:concentración arbitraria:punto en el tiempo:suero/plasma:ordinal: | Prueba de antiglobulina indirecta Reactivo específico IgG: Suero o Plasma : Punto temporal: Presencia o umbral: Ordinal: | Indirecte antiglobulinetest.IgG-specifiek reagent [aanwezigheid] in serum of plasma | IAT IgG-Sp Reag SerPl Ql | ||
100580-0 | HF+TC Hosp Prog note | ||||||
100581-8 | Hematology Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. hematologie (document) | |||||
100582-6 | HemOnc Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. hematologie + oncologie (document) | |||||
100583-4 | Hepatology Hosp Prog note | ||||||
100584-2 | Immunology Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. immunologie (document) | |||||
100585-9 | Infectious disease Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. infectioloog (document) | |||||
10058-6 | S' wave Amp L-AVF | amplitud de la onda S'.derivación AVF:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de onda S. Conducir AVF:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | S' onda Amp L-AVF | |||
100586-7 | Internal Med Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. interne geneeskunde (document) | |||||
100587-5 | IC Hosp Prog note | ||||||
100588-3 | IR Hosp Prog note | ||||||
100589-1 | Hosp MCS+progress note | ||||||
100590-9 | MAiD Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. medische zorg bij sterven (document) | |||||
100591-7 | Mental health Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. geestelijke gezondheidszorg (document) | |||||
100592-5 | Multi-spec prog Hosp Prog note | ||||||
100593-3 | Neo peri med Hosp Prog note | ||||||
10059-4 | S' wave Amp L-AVL | amplitud de la onda S'.derivación AVL:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de onda S. Conduzca AVL:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | S' onda Amp L-AVL | |||
100594-1 | Nephrology Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. nefrologie (document) | |||||
100595-8 | Neuro surgery Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. neurochirurgie (document) | |||||
100596-6 | Neurology Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. neurologie (document) | |||||
100597-4 | Child neuro Hosp Prog note | ||||||
100598-2 | Nurse pract Hosp Prog note | ||||||
100599-0 | Nurse Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. verpleegkundige (document) | |||||
100600-6 | Nutr+diet Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. voeding en diëtetiek (document) | |||||
100601-4 | OBGYN Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. obstetrie en gynaecologie (document) | |||||
10060-2 | S' wave Amp L-AVR | amplitud de la onda S'.derivación AVR:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de onda S. Conduzca AVR:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | S' onda Amp L-AVR | |||
100602-2 | OB Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. obstetrie (document) | |||||
100603-0 | OT Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. bezigheidstherapie (document) | |||||
100604-8 | Oncology Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. oncologie (document) | |||||
100605-5 | Ophthalmol Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. oogheelkunde (document) | |||||
100606-3 | OMS Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. oromaxillofaciale chirurgie (document) | |||||
100607-1 | Orthopaedic surgery Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. orthopedische chirurgie (document) | |||||
100608-9 | Orthotics prosthetics Hosp Prog note | ||||||
100609-7 | Otolaryngology Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. KNO (document) | |||||
10061-0 | S' wave Amp L-I | amplitud de la onda S'.derivación I:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de onda S. Conduzca I:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | S' onda Amp L-I | |||
100610-5 | Pain medicine Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. pijnbestrijding (document) | |||||
100611-3 | Palliative care Hosp Prog note | ||||||
100612-1 | Pastoral Care Hosp Prog note | ||||||
100613-9 | Peds cardiology Hosp Prog note | ||||||
100614-7 | Peds dermatology Hosp Prog note | ||||||
100615-4 | Peds endocrinology Hosp Prog note | ||||||
100616-2 | Peds gastroenterology Hosp Prog note | ||||||
100617-0 | Peds hem-onc Hosp Prog note | ||||||
100618-8 | Peds infect disease Hosp Prog note | ||||||
100619-6 | Peds otolaryngology Hosp Prog note | ||||||
100620-4 | Peds pulmonology Hosp Prog note | ||||||
100621-2 | Peds rheumatology Hosp Prog note | ||||||
100622-0 | Peds surgery Hosp Prog note | ||||||
100623-8 | Peds transpl hepato Hosp Prog note | ||||||
100624-6 | Pharmacogenomics Hosp Prog note | ||||||
100625-3 | Pharmacology Hosp Prog note | ||||||
100626-1 | PM+R Hosp Prog note | ||||||
100627-9 | PT Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. fysiotherapie (document) | |||||
10062-8 | S' wave Amp L-II | amplitud de la onda S'.derivación II:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de onda S. derivación II:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | S' onda Amp L-II | |||
100628-7 | Plastic surgery Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. plastische chirurgie (document) | |||||
100629-5 | Podiatry Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. podologie (document) | |||||
100630-3 | Psych Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. psychologie (document) | |||||
100631-1 | Radiation Onc Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. radiotherapie (document) | |||||
100632-9 | Radiology Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. radiologie (document) | |||||
100633-7 | Rapid response team Hosp Prog note | ||||||
100634-5 | Rec therapy Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. recreationele therapie (document) | |||||
100635-2 | REI Hosp Prog note | ||||||
10063-6 | S' wave Amp L-III | amplitud de la onda S'.derivación III:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de onda S. derivación III:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | S' onda Amp L-III | |||
100636-0 | Research Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. wetenschappelijk onderzoek (document) | |||||
100637-8 | Rheumatology Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. reumatologie (document) | |||||
100638-6 | Sleep med Hosp Prog note | ||||||
100639-4 | SW Hosp Prog note | ||||||
100640-2 | Solid Org Transplant Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. transplantatie van solide orgaan (document) | |||||
100641-0 | Speech-lang path Hosp Prog note | ||||||
100642-8 | Spinal surgery Hosp Prog note | ||||||
100643-6 | Hand Surgery Hosp Prog note | ||||||
10064-4 | S' wave Amp L-V1 | amplitud de la onda S'.derivación V1:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de onda S. derivación V1:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | S' onda Amp L-V1 | |||
100644-4 | Thromboemb Hosp Prog note | ||||||
100645-1 | Trauma Hosp Prog note | ||||||
100646-9 | Urology Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. urologie (document) | |||||
100647-7 | Vasc Neuro Hosp Prog note | ||||||
100648-5 | Vascular surgery Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. vaatchirurgie (document) | |||||
100649-3 | Wound care management Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. wondzorg (document) | |||||
100650-1 | WOC Hosp Prog note | ||||||
10065-1 | S' wave Amp L-V2 | amplitud de la onda S'.derivación V2:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de onda S. derivación V2:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | S' onda Amp L-V2 | |||
100651-9 | Hosp COVID-19 Intub+Progress | ||||||
100652-7 | Pure tone bone thresh Pnl | ||||||
100653-5 | Pure tone air thresh Pnl | ||||||
100654-3 | M2-PK (Pyruvatkinase) /Stuhl | Pyruvate kinase M2, Stool | Pyruvaatkinase M2 [aanwezigheid] in feces | ||||
100655-0 | XR ST Lat | ||||||
100656-8 | Mat fetal med OP Prog note | ||||||
100657-6 | Mat fetal med Phone+Hosp Prog note | ||||||
100658-4 | Hosp COVID-19 Progress note | ||||||
100659-2 | Mat fetal med Hosp Prog note | ||||||
1006-6 | Direkt-Antiglobulintest.IgG-spezifisches Reagenz [Interpretation] auf Erythrozyten | Direct Antiglobulin Test (DAT; Direct Coombs), Red blood cells | prueba de antiglobulina directa.reactivo específico de IgG [Inmunoglobulina G]:impresión/interpretación del estudio:punto en el tiempo:eritrocitos:Nominal: | Prueba de antiglobulina directa Reactivo específico IgG: Eritrocitos : Punto temporal: Impresión / interpretación del estudio: Nominal: | Directe antiglobulinetest.IgG specifiek reagens [interpretatie] in erytrocyten | DAT IgG-Sp Reag RBC-Imp | |
100660-0 | Mat fetal med Phone+OP Prog note | ||||||
100661-8 | Psychiatric OP Prog note | Voortgangsrapport [bevinding] in poliklinisch d.m.v. psychiatrie (document) | |||||
100662-6 | Cortisol free and total panel, Blood | Cortisol vrij & totaal panel in serum of plasma | |||||
100663-4 | TPMT gene c.460G>A&c.719A>G, Blood | TPMT-gen c.460G>A&c.719A>G [aanwezigheid] in bloed d.m.v. moleculair genetisch onderzoek | |||||
100664-2 | NUDT15 gene c.50_55dup&c.415C>T, Blood | NUDT15-gen c.50_55dup&c.415C>T [aanwezigheid] in bloed d.m.v. moleculair genetisch onderzoek | |||||
100665-9 | NUDT15 gene c.415C>T, Blood | NUDT15-gen c.415C>T [aanwezigheid] in bloed d.m.v. moleculair genetisch onderzoek | |||||
100666-7 | NUDT15 gene c.52G>A, Blood | NUDT15-gen c.416G>A [aanwezigheid] in bloed d.m.v. moleculair genetisch onderzoek | |||||
100667-5 | NUDT15 gene c.52G>A, Blood | NUDT15-gen c.52G>A [aanwezigheid] in bloed d.m.v. moleculair genetisch onderzoek | |||||
100668-3 | NUDT15 gene c.50_55dup, Blood | NUDT15-gen c.50_55dup [aanwezigheid] in bloed d.m.v. moleculair genetisch onderzoek | |||||
10066-9 | S' wave Amp L-V3 | amplitud de la onda S'.derivación V3:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de onda S. derivación V3:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | S' onda Amp L-V3 | |||
100669-1 | NUDT15 gene c.50_55del, Blood | NUDT15-gen c.50_55del [aanwezigheid] in bloed d.m.v. moleculair genetisch onderzoek | |||||
100670-9 | Fetal RHD gene allele--fetus | RHD-allel^foetus [identificator] in plasma.celvrij DNA | |||||
100671-7 | Aspergillus sp, Blood | Aspergillus sp. DNA [aanwezigheid] in bloed d.m.v. probe-detectie | |||||
100672-5 | Aspergillus fumigatus, Blood | Aspergillus fumigatus DNA [aanwezigheid] in bloed d.m.v. probe-detectie | |||||
100673-3 | Aspergillus terreus, Blood | Aspergillus terreus DNA [aanwezigheid] in bloed d.m.v. probe-detectie | |||||
100674-1 | BK virus, Blood | BK-virus DNA [logaritmisch aantal/volume] in bloed d.m.v. probe-detectie | |||||
100675-8 | Cytomegalie-Virus DNA [Einheiten/Volumen] (Viruslast) in Blut mittels Nukleinsäureamplifikation mit Sondendetektion | Cytomegalovirus (CMV), Blood | Cytomegalovirus DNA [eenheid/volume] in bloed d.m.v. probe-detectie | ||||
100676-6 | Cytomegalie-Virus DNA [log Einheiten/Volumen] (Viruslast) in Blut mittels Nukleinsäureamplifikation mit Sondendetektion | Cytomegalovirus (CMV), Blood | Cytomegalovirus DNA [logaritmische eenheid/volume] in bloed d.m.v. probe-detectie | ||||
10067-7 | S' wave Amp L-V4 | amplitud de la onda S'.derivación V4:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de onda S. derivación V4:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | S' onda Amp L-V4 | |||
100677-4 | Epstein Barr virus (EBV), Blood | Epstein-Barr-virus DNA [logaritmisch aantal/volume] in serum of plasma d.m.v. probe-detectie | |||||
100678-2 | Epstein Barr virus (EBV), Blood | Epstein-Barr-virus DNA [logaritmisch aantal/volume] in bloed d.m.v. probe-detectie | |||||
100679-0 | Herpes virus (HHV) 6, Blood | Humaan betaherpesvirus type 6 DNA [logaritmisch aantal/volume] in serum of plasma d.m.v. probe-detectie | |||||
100680-8 | Herpes virus (HHV) 6, Blood | Humaan betaherpesvirus type 6 DNA [logaritmisch aantal/volume] in bloed d.m.v. probe-detectie | |||||
100681-6 | Herpes virus (HHV) 7, Blood | Humaan betaherpesvirus type 7 DNA [logaritmisch aantal/volume] in serum of plasma d.m.v. probe-detectie | |||||
100682-4 | Herpes virus (HHV) 7, Blood | Humaan betaherpesvirus type 7 DNA [logaritmisch aantal/volume] in bloed d.m.v. probe-detectie | |||||
100683-2 | Herpes virus (HHV) 8, Blood | Humaan herpesvirus 8 DNA [logaritmisch aantal/volume] in serum of plasma d.m.v. probe-detectie | |||||
100684-0 | Herpes virus (HHV) 8, Blood | Humaan herpesvirus 8 DNA [logaritmisch aantal/volume] in bloed d.m.v. probe-detectie | |||||
10068-5 | S' wave Amp L-V5 | amplitud de la onda S'.derivación V5:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de onda S. derivación V5:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | S' onda Amp L-V5 | |||
100685-7 | JC virus, Blood | JC-virus DNA [logaritmisch aantal/volume] in serum of plasma d.m.v. probe-detectie | |||||
100686-5 | JC virus, Spinal fluid | JC-virus DNA [logaritmisch aantal/volume] in liquor cerebrospinalis d.m.v. probe-detectie | |||||
100687-3 | JC virus, Urine | JC-virus DNA [logaritmisch aantal/volume] in urine d.m.v. probe-detectie | |||||
100688-1 | Parvovirus B19 DNA [log #/Volumen] (Viruslast) in Blut mittels Nukleinsäureamplifikation mit Sondendetektion | Parvovirus B19, Blood | Parvovirus B19 DNA [logaritmisch aantal/volume] in bloed d.m.v. probe-detectie | ||||
100689-9 | Toxoplasma gondii DNA [log #/Volumen] in Serum oder Plasma mittels Nukleinsäureamplifikation mit Sondendetektion | Toxoplasma gondii, Blood | Toxoplasma gondii DNA [logaritmisch aantal/volume] in serum of plasma d.m.v. probe-detectie | ||||
100690-7 | Toxoplasma gondii DNA [log #/Volumen] in Liquor mittels Nukleinsäureamplifikation mit Sondendetektion | Toxoplasma gondii, Spinal fluid | Toxoplasma gondii DNA [logaritmisch aantal/volume] in liquor cerebrospinalis d.m.v. probe-detectie | ||||
100691-5 | Varicella-Zoster-Virus DNA [log #/Volumen] (Viruslast) in Blut mittels Nukleinsäureamplifikation mit Sondendetektion | Varicella zoster virus (VZV; Chickenpox), Blood | Varicella-zostervirus DNA [logaritmisch aantal/volume] in bloed d.m.v. probe-detectie | ||||
100692-3 | Varicella-Zoster-Virus DNA [log #/Volumen] (Viruslast) in Liquor mittels Nukleinsäureamplifikation mit Sondendetektion | Varicella zoster virus (VZV; Chickenpox), Spinal fluid | Varicella-zostervirus DNA [logaritmisch aantal/volume] in liquor cerebrospinalis d.m.v. probe-detectie | ||||
10069-3 | S' wave Amp L-V6 | amplitud de la onda S'.derivación V6:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de onda S. derivación V6:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | S' onda Amp L-V6 | |||
100693-1 | Pneumocystis jiroveci, Respiratory system specimen | Pneumocystis jiroveci DNA [logaritmisch aantal/volume] in respiratoir monster d.m.v. probe-detectie | |||||
100694-9 | SMN1 gene silent carrier analysis, Blood or tissue specimen | Stille drager van SMN1-gen analyse [aanwezigheid] in bloed of weefsel d.m.v. moleculair genetisch onderzoek | |||||
100695-6 | Genetic disease analysis overall carrier interpretation, Blood or tissue specimen | ||||||
100696-4 | CTNS related multigene analysis, Body Fld+S/P | CTNS-gerelateerde multigen-analyse [identificator] in lichaamsvloeistof en serum of plasma d.m.v. moleculair genetisch onderzoek | |||||
100697-2 | IR OP Note | ||||||
100698-0 | SDOH screen report Doc | ||||||
100699-8 | Rifabutin/Ethambutol-Empfindlichkeit | Rifabutin+Ethambutol [Empfindlichkeit] | Susceptibility to Rifabutin+Ethambutol | Rifabutine + ethambutol [gevoeligheid] in isolaat | |||
100700-4 | Trichomonas vaginalis, Urethra | Trichomonas vaginalis DNA [aanwezigheid] in urethra d.m.v. probe-detectie | |||||
10070-1 | S' wave dur L-AVF | duración de la onda S'.derivación AVF:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda S. Plomo AVF:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | S' onda dur L-AVF | |||
100701-2 | Trichomonas vaginalis, Urethra | Trichomonas vaginalis rRNA [aanwezigheid] in urethra d.m.v. probe-detectie | |||||
100702-0 | Mycoplasma genitalium rRNA [Nachweis] in Harnröhre mittels Nukleinsäureamplifikation mit Sondendetektion | Mycoplasma genitalium, Urethra | Mycoplasma genitalium rRNA [aanwezigheid] in urethra d.m.v. probe-detectie | ||||
100703-8 | Mycoplasma genitalium rRNA [Nachweis] in Urin mittels Nukleinsäureamplifikation mit Sondendetektion | Mycoplasma genitalium, Urine | Mycoplasma genitalium rRNA [aanwezigheid] in urine d.m.v. probe-detectie | ||||
100704-6 | Mycoplasma genitalium rRNA [Nachweis] in Probenmaterial vom Gebärmutterhals mittels Nukleinsäureamplifikation mit Sondendetektion | Mycoplasma genitalium, Cervix | Mycoplasma genitalium rRNA [aanwezigheid] in cervix d.m.v. probe-detectie | ||||
100705-3 | Mycoplasma genitalium rRNA [Nachweis] in anorektalem Probenmaterial mittels Nukleinsäureamplifikation mit Sondendetektion | Mycoplasma genitalium, Anorectal | Mycoplasma genitalium rRNA [aanwezigheid] in anorectaal d.m.v. probe-detectie | ||||
100706-1 | Mycoplasma genitalium rRNA [Nachweis] in Probenmaterial mittels Nukleinsäureamplifikation mit Sondendetektion | Mycoplasma genitalium, Specimen | Mycoplasma genitalium rRNA [aanwezigheid] d.m.v. probe-detectie | ||||
100707-9 | Polymorphonuclear cells, Peritoneal dialysis fluid | Polymorfonucleaire cellen [aantal/volume] in periteonale dialysevloeistof d.m.v. geautomatiseerde telling | |||||
100708-7 | Plasma cells per 100 white blood cells, Synovial fluid | Plasmacellen/100 leukocyten [getalsfractie] in synoviaal vocht | |||||
100709-5 | Hepatocellular carcinoma risk | Risico op hepatocellulair carcinoom [score] d.m.v. GAAD-score | |||||
100710-3 | Chlamydia trachomatis and Neisseria gonorrhoeae panel, Throat | Chlamydia trachomatis & Neisseria gonorrhoeae rRNA panel in keel d.m.v. probe-detectie | |||||
100711-1 | Borrelia burgdorferi.VlsE1+pepC10 Antikörper [Einheiten/Volumen] in Serum mittels Immunoassay | Borrelia burgdorferi.VlsE1+pepC10 antibody, Blood | Borrelia burgdorferi.VlsE1+pepC10 As [eenheid/volume] in serum d.m.v. immunoassay | ||||
100712-9 | Brexpiprazol | Brexpiprazole, Blood | Brexpiprazol [massa/volume] in serum of plasma | ||||
100713-7 | Cariprazin | Cariprazine, Blood | Cariprazine [massa/volume] in serum of plasma | ||||
100714-5 | Guanfacin | Guanfacine, Blood | Guanfacine [massa/volume] in serum of plasma | ||||
100715-2 | Prothipendyl | Prothipendyl, Blood | Prothipendyl [massa/volume] in serum of plasma | ||||
100716-0 | Prostate specific antigen, Dried blood spot | Prostaatspecifiek Ag [massa/volume] in gedroogde bloedspot | |||||
100717-8 | FCGR3A gene.p.Phe176Val, Blood or tissue specimen | FCGR3A-gen.p.Phe176Val [aanwezigheid] in bloed of weefsel d.m.v. moleculair genetisch onderzoek | |||||
100718-6 | Undersea+hyperbar D/C sum | ||||||
10071-9 | S' wave dur L-AVL | duración de la onda S'.derivación AVL:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda S. Liderar AVL:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | S' onda dur L-AVL | |||
100719-4 | Surg Onc D/C sum | ||||||
100720-2 | REI D/C sum | ||||||
100721-0 | Comm hlth care D/C sum | ||||||
100722-8 | Integrative medicine D/C sum | ||||||
100723-6 | Sports medicine D/C sum | ||||||
100724-4 | Diabetology D/C sum | Samenvattende ontslagbrief [bevinding] in {instelling} d.m.v. diabetologie (document) | |||||
100725-1 | Optometry D/C sum | Samenvattende ontslagbrief [bevinding] in {instelling} d.m.v. optometrie (document) | |||||
100726-9 | Podiatry D/C sum | Samenvattende ontslagbrief [bevinding] in {instelling} d.m.v. podologie (document) | |||||
10072-7 | S' wave dur L-AVR | duración de la onda S'.derivación AVR:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda S. adelantar AVR:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | S' onda dur L-AVR | |||
100727-7 | Chiropractic med D/C sum | Samenvattende ontslagbrief [bevinding] in {instelling} d.m.v. chiropractie (document) | |||||
100728-5 | Cardiac surgery D/C sum | Samenvattende ontslagbrief [bevinding] in {instelling} d.m.v. cardiochirurgie (document) | |||||
100729-3 | Breastfeeding D/C sum | Samenvattende ontslagbrief [bevinding] in {instelling} d.m.v. borstvoeding (document) | |||||
100730-1 | Transpl surg D/C sum | Samenvattende ontslagbrief [bevinding] in {instelling} d.m.v. transplantatiechirurgie (document) | |||||
100731-9 | Urgent care D/C sum | ||||||
100732-7 | Cholesterol.in lipoprotein (little a) & Cholesterol.in LDL panel, Blood | Cholesterol.in lipoproteïne (kleine a) & cholesterol.in LDL panel in serum | |||||
100733-5 | LDL cholesterol corrected for Cholesterol.in lipoprotein (little a), Blood | Cholesterol.in LDL^gecorrigeerd voor cholesterol.in lipoproteïne (kleine a) [massa/volume] in serum d.m.v. berekend | |||||
100734-3 | traMADol and Metabolites Panel, Urine | Tramadol & metabolieten panel in urine d.m.v. bevestiging | |||||
10073-5 | S' wave dur L-I | duración de la onda S'.derivación I:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda S.:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | S' onda dur L-I | |||
100735-0 | Mannose-6-phosphate isomerase and phosphomannomutase 1 panel, White blood cells | Mannose-6-fosfaatisomerase & fosfomannomutase 1 panel in leukocyten | |||||
100736-8 | Acylcarnitine Analysis Post Mortem, Specimen | Acylcarnitine postmortale analyse [bevinding] (document) | |||||
100737-6 | Alkaline phosphatase.macromolecular, Blood | Alkalinefosfatase.macromoleculair [aanwezigheid] in serum of plasma | |||||
100738-4 | Macromolecular alanine aminotransferase, Blood | Alanine-aminotransferase.macromoleculair [aanwezigheid] in serum of plasma | |||||
100739-2 | Macromolecular aspartate aminotransferase, Blood | Aspartaataminotransferase.macromoleculair [aanwezigheid] in serum of plasma | |||||
1007-4 | Direkter Coombs Test polyspezifisch | Direkt-Antiglobulintest.polyspezifisches Reagenz [Nachweis] auf Erythrozyten | Direct Antiglobulin Test (DAT; Direct Coombs), Red blood cells | prueba de antiglobulina directa.reactivo poliespecífico:concentración arbitraria:punto en el tiempo:eritrocitos:ordinal: | Prueba de antiglobulina directa, reactivo específico de poli: Eritrocitos : Punto temporal: Presencia o umbral: Ordinal: | Directe antiglobulinetest.polyspecifiek reagens [aanwezigheid] in erytrocyten | DAT Poly-Sp Reag RBC Ql |
100740-0 | Amylase.macromolecular, Blood | Amylase.macromoleculair [aanwezigheid] in serum of plasma | |||||
100741-8 | Gamma glutamyl transferase.macromolecular, Blood | Gamma-glutamyltransferase.macromoleculair [aanwezigheid] in serum of plasma | |||||
100742-6 | Lactate dehydrogenase.macromolecular, Blood | Lactaatdehydrogenase.macromoleculair [aanwezigheid] in serum of plasma | |||||
10074-3 | S' wave dur L-II | duración de la onda S'.derivación II:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda S. Plomo II:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | S' onda dur L-II | |||
100743-4 | Lipase.macromolecular, Blood | Lipase.macromoleculair [aanwezigheid] in serum of plasma | |||||
100744-2 | Alpha-1-acid glycoprotein, Blood | Alfa-1-zure glycoproteïne [massa/volume] in serum of plasma d.m.v. elektroforese | |||||
100745-9 | Chloride, Blood | Chloride [mol/volume] in gemengd veneus bloed | |||||
100746-7 | Glucose, Blood | Glucose [mol/volume] in gemengd veneus bloed | |||||
100747-5 | Legionella serogroup panel, Specimen | Legionella serogroep panel | |||||
100748-3 | Legionella spp [Nachweis] in Probenmaterial mittels Nukleinsäureamplifikation mit Sondendetektion | Legionella spp, Specimen | Legionella spp. [aanwezigheid] d.m.v. probe-detectie | ||||
100749-1 | Legionella pneumophila, Serogruppe 1 [Nachweis] in Probenmaterial mittels Nukleinsäureamplifikation mit Sondendetektion | Legionella pneumophila serogroup 1, Specimen | Legionella pneumophila serogroep 1 [aanwezigheid] d.m.v. probe-detectie | ||||
10075-0 | S' wave dur L-III | duración de la onda S'.derivación III:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda S. Plomo III:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | S' onda dur L-III | |||
100750-9 | Legionella pneumophila, nicht Serogruppe 1 [Nachweis] in Probenmaterial mittels Nukleinsäureamplifikation mit Sondendetektion | Legionella pneumophila non-serogroup 1, Specimen | Legionella pneumophila anders dan serogroep 1 [aanwezigheid] d.m.v. probe-detectie | ||||
100751-7 | Galactose-alpha-1,3-galactose (Alpha-Gal) panel, Blood | Galactose-alfa-1,3-galactose panel in serum of plasma | |||||
100752-5 | Exacerbating factors Reported | ||||||
100753-3 | Alleviating factors Reported | ||||||
100754-1 | Platelet disorders multigene analysis, Blood or tissue specimen | Trombocytopathie multigen-analyse [bevinding] in bloed of weefsel d.m.v. sequencing (document) | |||||
100755-8 | Oligoclonal bands, Blood | Eiwitfracties.oligoklonale banden [aantal] in serum of plasma d.m.v. iso-elektrisch focusseren | |||||
100756-6 | Oligoclonal bands, Spinal fluid | Eiwitfracties.oligoklonale banden [interpretatie] in liquor cerebrospinalis d.m.v. iso-elektrisch focusseren | |||||
100757-4 | Protein fractions.oligoclonal bands panel, Serum+Cerebrospinal fluid | Eiwitfracties.oligoklonale banden panel in serum en liquor cerebrospinalis d.m.v. iso-elektrisch focusseren | |||||
100758-2 | Estimated lung age from clin data | ||||||
100759-0 | Inspiratory reserve vol spirometry | ||||||
100760-8 | XR Radius+Ulna-L 1V | ||||||
100761-6 | PALB2 gene targeted mutation analysis, Blood or tissue specimen | PALB2-gen doelgerichte mutatie-analyse [bevinding] in bloed of weefsel d.m.v. moleculair genetisch onderzoek (document) | |||||
100762-4 | HBA2 gene.c.377T>C, Blood | HBA2-gen.c.377T>C [aanwezigheid] in bloed d.m.v. moleculair genetisch onderzoek | |||||
100763-2 | Mycobacterium sp comparative reaction interpretation, Skin | Comparatieve reactie op Mycobacterium sp. Interpretatie [interpretatie] in huid (tekstueel) | |||||
100764-0 | Mycobacterium bovis reaction wheal 3 days after Mammalian Tuberculin Intradermal, Skin | Mycobacterium bovis huidreactie^3 dagen na dosis zoogdiertuberculine ID [diameter] in huid | |||||
100765-7 | Homocysteine and Methylmalonate and Methylcitrate panel, Dried blood spot | Homocysteïne & methylmalonaat & 2-methylcitraat panel in gedroogde bloedspot | |||||
100766-5 | Center for Epidemiologic Studies Depression Scale panel [CES-D] | ||||||
100767-3 | Bothered by things that are not usually bothersome | ||||||
10076-8 | S' wave dur L-V1 | duración de la onda S'.derivación V1:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda S. Plomo V1:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | S' onda dur L-V1 | |||
100768-1 | Poor appetite | ||||||
100769-9 | Unhappy even with help from my family or friends | ||||||
100770-7 | Feeling just as good as others | ||||||
100771-5 | Trouble focusing | ||||||
100772-3 | Feeling depressed | ||||||
100773-1 | Feeling everything is too much of an effort | ||||||
100774-9 | Feeling hopeful about the future | ||||||
100775-6 | Feeling life had been a failure | ||||||
10077-6 | S' wave dur L-V2 | duración de la onda S'.derivación V2:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda S. Plomo V2:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | S' onda dur L-V2 | |||
100776-4 | Feeling fearful | ||||||
100777-2 | Restless sleep | ||||||
100778-0 | Feeling happy | ||||||
100779-8 | Quieter than usual | ||||||
100780-6 | Feeling lonely | ||||||
100781-4 | People were unfriendly | ||||||
100782-2 | Enjoying life | ||||||
100783-0 | Crying spells | ||||||
10078-4 | S' wave dur L-V3 | duración de la onda S'.derivación V3:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda S. Plomo V3:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | S' onda dur L-V3 | |||
100784-8 | Feeling sad | ||||||
100785-5 | Feeling people dislike me | ||||||
100786-3 | Lack of energy | ||||||
100787-1 | Total Score CES-D | ||||||
100788-9 | Stemphylium botryosum IgG4 antibody | Stemphylium botryosum As.IgG4 [massa/volume] in serum | |||||
100789-7 | Rhizopus nigricans IgG4 antibody | Rhizopus nigricans As.IgG4 [massa/volume] in serum | |||||
100790-5 | Lepidoglyphus destructor IgG antibody | Lepidoglyphus destructor As.IgG [massa/volume] in serum | |||||
100791-3 | Hamster epithelium IgG antibody | Hamsterepitheel As.IgG [massa/volume] in serum | |||||
10079-2 | S' wave dur L-V4 | duración de la onda S'.derivación V4:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda S. Plomo V4:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | S' onda dur L-V4 | |||
100792-1 | Forsythia allergy test | Forsythia As.IgE [eenheid/volume] in serum | |||||
100793-9 | Testosterone, Body fluid | Testosteron [massa/volume] in lichaamsvocht | |||||
100794-7 | Follitropin (FSH; Follicle Stimulating Hormone), Body fluid | Follikelstimulerend hormoon [eenheid/volume] in lichaamsvocht | |||||
100795-4 | S100 Calcium Binding Protein B, Body fluid | S100 calciumbindend eiwit B [massa/volume] in lichaamsvocht | |||||
100796-2 | Thyroglobulin, Body fluid | Thyreoglobuline [massa/volume] in lichaamsvocht | |||||
100797-0 | Free testosterone 1st specimen after challenge, Blood | Testosteron.vrij^1ste monster na XXX belasting [massa/volume] in serum | |||||
100798-8 | Free testosterone 2nd specimen after challenge, Blood | Testosteron.vrij^2de monster na XXX belasting [massa/volume] in serum | |||||
100799-6 | 21-Deoxycortisol 1st specimen after challenge, Blood | 21-deoxycortisol^1ste monster na XXX belasting [massa/volume] in serum | |||||
100-8 | Cefoperazon [Empfindlichkeit] mittels Bestimmung der minimalen Hemmkonzentration (MHK) | Susceptibility to Cefoperazone | cefoperazona:susceptibilidad:punto en el tiempo:cepa clínica:ordinal o cuantitativo:concentración inhibitoria mínima | Cefoperazona: Aislado : Punto temporal: Susceptibilidad (microorganismos): Ordinal Cuantitativo: Concentración mínima inhibitoria (MIC) | Cefoperazon [gevoeligheid] in isolaat d.m.v. minimaal inhiberende concentratie | Cefoperazone Islt MIC | |
10080-0 | S' wave dur L-V5 | duración de la onda S'.derivación V5:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda S. Plomo V5:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | S' onda dur L-V5 | |||
100800-2 | 21-Deoxycortisol 2nd specimen after challenge, Blood | 21-deoxycortisol^2de monster na XXX belasting [massa/volume] in serum | |||||
100801-0 | 21-Deoxycortisol 3rd specimen after challenge, Blood | 21-deoxycortisol^3de monster na XXX belasting [massa/volume] in serum | |||||
100802-8 | 21-Deoxycortisol 4th specimen after challenge, Blood | 21-deoxycortisol^4de monster na XXX belasting [massa/volume] in serum | |||||
100803-6 | 21-Deoxycortisol 5th specimen after challenge, Blood | 21-deoxycortisol^5de monster na XXX belasting [massa/volume] in serum | |||||
100804-4 | Vasopressin 1st specimen after challenge, Blood | Vasopressine^1ste monster na XXX belasting [mol/volume] in plasma | |||||
100805-1 | Vasopressin 2nd specimen after challenge, Blood | Vasopressine^2de monster na XXX belasting [mol/volume] in plasma | |||||
100806-9 | Vasopressin 3rd specimen after challenge, Blood | Vasopressine^3de monster na XXX belasting [mol/volume] in plasma | |||||
100807-7 | Vasopressin 4th specimen after challenge, Blood | Vasopressine^4de monster na XXX belasting [mol/volume] in plasma | |||||
100808-5 | Vasopressin 5th specimen after challenge, Blood | Vasopressine^5de monster na XXX belasting [mol/volume] in plasma | |||||
100809-3 | Vasopressin 6th specimen after challenge, Blood | Vasopressine^6de monster na XXX belasting [mol/volume] in plasma | |||||
100810-1 | Vasopressin 7th specimen after challenge, Blood | Vasopressine^7de monster na XXX belasting [mol/volume] in plasma | |||||
100811-9 | Vasopressin 8th specimen after challenge, Blood | Vasopressine^8ste monster na XXX belasting [mol/volume] in plasma | |||||
100812-7 | Vasopressin 9th specimen after challenge, Blood | Vasopressine^9de monster na XXX belasting [mol/volume] in plasma | |||||
100813-5 | Vasopressin 10th specimen after challenge, Blood | Vasopressine^10de monster na XXX belasting [mol/volume] in plasma | |||||
100814-3 | Vasopressin 11th specimen after challenge, Blood | Vasopressine^11de monster na XXX belasting [mol/volume] in plasma | |||||
100815-0 | Vasopressin 12th specimen after challenge, Blood | Vasopressine^12de monster na XXX belasting [mol/volume] in plasma | |||||
100816-8 | Glucagon 6th specimen after challenge, Blood | Glucagon^6de monster na XXX belasting [massa/volume] in serum of plasma | |||||
100817-6 | Glucagon 7th specimen after challenge, Blood | Glucagon^7de monster na XXX belasting [massa/volume] in serum of plasma | |||||
10081-8 | S' wave dur L-V6 | duración de la onda S'.derivación V6:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda S. Plomo V6:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | S' onda dur L-V6 | |||
100818-4 | Renin 1st specimen after challenge, Blood | Renine^1ste monster na XXX belasting [massa/volume] in plasma | |||||
100819-2 | Renin 2nd specimen after challenge, Blood | Renine^2de monster na XXX belasting [massa/volume] in plasma | |||||
1008-2 | Indirekter Coombs Test polyspezifisch | Indirect Antiglobulin Test (IAT; Indirect Coombs), Blood | prueba de antiglobulina indirecta.reactivo multiespecífico:concentración arbitraria:punto en el tiempo:suero/plasma:ordinal: | Prueba de antiglobulina indirecta, reactivo específico de poli: Suero o Plasma : Punto temporal: Presencia o umbral: Ordinal: | Indirecte antiglobulinetest.polyspecifiek reagent [aanwezigheid] in serum of plasma | IAT Poly-Sp Reag SerPl Ql | |
100820-0 | Renin 3rd specimen after challenge, Blood | Renine^3de monster na XXX belasting [massa/volume] in plasma | |||||
100821-8 | POLST panel | ||||||
100822-6 | Cardiopulmonary resuscitation orders | ||||||
100823-4 | Initial portable medical treatment orders | ||||||
100824-2 | Additional portable medical orders or instructions | ||||||
100825-9 | Medically assisted nutrition orders | ||||||
10082-6 | ST I-Amp 6ms L-AVF | amplitud inicial del segmento ST, 6 mseg.derivación AVF:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | ST amplitud inicial 6 ms plomo AVF:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | ST I-Amp 6ms L-AVF | |||
100826-7 | Portable medical order &or advance directive review | ||||||
100827-5 | Portable medical order discussion participants | ||||||
100828-3 | Portable medical order administrative information | ||||||
100829-1 | Renin 4th specimen after challenge, Blood | Renine^4de monster na XXX belasting [massa/volume] in plasma | |||||
100830-9 | Free alpha subunit 1st specimen after challenge, Blood | Alfa-subeenheid.vrij^1ste monster na XXX belasting [eenheid/volume] in serum of plasma | |||||
100831-7 | Free alpha subunit 2nd specimen after challenge, Blood | Alfa-subeenheid.vrij^2de monster na XXX belasting [eenheid/volume] in serum of plasma | |||||
100832-5 | Free alpha subunit 3rd specimen after challenge, Blood | Alfa-subeenheid.vrij^3de monster na XXX belasting [eenheid/volume] in serum of plasma | |||||
100833-3 | Free alpha subunit 4th specimen after challenge, Blood | Alfa-subeenheid.vrij^4de monster na XXX belasting [eenheid/volume] in serum of plasma | |||||
10083-4 | ST I-Amp 6ms L-AVL | amplitud inicial del segmento ST, 6 mseg.derivación AVL:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | ST amplitud inicial 6 ms plomo AVL:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | ST I-Amp 6ms L-AVL | |||
100834-1 | Free alpha subunit 5th specimen after challenge, Blood | Alfa-subeenheid.vrij^5de monster na XXX belasting [eenheid/volume] in serum of plasma | |||||
100835-8 | Free alpha subunit 6th specimen after challenge, Blood | Alfa-subeenheid.vrij^6de monster na XXX belasting [eenheid/volume] in serum of plasma | |||||
100836-6 | Free alpha subunit 7th specimen after challenge, Blood | Alfa-subeenheid.vrij^7de monster na XXX belasting [eenheid/volume] in serum of plasma | |||||
100837-4 | Insulin-like growth factor-I 9th specimen after challenge, Blood | Insulin-like growth factor-I^9de monster na XXX belasting [massa/volume] in serum of plasma | |||||
100838-2 | Testosterone 9th specimen after challenge, Blood | Testosteron^9de monster na XXX belasting [massa/volume] in serum of plasma | |||||
100839-0 | Vitamin A/Retinol binding protein, Blood | Retinol/retinolbindend eiwit [verhouding] in serum of plasma | |||||
100840-8 | IgE, Body fluid | IgE [eenheid/volume] in lichaamsvocht | |||||
100841-6 | Zinc finger protein of the cerebellum 4 antibody, Spinal fluid | Zinc finger proteïne of the cerebellum 4 As [aanwezigheid] in liquor cerebrospinalis d.m.v. lijnblot | |||||
10084-2 | ST I-Amp 6ms L-AVR | amplitud inicial del segmento ST, 6 mseg.derivación AVR:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | ST amplitud inicial 6 ms avance AVR:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | ST I-Amp 6ms L-AVR | |||
100842-4 | Nonalcoholic steatohepatitis score, Blood | ||||||
100843-2 | Liver fibrosis score, Blood | ||||||
100844-0 | Liver fibrosis score, Blood | ||||||
100845-7 | Neurofascin155 IgG4 antibody, Blood | Neurofascine155 As.IgG4 [aanwezigheid] in serum d.m.v. flowcytometrie | |||||
100846-5 | Dengue-Virus 1+2+3+4 nsP1 IgG IgG-Antikörper [Nachweis] in Serum oder Plasma mittels Immunoassay | Dengue virus 1+2+3+4 nsP1 IgG antibody, Blood | Denguevirus 1+2+3+4 niet-structureel proteïne 1 (nsP1) As.IgG [aanwezigheid] in serum of plasma d.m.v. immunoassay | ||||
100847-3 | Gas and ammonia panel, Blood | Gas en ammoniak panel in arterieel bloed | |||||
100848-1 | Cell count and Differential panel, Amniotic fluid | Celtelling & differentieel panel in vruchtwater d.m.v. manuele telling | |||||
100849-9 | White blood cell (WBC) count, Amniotic fluid | Leukocyten [aantal/volume] in vruchtwater d.m.v. manuele telling | |||||
100850-7 | Neutrophils, Amniotic fluid | Neutrofielen [aantal/volume] in vruchtwater d.m.v. manuele telling | |||||
100851-5 | Other cells, Amniotic fluid | Overige cellen [aantal/volume] in vruchtwater d.m.v. manuele telling | |||||
100852-3 | NM Bones Views for mets W Sr-89 IV | ||||||
100853-1 | NM Pericardial effusion | ||||||
100854-9 | Lymphocytes per 100 cells, Blood | Lymfocyten/100 cellen [getalsfractie] in mononucleaire cellen in bloed d.m.v. immunoassay | |||||
100855-6 | CD3 cells per 100 cells, Blood | Cellen.CD3/100 cellen [getalsfractie] in mononucleaire cellen in bloed | |||||
100856-4 | CD3+CD4+ (T4 Helper) Cells per 100 cells, Blood | Cellen.CD3+CD4+/100 cellen [getalsfractie] in mononucleaire cellen in bloed | |||||
100857-2 | CD3+CD8+ (T8 Suppressor) Cells per 100 cells, Blood | Cellen.CD3+CD8+/100 cellen [getalsfractie] in mononucleaire cellen in bloed | |||||
100858-0 | Zellen.CD4+CD154+/CD4-Zellen in Blut --nach Stimulierung mit SARS-CoV-2-Spike-Peptid | Cells.CD4+CD154+ /CD4 Cells - after stimulation with SARS-CoV-2 Spike peptide, Blood | Cellen.CD4+CD154+/cellen.CD4^na stimulatie met SARS-CoV-2 spike-peptide [getalsfractie] in bloed | ||||
10085-9 | ST I-Amp 6ms L-I | amplitud inicial del segmento ST, 6 mseg.derivación I:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | ST amplitud inicial 6 ms plomo I:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | ST I-Amp 6ms L-I | |||
100859-8 | Zellen.CD4.Interferon-gamma-exprimierend/CD4-Zellen in Blut --nach Stimulierung mit SARS-CoV-2-Spike-Peptid | Cells.CD4.Interferon gamma-expressing/CD4 Cells - after stimulation with SARS-CoV-2 Spike peptide, Blood | Cellen.CD4.interferon-gamma-positief/cellen.CD4^na stimulatie met SARS-CoV-2 spike-peptide [getalsfractie] in bloed | ||||
100860-6 | Zellen.CD4.Tumor-Nekrose-Faktor-alfa-exprimierend/CD4-Zellen in Blut --nach Stimulierung mit SARS-CoV-2-Spike-Peptid | Cells.CD4.Tumor necrosis factor alfa-expressing/CD4 Cells - after stimulation with SARS-CoV-2 Spike peptide, Blood | Cellen.CD4.tumornecrosefactor alfa-positief/cellen.CD4^na stimulatie met SARS-CoV-2 spike-peptide [getalsfractie] in bloed | ||||
100861-4 | Zellen.CD4+CD154+/CD4-Zellen in Blut --nach Stimulierung mit SARS-CoV-2-Nucleokapsid-Peptid | Cells.CD4+CD154+ /CD4 Cells - after stimulation with SARS-CoV-2 Nucleocapsid peptide, Blood | Cellen.CD4+CD154+/cellen.CD4^na stimulatie met SARS-CoV-2 nucleocapsidepeptide [getalsfractie] in bloed | ||||
100862-2 | Zellen.CD4.Interferon-gamma-exprimierend/CD4-Zellen in Blut --nach Stimulierung mit SARS-CoV-2-Nucleokapsid-Peptid | Cells.CD4.Interferon gamma-expressing/CD4 Cells - after stimulation with SARS-CoV-2 Nucleocapsid peptide, Blood | Cellen.CD4.interferon-gamma-positief/cellen.CD4^na stimulatie met SARS-CoV-2 nucleocapsidepeptide [getalsfractie] in bloed | ||||
100863-0 | Zellen.CD4.Tumor-Nekrose-Faktor-alfa-exprimierend/CD4-Zellen in Blut --nach Stimulierung mit SARS-CoV-2-Nucleokapsid-Peptid | Cells.CD4.Tumor necrosis factor alfa-expressing/CD4 Cells - after stimulation with SARS-CoV-2 Nucleocapsid peptide, Blood | Cellen.CD4.tumornecrosefactor alfa-positief/cellen.CD4^na stimulatie met SARS-CoV-2 nucleocapsidepeptide [getalsfractie] in bloed | ||||
100864-8 | Giardia lamblia bg-Gen [Genotyp] in Probenmaterial mittels Molekulargenetik | Giardia lamblia bg gene genotype, Specimen | Giardia lamblia bg-gen [genotype] d.m.v. moleculair genetisch onderzoek | ||||
100865-5 | Avian schistosomes, Specimen | Aviaire Schistosoma DNA [aanwezigheid] d.m.v. probe-detectie | |||||
100866-3 | Febrile antibody profile, Blood | ||||||
10086-7 | ST I-Amp 6ms L-II | amplitud inicial del segmento ST, 6 mseg.derivación II:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | ST amplitud inicial 6 ms plomo II:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | ST I-Amp 6ms L-II | |||
100867-1 | Campylobacter jejuni+coli+lari+upsaliensis Antigen [Nachweis] in Stuhl mittels Immunoassay-Schnelltest | Campylobacter jejuni+coli+lari+upsaliensis antigen, Stool | Campylobacter jejuni + coli + lari + upsaliensis Ag [aanwezigheid] in feces d.m.v. immunoassay.sneltest | ||||
100868-9 | Cryptosporidium sp 18S-LC2 rRNA [Genotyp] in Probenmaterial mittels Molekulargenetik | Cryptosporidium sp 18S-LC2 genotype, Specimen | Cryptosporidium sp. 18S-LC2 rRNA [genotype] d.m.v. moleculair genetisch onderzoek | ||||
100869-7 | Cryptosporidium gp60-Gen [Typ] in Probenmaterial mittels Molekulargenetik | Cryptosporidium gp60 gene, Specimen | Cryptosporidium gp60-gen [type] d.m.v. moleculair genetisch onderzoek | ||||
100870-5 | Cryptosporidium 18S rRNA [Genotyp] in Probenmaterial mittels Molekulargenetik | Cryptosporidium 18S genotype, Specimen | Cryptosporidium 18S rRNA [genotype] d.m.v. moleculair genetisch onderzoek | ||||
100871-3 | Giardia lamblia gdh-Gen [Genotyp] in Probenmaterial mittels Molekulargenetik | Giardia lamblia gdh gene genotype, Specimen | Giardia lamblia gdh-gen [genotype] d.m.v. moleculair genetisch onderzoek | ||||
100872-1 | Bacteria producing polysaccharide from sucrose | Uit sucrose polysacharideproducerende bacterie [aanwezigheid] in isolaat | |||||
100873-9 | Giardia lamblia tpi-Gen [Genotyp] in Probenmaterial mittels Molekulargenetik | Giardia lamblia tpi gene genotype, Specimen | Giardia lamblia tpi-gen [genotype] d.m.v. moleculair genetisch onderzoek | ||||
100874-7 | Basidiobolus sp, Specimen | Basidiobolus sp. [aanwezigheid] | |||||
10087-5 | ST I-Amp 6ms L-III | amplitud inicial del segmento ST, 6 mseg.derivación III:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | ST amplitud inicial 6 ms plomo III:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | ST I-Amp 6ms L-III | |||
100875-4 | Fet Hrt Doc Ltd US | ||||||
100876-2 | Fet Hrt Doc US | ||||||
100877-0 | US Heart Transesophageal during surgery | ||||||
100878-8 | Endo US study Upr GI Tract Doc | ||||||
100879-6 | US Guided Brst-R Cryoablation | ||||||
100880-4 | US Guided Brst-L Cryoablation | ||||||
100881-2 | MR Guided Bone Cryoablation | ||||||
100882-0 | MR Peritoneum W contr percu | ||||||
10088-3 | ST I-Amp 6ms L-V1 | amplitud inicial del segmento ST, 6 mseg.derivación V1:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | ST amplitud inicial 6 ms cable V1:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | Deprecated ST initial amp 6 ms.lead | |||
100883-8 | MR Guided Kidney-L Bx | ||||||
100884-6 | MR Guided Kidney-R Bx | ||||||
100885-3 | Parapoxvirus , Specimen | Parapoxvirus DNA [aanwezigheid] d.m.v. probe-detectie | |||||
100886-1 | Orf virus, Specimen | Orfvirus DNA [aanwezigheid] d.m.v. probe-detectie | |||||
100887-9 | Pseudocowpox virus, Specimen | Pseudokoepokvirus DNA [aanwezigheid] d.m.v. probe-detectie | |||||
100888-7 | Affenpocken-Virus Klade II DNA [Nachweis] in Probenmaterial mittels Nukleinsäureamplifikation mit Sondendetektion | Monkeypox virus clade II, Specimen | 'Mpox'-virus clade II DNA [aanwezigheid] d.m.v. probe-detectie | ||||
100889-5 | Affenpocken-Virus Klade I DNA [Nachweis] in Probenmaterial mittels Nukleinsäureamplifikation mit Sondendetektion | Monkeypox virus clade I, Specimen | 'Mpox'-virus clade I DNA [aanwezigheid] d.m.v. probe-detectie | ||||
100890-3 | Poxvirus DNA panel | Pokkenvirus DNA panel | |||||
10089-1 | ST I-Amp 6ms L-V2 | amplitud inicial del segmento ST, 6 mseg.derivación V2:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | ST amplitud inicial 6 ms. Derivación V2:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | ST I-Amp 6ms L-V2 | |||
100891-1 | Orthopoxvirus IgG-Antikörper [Nachweis] in Serum oder Plasma mittels Immunoassay | Orthopoxvirus IgG antibody, Blood | Orthopoxvirus As.IgG [aanwezigheid] in serum of plasma d.m.v. immunoassay | ||||
100892-9 | Orthopoxvirus IgM-Antikörper [Nachweis] in Serum oder Plasma mittels Immunoassay | Orthopoxvirus IgM antibody, Blood | Orthopoxvirus As.IgM [aanwezigheid] in serum of plasma d.m.v. immunoassay | ||||
100893-7 | Orthopoxvirus IgG & IgM Ab panel, Blood | Orthopoxvirus IgG & IgM As panel in serum of plasma | |||||
100894-5 | Recommended screen freq | ||||||
100895-2 | Rickettsia conorii IgG and IgM antibodies, Blood | Rickettsia conorii As.IgG & IgM [interpretatie] in serum | |||||
100896-0 | Vasopressin 13th specimen after challenge, Blood | Vasopressine^13de monster na XXX belasting [mol/volume] in plasma | |||||
100897-8 | Staphylococcus aureus culture, Specimen | Staphylococcus aureus [aanwezigheid] d.m.v. organisme-specifieke kweek | |||||
100898-6 | Lipid panel, Blood | Lipiden panel in serum of plasma | |||||
100899-4 | Enterobacteriaceae.extended spectrum beta lactamase resistance phenotype culture, Specimen | Enterobacteriaceae.ESBL-resistentie fenotype [identificator] d.m.v. organisme-specifieke kweek |
See the full registry of value sets defined as part of FHIR.
Explanation of the columns that may appear on this page:
Lvl | A few code lists that FHIR defines are hierarchical - each code is assigned a level. For value sets, levels are mostly used to organize codes for user convenience, but may follow code system hierarchy - see Code System for further information |
Source | The source of the definition of the code (when the value set draws in codes defined elsewhere) |
Code | The code (used as the code in the resource instance). If the code is in italics, this indicates that the code is not selectable ('Abstract') |
Display | The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application |
Definition | An explanation of the meaning of the concept |
Comments | Additional notes about how to use the code |